FN Clarivate Analytics Web of Science VR 1.0 PT J AU Leonardi, GC Oxnard, GR Haas, A Lana, JP Williams, JS Awad, MM AF Leonardi, Giulia C. Oxnard, Geoffrey R. Haas, Andrea Lana, Joshua P. Williams, Jonathan S. Awad, Mark M. TI Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non Small Cell Lung Cancer SO JOURNAL OF IMMUNOTHERAPY TC 0 Z9 0 SN 1524-9557 EI 1537-4513 PD JUL-AUG PY 2017 VL 40 IS 6 BP 249 EP 251 UT WOS:000404000500005 PM 28557813 ER PT J AU El-Khoueiry, AB Sangro, B Yau, T Crocenzi, TS Kudo, M Hsu, CN Kim, TY Choo, SP Trojan, J Welling, TH Meyer, T Kang, YK Yeo, W Chopra, A Anderson, J dela Cruz, C Lang, LX Neely, J Tang, H Dastani, HB Melero, I AF El-Khoueiry, Anthony B. Sangro, Bruno Yau, Thomas Crocenzi, Todd S. Kudo, Masatoshi Hsu, Chiun Kim, Tae-You Choo, Su-Pin Trojan, Jorg Welling, Theodore H., III Meyer, Tim Kang, Yoon-Koo Yeo, Winnie Chopra, Akhil Anderson, Jeffrey dela Cruz, Christine Lang, Lixin Neely, Jaclyn Tang, Hao Dastani, Homa B. Melero, Ignacio TI Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial SO LANCET TC 2 Z9 2 SN 0140-6736 EI 1474-547X PD JUN 24 PY 2017 VL 389 IS 10088 BP 2492 EP 2502 DI 10.1016/S0140-6736(17)31046-2 UT WOS:000403901800028 ER PT J AU Xiao, ZX Chen, RQ Hu, DX Xie, XQ Yu, SB Chen, XQ AF Xiao, Zui Xuan Chen, Ruo Qiao Hu, Dian Xing Xie, Xiao Qiang Yu, Shang Bin Chen, Xiao Qian TI Identification of repaglinide as a therapeutic drug for glioblastoma multiforme SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS TC 0 Z9 0 SN 0006-291X EI 1090-2104 PD JUN 17 PY 2017 VL 488 IS 1 BP 33 EP 39 DI 10.1016/j.bbrc.2017.04.157 UT WOS:000402587000006 PM 28476618 ER PT J AU Pyzik, A Grywalska, E Matyjaszek-Matuszek, B Smolen, A Pyzik, D Rolinski, J AF Pyzik, Aleksandra Grywalska, Ewelina Matyjaszek-Matuszek, Beata Smolen, Agata Pyzik, Dawid Rolinski, Jacek TI Frequencies of PD-1-positive T CD3+CD4+, T CD3+CD8+and B CD19+lymphocytes in female patients with Graves' disease and healthy controls preliminary study SO MOLECULAR AND CELLULAR ENDOCRINOLOGY TC 0 Z9 0 SN 0303-7207 PD JUN 15 PY 2017 VL 448 IS C BP 28 EP 33 DI 10.1016/j.mce.2017.03.006 UT WOS:000401218000003 PM 28284988 ER PT J AU Gay, CL Bosch, RJ Ritz, J Hataye, JM Aga, E Tressler, RL Mason, SW Hwang, CK Grasela, DM Ray, N Cyktor, JC Coffin, JM Acosta, EP Koup, RA Mellors, JW Eron, JJ AF Gay, Cynthia L. Bosch, Ronald J. Ritz, Justin Hataye, Jason M. Aga, Evgenia Tressler, Randall L. Mason, Stephen W. Hwang, Carey K. Grasela, Dennis M. Ray, Neelanjana Cyktor, Josh C. Coffin, John M. Acosta, Edward P. Koup, Richard A. Mellors, John W. Eron, Joseph J. CA AIDS Clinical Trials 5326 Study TI Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy SO JOURNAL OF INFECTIOUS DISEASES TC 0 Z9 0 SN 0022-1899 EI 1537-6613 PD JUN 1 PY 2017 VL 215 IS 11 BP 1725 EP 1733 DI 10.1093/infdis/jix191 UT WOS:000403230600016 ER PT J AU Sharabi, A Kim, SS Kato, S Sanders, PD Patel, SP Sanghvi, P Weihe, E Kurzrock, R AF Sharabi, Andrew Kim, Sangwoo Shawn Kato, Shumei Sanders, Philip D. Patel, Sandip Pravin Sanghvi, Parag Weihe, Elizabeth Kurzrock, Razelle TI Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center SO ONCOLOGIST TC 0 Z9 0 SN 1083-7159 EI 1549-490X PD JUN PY 2017 VL 22 IS 6 BP 631 EP 637 DI 10.1634/theoncologist.2016-0517 UT WOS:000403210700002 PM 28550027 ER PT J AU Ning, YM Suzman, D Maher, VE Zhang, LJ Tang, SH Ricks, T Palmby, T Fu, WT Liu, Q Goldberg, KB Kim, G Pazdur, R AF Ning, Yang-Min Suzman, Daniel Maher, V. Ellen Zhang, Lijun Tang, Shenghui Ricks, Tiffany Palmby, Todd Fu, Wentao Liu, Qi Goldberg, Kirsten B. Kim, Geoffrey Pazdur, Richard TI FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy SO ONCOLOGIST TC 0 Z9 0 SN 1083-7159 EI 1549-490X PD JUN PY 2017 VL 22 IS 6 BP 743 EP 748 DI 10.1634/theoncologist.2017-0087 UT WOS:000403210700016 PM 28424325 ER PT J AU Chintakuntlawar, AV Rumilla, KM Smith, CY Jenkins, SM Foote, RL Kasperbauer, JL Morris, JC Ryder, M Alsidawi, S Hilger, C Bible, KC AF Chintakuntlawar, Ashish V. Rumilla, Kandelaria M. Smith, Carin Y. Jenkins, Sarah M. Foote, Robert L. Kasperbauer, Jan L. Morris, John C. Ryder, Mabel Alsidawi, Samer Hilger, Crystal Bible, Keith C. TI Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 0 Z9 0 SN 0021-972X EI 1945-7197 PD JUN PY 2017 VL 102 IS 6 BP 1943 EP 1950 DI 10.1210/jc.2016-3756 UT WOS:000403139100019 PM 28324060 ER PT J AU Zarbo, A Belum, VR Sibaud, V Oudard, S Postow, MA Hsieh, JJ Motzer, RJ Busam, KJ Lacouture, ME AF Zarbo, A. Belum, V. R. Sibaud, V. Oudard, S. Postow, M. A. Hsieh, J. J. Motzer, R. J. Busam, K. J. Lacouture, M. E. TI Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors SO BRITISH JOURNAL OF DERMATOLOGY TC 1 Z9 1 SN 0007-0963 EI 1365-2133 PD JUN PY 2017 VL 176 IS 6 BP 1649 EP 1652 DI 10.1111/bjd.15237 UT WOS:000402794200055 PM 27943234 ER PT J AU Oda, T Sawada, Y Okada, E Yamaguchi, T Ohmori, S Haruyama, S Yoshioka, M Nakamura, M AF Oda, Tomoko Sawada, Yu Okada, Etsuko Yamaguchi, Takashi Ohmori, Shun Haruyama, Sanehito Yoshioka, Manabu Nakamura, Motonobu TI Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment SO JOURNAL OF DERMATOLOGY TC 0 Z9 0 SN 0385-2407 EI 1346-8138 PD JUN PY 2017 VL 44 IS 6 BP E144 EP E145 DI 10.1111/1346-8138.13797 UT WOS:000402791900019 PM 28295551 ER PT J AU Gambichler, T Strutzmann, S Tannapfel, A Susok, L AF Gambichler, Thilo Strutzmann, Stefanie Tannapfel, Andrea Susok, Laura TI Y Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade SO BMC CANCER TC 0 Z9 0 SN 1471-2407 PD MAY 12 PY 2017 VL 17 AR 327 DI 10.1186/s12885-017-3313-6 UT WOS:000401616400003 PM 28499411 ER PT J AU Mellah, CM Perez, MS Rey, MDS Garcia, MH AF Mizab Mellah, Chadia Sanchez Perez, Marta Santos Rey, Maria Dolores Hernandez Garcia, Marta TI Fulminant type 1 diabetes mellitus associated with pembrolizumab SO ENDOCRINOLOGIA DIABETES Y NUTRICION TC 0 Z9 0 SN 2530-0180 PD MAY PY 2017 VL 64 IS 5 BP 272 EP 273 UT WOS:000404372600006 ER PT J AU Maruyama, D Hatake, K Kinoshita, T Fukuhara, N Choi, I Taniwaki, M Ando, K Terui, Y Higuchi, Y Onishi, Y Abe, Y Kobayashi, T Shirasugi, Y Tobinai, K AF Maruyama, Dai Hatake, Kiyohiko Kinoshita, Tomohiro Fukuhara, Noriko Choi, Ilseung Taniwaki, Masafumi Ando, Kiyoshi Terui, Yasuhito Higuchi, Yusuke Onishi, Yasushi Abe, Yasunobu Kobayashi, Tsutomu Shirasugi, Yukari Tobinai, Kensei TI Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma SO CANCER SCIENCE TC 0 Z9 0 SN 1349-7006 PD MAY PY 2017 VL 108 IS 5 BP 1007 EP 1012 DI 10.1111/cas.13230 UT WOS:000402298000024 PM 28267244 ER PT J AU Ramjiawan, RR Griffioen, AW Duda, DG AF Ramjiawan, Rakesh R. Griffioen, Arjan W. Duda, Dan G. TI Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? SO ANGIOGENESIS TC 4 Z9 4 SN 0969-6970 EI 1573-7209 PD MAY PY 2017 VL 20 IS 2 SI SI BP 185 EP 204 DI 10.1007/s10456-017-9552-y UT WOS:000401851100002 PM 28361267 ER PT J AU Comstock, DE Nishino, M Giardino, AA AF Comstock, Dawn E. Nishino, Mizuki Giardino, Angela A. TI Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma SO JAMA ONCOLOGY TC 0 Z9 0 SN 2374-2437 EI 2374-2445 PD MAY PY 2017 VL 3 IS 5 BP 703 EP 704 DI 10.1001/jamaoncol.2016.6611 UT WOS:000401114700018 PM 28196215 ER PT J AU Koelzer, VH Glatz, K Bubendorf, L Weber, A Gaspert, A Cathomas, G Lugli, A Zippelius, A Kempf, W Mertz, KD AF Koelzer, V. H. Glatz, K. Bubendorf, L. Weber, A. Gaspert, A. Cathomas, G. Lugli, A. Zippelius, A. Kempf, W. Mertz, K. D. TI The pathology of adverse events with immune checkpoint inhibitors SO PATHOLOGE RI Kempf, Werner/A-4875-2008 TC 0 Z9 0 SN 0172-8113 EI 1432-1963 PD MAY PY 2017 VL 38 IS 3 BP 197 EP 207 DI 10.1007/s00292-017-0281-1 UT WOS:000401671000008 PM 28421272 ER PT J AU Kitajima, K Ashida, K Wada, N Suetsugu, R Takeichi, Y Sakamoto, S Uchi, H Matsushima, T Shiratsuchi, M Ohnaka, K Furue, M Nomura, M AF Kitajima, Keiko Ashida, Kenji Wada, Naoko Suetsugu, Ryoko Takeichi, Yukina Sakamoto, Shohei Uchi, Hiroshi Matsushima, Takamitsu Shiratsuchi, Motoaki Ohnaka, Keizo Furue, Masutaka Nomura, Masatoshi TI Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab SO JAPANESE JOURNAL OF CLINICAL ONCOLOGY TC 0 Z9 0 SN 0368-2811 EI 1465-3621 PD MAY PY 2017 VL 47 IS 5 BP 463 EP 466 DI 10.1093/jjco/hyx018 UT WOS:000400907100015 PM 28334791 ER PT J AU Karasaki, T Nagayama, K Kuwano, H Nitadori, J Sato, M Anraku, M Hosoi, A Matsushita, H Morishita, Y Kashiwabara, K Takazawa, M Ohara, O Kakimi, K Nakajima, J AF Karasaki, Takahiro Nagayama, Kazuhiro Kuwano, Hideki Nitadori, Jun-ichi Sato, Masaaki Anraku, Masaki Hosoi, Akihiro Matsushita, Hirokazu Morishita, Yasuyuki Kashiwabara, Kosuke Takazawa, Masaki Ohara, Osamu Kakimi, Kazuhiro Nakajima, Jun TI An Immunogram Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer SO JOURNAL OF THORACIC ONCOLOGY TC 1 Z9 1 SN 1556-0864 EI 1556-1380 PD MAY PY 2017 VL 12 IS 5 BP 791 EP 803 DI 10.1016/j.jtho.2017.01.005 UT WOS:000400323800006 PM 28088513 ER PT J AU Ascierto, PA Del Vecchio, M Robert, C Mackiewicz, A Chiarion-Sileni, V Arance, A Lebbe, C Bastholt, L Hamid, O Rutkowski, P McNeil, C Garbe, C Loquai, C Dreno, B Thomas, L Grob, JJ Liszkay, G Nyakas, M Gutzmer, R Pikiel, J Grange, F Hoeller, C Ferraresi, V Smylie, M Schadendorf, D Mortier, L Svane, IM Hennicken, D Qureshi, A Maio, M AF Ascierto, Paolo A. Del Vecchio, Michele Robert, Caroline Mackiewicz, Andrzej Chiarion-Sileni, Vanna Arance, Ana Lebbe, Celeste Bastholt, Lars Hamid, Omid Rutkowski, Piotr McNeil, Catriona Garbe, Claus Loquai, Carmen Dreno, Brigitte Thomas, Luc Grob, Jean-Jacques Liszkay, Gabriella Nyakas, Marta Gutzmer, Ralf Pikiel, Joanna Grange, Florent Hoeller, Christoph Ferraresi, Virginia Smylie, Michael Schadendorf, Dirk Mortier, Laurent Svane, Inge Marie Hennicken, Delphine Qureshi, Anila Maio, Michele TI Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial SO LANCET ONCOLOGY OI Svane, Inge Marie/0000-0002-9451-6037 TC 1 Z9 1 SN 1470-2045 EI 1474-5488 PD MAY PY 2017 VL 18 IS 5 BP 611 EP 622 DI 10.1016/S1470-2045(17)30231-0 UT WOS:000400401100049 PM 28359784 ER PT J AU Alley, EW Lopez, J Santoro, A Morosky, A Saraf, S Piperdi, B van Brummelen, E AF Alley, Evan W. Lopez, Juanita Santoro, Armando Morosky, Anne Saraf, Sanatan Piperdi, Bilal van Brummelen, Emilie TI Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial SO LANCET ONCOLOGY TC 1 Z9 1 SN 1470-2045 EI 1474-5488 PD MAY PY 2017 VL 18 IS 5 BP 623 EP 630 DI 10.1016/S1470-2045(17)30169-9 UT WOS:000400401100050 PM 28291584 ER PT J AU Zhao, P Atanackovic, D Dong, SY Yagita, HD He, X Chen, MN AF Zhao, Peng Atanackovic, Djordje Dong, Shuyun Yagita, Hideo He, Xiao Chen, Mingnan TI An Anti-Programmed Death-1 Antibody (alpha PD-1) Fusion Protein That Self-Assembles into a Multivalent and Functional alpha PD-1 Nanoparticle SO MOLECULAR PHARMACEUTICS TC 0 Z9 0 SN 1543-8384 PD MAY PY 2017 VL 14 IS 5 BP 1494 EP 1500 UT WOS:000400633300017 PM 28343398 ER PT J AU Teramoto, Y Nakamura, Y Asami, Y Imamura, T Takahira, S Nemoto, M Sakai, G Shimada, A Noda, M Yamamoto, A AF Teramoto, Yukiko Nakamura, Yasuhiro Asami, Yuri Imamura, Taichi Takahira, Shuji Nemoto, Manabu Sakai, Gota Shimada, Akira Noda, Mitsuhiko Yamamoto, Akifumi TI Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient SO JOURNAL OF DERMATOLOGY TC 3 Z9 3 SN 0385-2407 EI 1346-8138 PD MAY PY 2017 VL 44 IS 5 SI SI BP 605 EP + DI 10.1111/1346-8138.13486 UT WOS:000400187800043 PM 27334247 ER PT J AU Reu, S Huber, RM AF Reu, Simone Huber, Rudolf M. TI Small cell lung cancer SO ONKOLOGE TC 0 Z9 0 SN 0947-8965 EI 1433-0415 PD MAY PY 2017 VL 23 IS 5 BP 340 EP 346 DI 10.1007/s00761-017-0203-0 UT WOS:000399878200004 ER PT J AU Bernier, M Guillaume, C Leon, N Alexandre, J Hamel-Senecal, L Chretien, B Lecaignec, F Humbert, X Fedrizzi, S Madelaine, J Sassier, M AF Bernier, Marjorie Guillaume, Cyril Leon, Nathalie Alexandre, Joachim Hamel-Senecal, Lea Chretien, Basile Lecaignec, Florian Humbert, Xavier Fedrizzi, Sophie Madelaine, Jeannick Sassier, Marion TI Nivolumab Causing a Polymyalgia Rheumatica in a Patient With a Squamous Non-Small Cell Lung Cancer SO JOURNAL OF IMMUNOTHERAPY TC 0 Z9 0 SN 1524-9557 EI 1537-4513 PD MAY PY 2017 VL 40 IS 4 BP 129 EP 131 DI 10.1097/CJI.0000000000000163 UT WOS:000398850800002 ER PT J AU Larsabal, M Marti, A Jacquemin, C Rambert, J Thiolat, D Dousset, L Taieb, A Dutriaux, C Prey, S Boniface, K Seneschal, J AF Larsabal, Maiana Marti, Aurelie Jacquemin, Clement Rambert, Jerome Thiolat, Denis Dousset, Lea Taieb, Alain Dutriaux, Caroline Prey, Sorilla Boniface, Katia Seneschal, Julien TI Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY TC 1 Z9 1 SN 0190-9622 PD MAY PY 2017 VL 76 IS 5 BP 863 EP 870 DI 10.1016/j.jaad.2016.10.044 UT WOS:000399217200028 PM 28094061 ER PT J AU Vigarios, E Epstein, JB Sibaud, V AF Vigarios, Emmanuelle Epstein, Joel B. Sibaud, Vincent TI Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors SO SUPPORTIVE CARE IN CANCER TC 1 Z9 1 SN 0941-4355 EI 1433-7339 PD MAY PY 2017 VL 25 IS 5 BP 1713 EP 1739 DI 10.1007/s00520-017-3629-4 UT WOS:000399153200040 PM 28224235 ER PT J AU Kroschinsky, F Stolzel, F von Bonin, S Beutel, G Kochanek, M Kiehl, M Schellongowski, P AF Kroschinsky, Frank Stoelzel, Friedrich von Bonin, Simone Beutel, Gernot Kochanek, Matthias Kiehl, Michael Schellongowski, Peter CA Intensive Care Hematological Oncol TI New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management SO CRITICAL CARE TC 0 Z9 0 SN 1466-609X EI 1364-8535 PD APR 14 PY 2017 VL 21 AR 89 DI 10.1186/s13054-017-1678-1 UT WOS:000399361200001 PM 28407743 ER PT J AU Allen, E Jabouille, A Rivera, LB Lodewijckx, I Missiaen, R Steri, V Feyen, K Tawney, J Hanahan, D Michael, IP Bergers, G AF Allen, Elizabeth Jabouille, Arnaud Rivera, Lee B. Lodewijckx, Inge Missiaen, Rindert Steri, Veronica Feyen, Kevin Tawney, Jaime Hanahan, Douglas Michael, Iacovos P. Bergers, Gabriele TI Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation SO SCIENCE TRANSLATIONAL MEDICINE TC 2 Z9 2 SN 1946-6234 EI 1946-6242 PD APR 12 PY 2017 VL 9 IS 385 AR eaak9679 DI 10.1126/scitranslmed.aak9679 UT WOS:000399009200006 ER PT J AU Schmittnaegel, M Rigamonti, N Kadioglu, E Cassara, A Rmili, CW Kiialainen, A Kienast, Y Mueller, HJ Ooi, CH Laoui, D De Palma, M AF Schmittnaegel, Martina Rigamonti, Nicolo Kadioglu, Ece Cassara, Antonino Rmili, Celine Wyser Kiialainen, Anna Kienast, Yvonne Mueller, Hans-Joachim Ooi, Chia-Huey Laoui, Damya De Palma, Michele TI Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade SO SCIENCE TRANSLATIONAL MEDICINE TC 2 Z9 2 SN 1946-6234 EI 1946-6242 PD APR 12 PY 2017 VL 9 IS 385 AR eaak9670 DI 10.1126/scitranslmed.aak9670 UT WOS:000399009200005 ER PT J AU Alhusseini, M Samantray, J AF Alhusseini, M. Samantray, J. TI Hypothyroidism in Cancer Patients on Immune Checkpoint Inhibitors with anti-PD1 Agents: Insights on Underlying Mechanisms SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES TC 0 Z9 0 SN 0947-7349 EI 1439-3646 PD APR PY 2017 VL 125 IS 4 BP 267 EP 269 DI 10.1055/s-0042-119528 UT WOS:000400482900010 PM 28073132 ER PT J AU Hickmott, L De La Pena, H Turner, H Ahmed, F Protheroe, A Grossman, A Gupta, A AF Hickmott, Laura De La Pena, Hugo Turner, Helen Ahmed, Fathelrahman Protheroe, Andrew Grossman, Ashley Gupta, Avinash TI Anti-PD-L1 atezolizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Literature SO TARGETED ONCOLOGY TC 0 Z9 0 SN 1776-2596 EI 1776-260X PD APR PY 2017 VL 12 IS 2 BP 235 EP 241 DI 10.1007/s11523-017-0480-y UT WOS:000398947800010 PM 28255845 ER PT J AU Yamazaki, N Takenouchi, T Fujimoto, M Ihn, H Uchi, H Inozume, T Kiyohara, Y Uhara, H Nakagawa, K Furukawa, H Wada, H Noguchi, K Shimamoto, T Yokota, K AF Yamazaki, Naoya Takenouchi, Tatsuya Fujimoto, Manabu Ihn, Hironobu Uchi, Hiroshi Inozume, Takashi Kiyohara, Yoshio Uhara, Hisashi Nakagawa, Kazuhiko Furukawa, Hiroshi Wada, Hidefumi Noguchi, Kazuo Shimamoto, Takashi Yokota, Kenji TI Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041) SO CANCER CHEMOTHERAPY AND PHARMACOLOGY TC 0 Z9 0 SN 0344-5704 EI 1432-0843 PD APR PY 2017 VL 79 IS 4 BP 651 EP 660 DI 10.1007/s00280-016-3237-x UT WOS:000398820000002 PM 28283736 ER PT J AU De Velasco, G Je, YJ Bosse, D Awad, MM Ott, PA Moreira, RB Schutz, F Bellmunt, J Sonpavde, GP Hodi, FS Choueiri, TK AF De Velasco, Guillermo Je, Youjin Bosse, Dominick Awad, Mark M. Ott, Patrick A. Moreira, Raphael B. Schutz, Fabio Bellmunt, Joaquim Sonpavde, Guru P. Hodi, F. Stephen Choueiri, Toni K. TI Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients SO CANCER IMMUNOLOGY RESEARCH OI de velasco, Guillermo/0000-0002-8075-0666 TC 0 Z9 0 SN 2326-6066 EI 2326-6074 PD APR PY 2017 VL 5 IS 4 BP 312 EP 318 DI 10.1158/2326-6066.CIR-16-0237 UT WOS:000398814100007 PM 28246107 ER PT J AU Narahira, A Yanagi, T Cho, KY Nakamura, A Miyoshi, H Hata, H Imafuku, K Kitamura, S Shimizu, H AF Narahira, Atsushi Yanagi, Teruki Cho, Kyu Yong Nakamura, Akinobu Miyoshi, Hideaki Hata, Hiroo Imafuku, Keisuke Kitamura, Shinya Shimizu, Hiroshi TI Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy SO JOURNAL OF DERMATOLOGY OI Yanagi, Teruki/0000-0003-2196-7600 TC 1 Z9 1 SN 0385-2407 EI 1346-8138 PD APR PY 2017 VL 44 IS 4 BP E70 EP E70 DI 10.1111/1346-8138.13571 UT WOS:000398690600010 PM 27608187 ER PT J AU Morganstein, DL Lai, Z Spain, L Diem, S Levine, D Mace, C Gore, M Larkin, J AF Morganstein, D. L. Lai, Z. Spain, L. Diem, S. Levine, D. Mace, C. Gore, M. Larkin, J. TI Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma SO CLINICAL ENDOCRINOLOGY TC 0 Z9 0 SN 0300-0664 EI 1365-2265 PD APR PY 2017 VL 86 IS 4 BP 614 EP 620 DI 10.1111/cen.13297 UT WOS:000397465800021 PM 28028828 ER PT J AU Lomax, AJ McNeil, C AF Lomax, Anna J. McNeil, Catriona TI Acute management of autoimmune toxicity in cancer patients on immunotherapy: Common toxicities and the approach for the emergency physician SO EMERGENCY MEDICINE AUSTRALASIA TC 0 Z9 0 SN 1742-6731 EI 1742-6723 PD APR PY 2017 VL 29 IS 2 BP 245 EP 251 DI 10.1111/1742-6723.12718 UT WOS:000397212800023 PM 28093870 ER PT J AU Kyriacou, A Gnanalingham, K Kearney, T AF Kyriacou, Angelos Gnanalingham, Kanna Kearney, Tara TI Lymphocytic hypophysitis: modern day management with limited role for surgery SO PITUITARY TC 0 Z9 0 SN 1386-341X EI 1573-7403 PD APR PY 2017 VL 20 IS 2 BP 241 EP 250 DI 10.1007/s11102-016-0769-3 UT WOS:000398474800009 PM 27778295 ER PT J AU Shi, RL Qu, N Luo, TX Xiang, J Liao, T Sun, GH Wang, Y Wang, YL Huang, CP Ji, QH AF Shi, Rong-liang Qu, Ning Luo, Ting-xian Xiang, Jun Liao, Tian Sun, Guo-hua Wang, Yu Wang, Yu-long Huang, Cai-ping Ji, Qing-hai TI Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence SO THYROID TC 1 Z9 1 SN 1050-7256 EI 1557-9077 PD APR PY 2017 VL 27 IS 4 BP 537 EP 545 DI 10.1089/thy.2016.0228 UT WOS:000398444900010 PM 27825291 ER PT J AU Morris, VK Salem, ME Nimeiri, H Iqbal, S Singh, P Ciombor, K Polite, B Deming, D Chan, E Wade, JL Xiao, LC Bekaii-Saab, T Vence, L Blando, J Mahvash, A Foo, WC Ohaji, C Pasia, M Bland, G Ohinata, A Rogers, J Mehdizadeh, A Banks, K Lanman, R Wolff, RA Streicher, H Allison, J Sharma, P Eng, C AF Morris, Van K. Salem, Mohamed E. Nimeiri, Halla Iqbal, Syma Singh, Preet Ciombor, Kristen Polite, Blase Deming, Dustin Chan, Emily Wade, James L. Xiao, Lianchun Bekaii-Saab, Tanios Vence, Luis Blando, Jorge Mahvash, Armeen Foo, Wai Chin Ohaji, Chimela Pasia, Manolo Bland, Gail Ohinata, Aki Rogers, Jane Mehdizadeh, Amir Banks, Kimberly Lanman, Richard Wolff, Robert A. Streicher, Howard Allison, James Sharma, Padmanee Eng, Cathy TI Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study SO LANCET ONCOLOGY TC 0 Z9 0 SN 1470-2045 EI 1474-5488 PD APR PY 2017 VL 18 IS 4 BP 446 EP 453 DI 10.1016/S1470-2045(17)30104-3 UT WOS:000397762000033 PM 28223062 ER PT J AU Brunet-Possenti, F Opsomer, MA Gomez, L Ouzaid, I Descamps, V AF Brunet-Possenti, F. Opsomer, M. A. Gomez, L. Ouzaid, I. Descamps, V. TI Immune checkpoint inhibitors-related orchitis SO ANNALS OF ONCOLOGY TC 0 Z9 0 SN 0923-7534 EI 1569-8041 PD APR PY 2017 VL 28 IS 4 BP 906 EP 907 DI 10.1093/annonc/mdw696 UT WOS:000397622100043 PM 28039179 ER PT J AU Byun, DJ Wolchok, JD Rosenberg, LM Girotra, M AF Byun, David J. Wolchok, Jedd D. Rosenberg, Lynne M. Girotra, Monica TI Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies SO NATURE REVIEWS ENDOCRINOLOGY TC 1 Z9 1 SN 1759-5029 EI 1759-5037 PD APR PY 2017 VL 13 IS 4 BP 195 EP 207 DI 10.1038/nrendo.2016.205 UT WOS:000396002800003 PM 28106152 ER PT J AU Li, XZ Xu, P Wang, CS Xu, NJ Xu, AB Xu, YW Sadahira, T Araki, M Wada, K Matsuura, E Watanabe, M Zheng, JX Sun, PH Huang, P Nasu, Y Liu, CX AF Li, Xiezhao Xu, Peng Wang, Chongshan Xu, Naijin Xu, Abai Xu, Yawen Sadahira, Takuya Araki, Motoo Wada, Koichiro Matsuura, Eiji Watanabe, Masami Zheng, Junxia Sun, Pinghua Huang, Peng Nasu, Yasutomo Liu, Chunxiao TI Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma SO ONCOTARGET TC 0 Z9 0 SN 1949-2553 PD MAR 28 PY 2017 VL 8 IS 13 BP 21177 EP 21186 DI 10.18632/oncotarget.15505 UT WOS:000397642400056 PM 28416753 ER PT J AU Chen, F Zhang, Y Parra, E Rodriguez, J Behrens, C Akbani, R Lu, Y Kurie, JM Gibbons, DL Mills, GB Wistuba, II Creighton, CJ AF Chen, F. Zhang, Y. Parra, E. Rodriguez, J. Behrens, C. Akbani, R. Lu, Y. Kurie, J. M. Gibbons, D. L. Mills, G. B. Wistuba, I. I. Creighton, C. J. TI Multiplatform-based molecular subtypes of non-small-cell lung cancer SO ONCOGENE TC 0 Z9 0 SN 0950-9232 EI 1476-5594 PD MAR 9 PY 2017 VL 36 IS 10 BP 1384 EP 1393 DI 10.1038/onc.2016.303 UT WOS:000395862500007 PM 27775076 ER PT J AU Lin, HH Gutenberg, A Chen, TY Tsai, NM Lee, CJ Cheng, YC Cheng, WH Tzou, YM Caturegli, P Tzou, SC AF Lin, Han-Huei Gutenberg, Angelika Chen, Tzu-Yu Tsai, Nu-Man Lee, Chia-Jung Cheng, Yu-Che Cheng, Wen-Hui Tzou, Ywh-Min Caturegli, Patrizio Tzou, Shey-Cherng TI In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis SO SCIENTIFIC REPORTS TC 0 Z9 0 SN 2045-2322 PD MAR 6 PY 2017 VL 7 AR 43492 DI 10.1038/srep43492 UT WOS:000395428000001 PM 28262761 ER PT J AU Ishikawa, K Shono-Saito, T Yamate, T Kai, Y Sakai, T Shimizu, F Yamada, Y Mori, H Noso, S Ikegami, H Kojima, H Tanaka, H Fujiwara, S Hatano, Y AF Ishikawa, Kazushi Shono-Saito, Tomoko Yamate, Tomoko Kai, Yoshitaka Sakai, Takashi Shimizu, Fumiaki Yamada, Yasunari Mori, Hiromu Noso, Shinsuke Ikegami, Hiroshi Kojima, Hiroto Tanaka, Hidenori Fujiwara, Sakuhei Hatano, Yutaka TI A case of fulminant type 1 diabetes mellitus, with a precipitous decrease in pancreatic volume, induced by nivolumab for malignant melanoma: analysis of HLA and CTLA-4 polymorphisms SO EUROPEAN JOURNAL OF DERMATOLOGY TC 0 Z9 0 SN 1167-1122 EI 1952-4013 PD MAR PY 2017 VL 27 IS 2 BP 184 EP 185 DI 10.1684/ejd.2016.2923 UT WOS:000400143700017 PM 27934619 ER PT J AU Thoreau, B Gouaillier-Vulcain, F Machet, L Mateus, C Robert, C Ferreira-Maldent, N Maillot, F Lioger, B AF Thoreau, Benjamin Gouaillier-Vulcain, Flora Machet, Laurent Mateus, Christine Robert, Caroline Ferreira-Maldent, Nicole Maillot, Francois Lioger, Bertrand TI Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma SO ACTA DERMATO-VENEREOLOGICA OI thoreau, benjamin/0000-0002-9046-4524 TC 0 Z9 0 SN 0001-5555 EI 1651-2057 PD MAR PY 2017 VL 97 IS 3 BP 408 EP 409 DI 10.2340/00015555-2504 UT WOS:000398919200030 PM 27377178 ER PT J AU Osorio, JC Ni, A Chaft, JE Pollina, R Kasler, MK Stephens, D Rodriguez, C Cambridge, L Rizvi, H Wolchok, JD Merghoub, T Rudin, CM Fish, S Hellmann, MD AF Osorio, J. C. Ni, A. Chaft, J. E. Pollina, R. Kasler, M. K. Stephens, D. Rodriguez, C. Cambridge, L. Rizvi, H. Wolchok, J. D. Merghoub, T. Rudin, C. M. Fish, S. Hellmann, M. D. TI Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer SO ANNALS OF ONCOLOGY OI Osorio, Juan C/0000-0001-8090-1551 TC 1 Z9 1 SN 0923-7534 EI 1569-8041 PD MAR PY 2017 VL 28 IS 3 BP 583 EP 589 DI 10.1093/annonc/mdw640 UT WOS:000397300100024 PM 27998967 ER PT J AU Fujimura, T Kambayashi, Y Furudate, S Kakizaki, A Hidaka, T Haga, T Hashimoto, A Morimoto, R Aiba, S AF Fujimura, Taku Kambayashi, Yumi Furudate, Sadanori Kakizaki, Aya Hidaka, Takanori Haga, Takahiro Hashimoto, Akira Morimoto, Ryo Aiba, Setsuya TI Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient SO JOURNAL OF DERMATOLOGY TC 1 Z9 1 SN 0385-2407 EI 1346-8138 PD MAR PY 2017 VL 44 IS 3 SI SI BP E13 EP E14 DI 10.1111/1346-8138.13532 UT WOS:000398084600007 PM 27440178 ER PT J AU da Silva, A Qian, ZR Zhang, S Masugi, Y Rodig, S Brais, L Dutton, T Chan, J Hodi, S Ogino, S Kulke, M AF da Silva, Annacarolina Qian, Zhirong Zhang, Sui Masugi, Yohei Rodig, Scott Brais, Lauren Dutton, Trevor Chan, Jennifer Hodi, Stephen Ogino, Shuji Kulke, Matthew TI Immune Checkpoint Markers and Immune Response in Well Differentiated Neuroendocrine Tumors (NET) of the Small Intestine and Pancreas SO PANCREAS TC 0 Z9 0 SN 0885-3177 EI 1536-4828 PD MAR PY 2017 VL 46 IS 3 BP 427 EP 427 UT WOS:000394448600030 ER PT J AU Farrell, CM Casasola, R Pearson, EZ Schofield, C AF Farrell, C. M. Casasola, R. Pearson, E. Z. Schofield, C. TI Acute onset Type 1 diabetes precipitated by Pembrolizumab, an anti-PD-1 monoclonal antibody used as a treatment for melanoma SO DIABETIC MEDICINE TC 0 Z9 0 SN 0742-3071 EI 1464-5491 PD MAR PY 2017 VL 34 SU 1 SI SI MA P205 BP 95 EP 95 UT WOS:000395717800235 ER PT J AU Daltry, S Bujanova, J Cranston, I AF Daltry, S. Bujanova, J. Cranston, I. TI Autoimmune diabetes and anti-programmed cell death-1 (anti-PD-1) cancer immunotherapy SO DIABETIC MEDICINE TC 0 Z9 0 SN 0742-3071 EI 1464-5491 PD MAR PY 2017 VL 34 SU 1 SI SI MA P230 BP 102 EP 102 UT WOS:000395717800259 ER PT J AU Shang, YH Zhang, Y Li, JH Li, P Zhang, X AF Shang, Yan Hong Zhang, Yu Li, Jing Hua Li, Peng Zhang, Xi TI Risk of endocrine adverse events in cancer patients treated with PD-1 inhibitors: a systematic review and meta-analysis SO IMMUNOTHERAPY TC 1 Z9 1 SN 1750-743X EI 1750-7448 PD MAR PY 2017 VL 9 IS 3 BP 261 EP 272 DI 10.2217/imt-2016-0147 UT WOS:000395305700005 PM 28231723 ER PT J AU Munakata, W Ohashi, K Yamauchi, N Tobinai, K AF Munakata, Wataru Ohashi, Ken Yamauchi, Nobuhiko Tobinai, Kensei TI Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphoma SO INTERNATIONAL JOURNAL OF HEMATOLOGY TC 4 Z9 4 SN 0925-5710 EI 1865-3774 PD MAR PY 2017 VL 105 IS 3 BP 383 EP 386 DI 10.1007/s12185-016-2101-4 UT WOS:000394996300021 PM 27696192 ER PT J AU Imafuku, K Yoshino, K Yamaguchi, K Tsuboi, S Ohara, K Hata, H AF Imafuku, K. Yoshino, K. Yamaguchi, K. Tsuboi, S. Ohara, K. Hata, H. TI Hypothyroidism associated with nivolumab treatment of unresectable malignant melanoma SO CLINICAL AND EXPERIMENTAL DERMATOLOGY TC 0 Z9 0 SN 0307-6938 EI 1365-2230 PD MAR PY 2017 VL 42 IS 2 BP 217 EP 218 DI 10.1111/ced.13028 UT WOS:000393959700025 PM 28052364 ER PT J AU Heinzerling, L Goldinger, SM AF Heinzerling, Lucie Goldinger, Simone M. TI A review of serious adverse effects under treatment with checkpoint inhibitors SO CURRENT OPINION IN ONCOLOGY TC 1 Z9 1 SN 1040-8746 EI 1531-703X PD MAR PY 2017 VL 29 IS 2 BP 136 EP 144 DI 10.1097/CCO.0000000000000358 UT WOS:000394378300008 PM 28059853 ER PT J AU Weber, JS Hodi, FS Wolchok, JD Topalian, SL Schadendorf, D Larkin, J Sznol, M Long, GV Li, HW Waxman, IM Jiang, J Robert, C AF Weber, Jeffrey S. Hodi, F. Stephen Wolchok, Jedd D. Topalian, Suzanne L. Schadendorf, Dirk Larkin, James Sznol, Mario Long, Georgina V. Li, Hewei Waxman, Ian M. Jiang, Joel Robert, Caroline TI Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma SO JOURNAL OF CLINICAL ONCOLOGY TC 6 Z9 6 SN 0732-183X EI 1527-7755 PD MAR 1 PY 2017 VL 35 IS 7 BP 785 EP + DI 10.1200/JCO.2015.66.1389 UT WOS:000396366100013 PM 28068177 ER PT J AU Coens, C Suciu, S Chiarion-Sileni, V Grob, JJ Dummer, R Wolchok, JD Schmidt, H Hamid, O Robert, C Ascierto, PA Richards, JM Lebbe, C Ferraresi, V Smylie, M Weber, JS Maio, M Bottomley, A Kotapati, S de Pril, V Testori, A Eggermont, AMM AF Coens, Corneel Suciu, Stefan Chiarion-Sileni, Vanna Grob, Jean-Jacques Dummer, Reinhard Wolchok, Jedd D. Schmidt, Henrik Hamid, Omid Robert, Caroline Ascierto, Paolo A. Richards, Jon M. Lebbe, Celeste Ferraresi, Virginia Smylie, Michael Weber, Jeffrey S. Maio, Michele Bottomley, Andrew Kotapati, Srividya de Pril, Veerle Testori, Alessandro Eggermont, Alexander M. M. TI Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial SO LANCET ONCOLOGY TC 1 Z9 1 SN 1470-2045 EI 1474-5488 PD MAR PY 2017 VL 18 IS 3 BP 393 EP 403 DI 10.1016/S1470-2045(17)30015-3 UT WOS:000396344600050 PM 28162999 ER PT J AU Rzechorzek, NM Liuti, T Stalin, C Marioni-Henry, K AF Rzechorzek, Nina Marie Liuti, Tiziana Stalin, Catherine Marioni-Henry, Katia TI Restored vision in a young dog following corticosteroid treatment of presumptive hypophysitis SO BMC VETERINARY RESEARCH TC 0 Z9 0 SN 1746-6148 PD FEB 28 PY 2017 VL 13 AR 63 DI 10.1186/s12917-017-0983-x UT WOS:000397158700001 PM 28241874 ER PT J AU Kumar, V Chaudhary, N Garg, M Floudas, CS Soni, P Chandra, AB AF Kumar, Vivek Chaudhary, Neha Garg, Mohit Floudas, Charalampos S. Soni, Parita Chandra, Abhinav B. TI Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy SO FRONTIERS IN PHARMACOLOGY TC 1 Z9 1 SN 1663-9812 PD FEB 8 PY 2017 VL 8 AR 49 DI 10.3389/fphar.2017.00049 UT WOS:000393708400001 PM 28228726 ER PT J AU Moretti, S Menicali, E Nucci, N Voce, P Colella, R Melillo, RM Liotti, F Morelli, S Fallarino, F Macchiarulo, A Santoro, M Avenia, N Puxeddu, E AF Moretti, Sonia Menicali, Elisa Nucci, Nicole Voce, Pasquale Colella, Renato Melillo, Rosa Marina Liotti, Federica Morelli, Silvia Fallarino, Francesca Macchiarulo, Antonio Santoro, Massimo Avenia, Nicola Puxeddu, Efisio TI Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1 SO JOURNAL OF BIOLOGICAL CHEMISTRY RI Macchiarulo , Antonio /L-2846-2017 OI Macchiarulo , Antonio /0000-0001-9535-4183 TC 0 Z9 0 SN 0021-9258 EI 1083-351X PD FEB 3 PY 2017 VL 292 IS 5 BP 1785 EP 1797 DI 10.1074/jbc.M116.745448 UT WOS:000395515600020 PM 27994058 ER PT J AU McElduff, A AF McElduff, Aidan TI THE EFFECT OF PD-1 INHIBITORS ON ENDOCRINE FUNCTION SO ENDOCRINE PRACTICE TC 0 Z9 0 SN 1530-891X EI 1934-2403 PD FEB PY 2017 VL 23 IS 2 BP 239 EP 240 UT WOS:000397862800013 PM 28199153 ER PT J AU Alhusseini, M Samantray, J AF Alhusseini, M. Samantray, J. TI Autoimmune diabetes superimposed on type 2 diabetes in a patient initiated on immunotherapy for lung cancer SO DIABETES & METABOLISM TC 0 Z9 0 SN 1262-3636 EI 1878-1780 PD FEB PY 2017 VL 43 IS 1 BP 86 EP 88 DI 10.1016/j.diabet.2016.05.007 UT WOS:000395356800012 PM 27291328 ER PT J AU Ahn, S Kim, TH Kim, SW Ki, CS Jang, HW Kim, JS Kim, JH Choe, JH Shin, JH Hahn, SY Oh, YL Chung, JL AF Ahn, Soomin Kim, Tae Hyuk Kim, Sun Wook Ki, Chang Seok Jang, Hye Won Kim, Jee Soo Kim, Jung Han Choe, Jun-Ho Shin, Jung Hee Hahn, Soo Yeon Oh, Young Lyun Chung, Jae Loon TI Comprehensive screening for PD-L1 expression in thyroid cancer SO ENDOCRINE-RELATED CANCER RI KIM, SUN WOOK/I-9389-2017; ki, cs/O-5931-2014 OI Kim, Tae Hyuk/0000-0002-7975-2437 TC 1 Z9 1 SN 1351-0088 EI 1479-6821 PD FEB PY 2017 VL 24 IS 2 BP 97 EP 106 DI 10.1530/ERC-16-0421 UT WOS:000395903500008 PM 28093480 ER PT J AU Roberts, JA Gonzalez, RS Shi, CJ AF Roberts, Jordan A. Gonzalez, Raul S. Shi, Chanjuan TI Expression of PD-1 and PD-L1 in High Grade Neuroendocrine Carcinomas of the Gastrointestinal Tract and Associated Host Immune Cells: A Potential Target for Anti-PD-1/PD-L1 Therapy SO MODERN PATHOLOGY CT 106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) CY MAR 04-10, 2017 CL San Antonio, TX TC 0 Z9 0 SN 0893-3952 EI 1530-0285 PD FEB PY 2017 VL 30 SU 2 MA 786 BP 196A EP 196A UT WOS:000394467301059 ER PT J AU Knepper, TC Saller, J Walko, CM AF Knepper, Todd C. Saller, James Walko, Christine M. TI Novel and Expanded Oncology Drug Approvals of 2016 PART 1: New Options in Solid Tumor Management SO ONCOLOGY-NEW YORK TC 0 Z9 0 SN 0890-9091 PD FEB PY 2017 VL 31 IS 2 BP 110 EP 121 UT WOS:000394636400004 PM 28205191 ER PT J AU Botti, G Collina, F Scognamiglio, G Rao, F Peluso, V De Cecio, R Piezzo, M Landi, G De Laurentiis, M Cantile, M Di Bonito, M AF Botti, Gerardo Collina, Francesca Scognamiglio, Giosue Rao, Federica Peluso, Valentina De Cecio, Rossella Piezzo, Michela Landi, Gabriella De Laurentiis, Michelino Cantile, Monica Di Bonito, Maurizio TI Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES TC 1 Z9 1 SN 1422-0067 PD FEB PY 2017 VL 18 IS 2 AR 459 DI 10.3390/ijms18020459 UT WOS:000395457700226 ER PT J AU Roberts, JA Gonzalez, RS Shi, CJ AF Roberts, Jordan A. Gonzalez, Raul S. Shi, Chanjuan TI Expression of PD-1 and PD-L1 in High Grade Neuroendocrine Carcinomas of the Gastrointestinal Tract and Associated Host Immune Cells: A Potential Target for Anti-PD-1/PD-L1 Therapy SO LABORATORY INVESTIGATION CT 106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) CY MAR 04-10, 2017 CL San Antonio, TX TC 0 Z9 0 SN 0023-6837 EI 1530-0307 PD FEB PY 2017 VL 97 SU 1 MA 786 BP 196A EP 196A UT WOS:000393724401059 ER PT J AU Kusters-Vandevelde, HVN Kruse, V Van Maerken, T Boterberg, T Pfundt, R Creytens, D Van den Broecke, C Machielsen, TC Koelsche, C von Deimling, A Kusters, B Groenen, PJTA Wesseling, P Blokx, WAM AF Kusters-Vandevelde, Heidi V. N. Kruse, Vibeke Van Maerken, Tom Boterberg, Tom Pfundt, Rolph Creytens, David Van den Broecke, Caroline Machielsen, Trudi C. Koelsche, Christian von Deimling, Andreas Kusters, Benno Groenen, Patricia J. T. A. Wesseling, Pieter Blokx, Willeke A. M. TI LECopy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis SO EXPERIMENTAL AND MOLECULAR PATHOLOGY RI von Deimling, Andreas/F-7774-2013 OI von Deimling, Andreas/0000-0002-5863-540X TC 0 Z9 0 SN 0014-4800 EI 1096-0945 PD FEB PY 2017 VL 102 IS 1 BP 25 EP 31 DI 10.1016/j.yexmp.2016.12.006 UT WOS:000393927400005 PM 27974237 ER PT J AU Kalemkerian, GP Schneider, BJ AF Kalemkerian, Gregory P. Schneider, Bryan J. TI Advances in Small Cell Lung Cancer SO HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA TC 0 Z9 0 SN 0889-8588 EI 1558-1977 PD FEB PY 2017 VL 31 IS 1 BP 143 EP + DI 10.1016/j.hoc.2016.08.005 UT WOS:000390984800012 PM 27912830 ER PT J AU Bunchorntavakul, C Reddy, KR AF Bunchorntavakul, Chalermrat Reddy, K. Rajender TI Drug Hepatotoxicity Newer Agents SO CLINICS IN LIVER DISEASE TC 0 Z9 0 SN 1089-3261 EI 1557-8224 PD FEB PY 2017 VL 21 IS 1 BP 115 EP + DI 10.1016/j.cld.2016.08.009 UT WOS:000390730900009 PM 27842767 ER PT J AU Costa, R Carneiro, BA Agulnik, M Rademaker, AW Pai, SG Villaflor, VM Cristofanilli, M Sosman, JA Giles, FJ AF Costa, Ricardo Carneiro, Benedito A. Agulnik, Mark Rademaker, Alfred W. Pai, Sachin G. Villaflor, Victoria M. Cristofanilli, Massimo Sosman, Jeffrey A. Giles, Francis J. TI Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials SO ONCOTARGET TC 4 Z9 4 SN 1949-2553 PD JAN 31 PY 2017 VL 8 IS 5 BP 8910 EP 8920 DI 10.18632/oncotarget.13315 UT WOS:000393295500147 PM 27852042 ER PT J AU Layer, JP Kronmuller, MT Quast, T van den Boorn-Konijnenberg, D Effern, M Hinze, D Althoff, K Schramm, A Westermann, F Peifer, M Hartmann, G Tuting, T Kolanus, W Fischer, M Schulte, J Holzel, M AF Layer, Julian P. Kronmueller, Marie T. Quast, Thomas van den Boorn-Konijnenberg, Debby Effern, Maike Hinze, Daniel Althoff, Kristina Schramm, Alexander Westermann, Frank Peifer, Martin Hartmann, Gunther Tueting, Thomas Kolanus, Waldemar Fischer, Matthias Schulte, Johannes Hoelzel, Michael TI Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression SO ONCOIMMUNOLOGY TC 0 Z9 0 SN 2162-402X PY 2017 VL 6 IS 6 AR e1320626 DI 10.1080/2162402X.2017.1320626 UT WOS:000404014300015 ER PT J AU Yu, D Leja-Jarblad, J Loskog, A Hellman, P Giandomenico, V Oberg, K Essand, M AF Yu, Di Leja-Jarblad, Justyna Loskog, Angelica Hellman, Per Giandomenico, Valeria Oberg, Kjell Essand, Magnus TI Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer SO NEUROENDOCRINOLOGY TC 0 Z9 0 SN 0028-3835 EI 1423-0194 PY 2017 VL 105 IS 1 BP 54 EP 66 DI 10.1159/000448430 UT WOS:000403362100006 PM 27442441 ER PT J AU Petersen, CT Li, JM Waller, EK AF Petersen, Christopher T. Li, Jian-Ming Waller, Edmund K. TI Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia SO ONCOIMMUNOLOGY TC 0 Z9 0 SN 2162-402X PY 2017 VL 6 IS 5 AR e1304336 DI 10.1080/2162402X.2017.1304336 UT WOS:000402926200002 PM 28638725 ER PT S AU Guaraldi, F Giordano, R Grottoli, S Ghizzoni, L Arvat, E Ghigo, E AF Guaraldi, Federica Giordano, Roberta Grottoli, Silvia Ghizzoni, Lucia Arvat, Emanuela Ghigo, Ezio BE Savino, W Guaraldi, F TI Pituitary Autoimmunity SO ENDOCRINE IMMUNOLOGY SE Frontiers of Hormone Research TC 0 Z9 0 SN 0301-3073 BN 978-3-318-06014-0; 978-3-318-06013-3 PY 2017 VL 48 BP 48 EP 68 DI 10.1159/000452905 D2 10.1159/isbn.978-3-318-06014-0 UT WOS:000402259600005 PM 28245451 ER PT J AU Mansoor, S Hall, R Mihalek, A AF Mansoor, S. Hall, R. Mihalek, A. TI Use Of Immune Checkpoint Inhibitors Induces An Immune Mediated Hypophysitis SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE CT International Conference of the American-Thoracic-Society (ATS) CY MAY 19-24, 2017 CL Washington, DC TC 0 Z9 0 SN 1073-449X EI 1535-4970 PY 2017 VL 195 MA A3831 UT WOS:000400372503322 ER PT J AU Kasamon, YL de Claro, RA Wang, YP Shen, YL Farrell, AT Pazdur, R AF Kasamon, Yvette L. de Claro, R. Angelo Wang, Yaping Shen, Yuan Li Farrell, Ann T. Pazdur, Richard TI FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma SO ONCOLOGIST TC 0 Z9 0 SN 1083-7159 EI 1549-490X PY 2017 VL 22 IS 5 BP 585 EP 591 DI 10.1634/theoncologist.2017-0004 UT WOS:000401037600015 PM 28438889 ER PT J AU Nishijima, TF Shachar, SS Nyrop, KA Muss, HB AF Nishijima, Tomohiro F. Shachar, Shlomit S. Nyrop, Kirsten A. Muss, Hyman B. TI Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis SO ONCOLOGIST TC 0 Z9 0 SN 1083-7159 EI 1549-490X PY 2017 VL 22 IS 4 BP 470 EP 479 DI 10.1634/theoncologist.2016-0419 UT WOS:000399440600017 PM 28275115 ER PT J AU Pollock, AJ Seibert, TS Salvatori, C Caturegli, P Allen, DB AF Pollock, Allison J. Seibert, Tasa S. Salvatori, Cristiana Caturegli, Patrizio Allen, David B. TI Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome SO HORMONE RESEARCH IN PAEDIATRICS TC 0 Z9 0 SN 1663-2818 EI 1663-2826 PY 2017 VL 87 IS 2 BP 123 EP 129 DI 10.1159/000446912 UT WOS:000398529000008 PM 27355580 ER PT J AU Telo, GH Carvalhal, GF Cauduro, CGS Webber, VS Barrios, CH Fay, AP AF Telo, G. H. Carvalhal, G. F. Cauduro, C. G. S. Webber, V. S. Barrios, C. H. Fay, A. P. TI Fulminant type 1 diabetes caused by dual immune checkpoint blockade in metastatic renal cell carcinoma SO ANNALS OF ONCOLOGY TC 0 Z9 0 SN 0923-7534 EI 1569-8041 PD JAN PY 2017 VL 28 IS 1 BP 191 EP 192 DI 10.1093/annonc/mdw447 UT WOS:000397239800031 PM 28043983 ER PT J AU Rinke, A Gress, TM AF Rinke, Anja Gress, Thomas M. TI Neuropendocrine Cancer, Therapeutic Strategies in G3 Cancers SO DIGESTION TC 0 Z9 0 SN 0012-2823 EI 1421-9867 PY 2017 VL 95 IS 2 BP 109 EP 114 DI 10.1159/000454761 UT WOS:000397358000001 PM 28161703 ER PT J AU Singh, D Hsu, CCT Kwan, GNC Bhuta, S AF Singh, Dalveer Hsu, Charlie Chia-Tsong Kwan, Gigi Nga Chi Bhuta, Sandeep TI Ipilimumab-induced hypophysitis and ileocolitis: Serial pituitary MRI findings SO NEUROLOGY INDIA OI Hsu, Charlie Chia-Tsong/0000-0003-0803-593X TC 0 Z9 0 SN 0028-3886 EI 1998-4022 PD JAN-FEB PY 2017 VL 65 IS 1 BP 165 EP + DI 10.4103/0028-3886.198182 UT WOS:000395403800034 PM 28084260 ER PT J AU Cho, KY Miyoshi, H Nakamura, A Kurita, T Atsumi, T AF Cho, Kyu Yong Miyoshi, Hideaki Nakamura, Akinobu Kurita, Takashi Atsumi, Tatsuya TI Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment SO ENDOCRINE JOURNAL TC 0 Z9 0 SN 0918-8959 EI 1348-4540 PY 2017 VL 64 IS 2 BP 235 EP 236 UT WOS:000396625100014 PM 28070057 ER PT J AU Hellmann, MD Rizvi, NA Goldman, JW Gettinger, SN Borghaei, H Brahmer, JR Ready, NE Gerber, DE Chow, LQ Juergens, RA Shepherd, FA Laurie, SA Geese, WJ Agrawal, S Young, TC Li, XM Antonia, SJ AF Hellmann, Matthew D. Rizvi, Naiyer A. Goldman, Jonathan W. Gettinger, Scott N. Borghaei, Hossein Brahmer, Julie R. Ready, Neal E. Gerber, David E. Chow, Laura Q. Juergens, Rosalyn A. Shepherd, Frances A. Laurie, Scott A. Geese, William J. Agrawal, Shruti Young, Tina C. Li, Xuemei Antonia, Scott J. TI Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study SO LANCET ONCOLOGY TC 13 Z9 14 SN 1470-2045 EI 1474-5488 PD JAN PY 2017 VL 18 IS 1 BP 31 EP 41 DI 10.1016/s1470-2045(16)30624-6 UT WOS:000396341000045 PM 27932067 ER PT J AU Chae, YK Chiec, L Mohindra, N Gentzler, R Patel, J Giles, F AF Chae, Young Kwang Chiec, Lauren Mohindra, Nisha Gentzler, Ryan Patel, Jyoti Giles, Francis TI A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes SO CANCER IMMUNOLOGY IMMUNOTHERAPY TC 5 Z9 5 SN 0340-7004 EI 1432-0851 PD JAN PY 2017 VL 66 IS 1 BP 25 EP 32 DI 10.1007/s00262-016-1913-7 UT WOS:000393598500004 PM 27761609 ER PT J AU Sweeting, AN Lomax, A Lim, J Cheng, R McGill, N Lowe, P Shackel, N McNeil, C Chua, E AF Sweeting, Arianne N. Lomax, Anna Lim, Jennifer Cheng, Robert McGill, Neil Lowe, Patricia Shackel, Nicholas McNeil, Catriona Chua, Elizabeth TI Pembrolizumab-induced thyroiditis in patients with metastatic melanoma: A novel form of autoimmune thyroid disease SO CLINICAL ENDOCRINOLOGY TC 0 Z9 0 SN 0300-0664 EI 1365-2265 PD JAN PY 2017 VL 86 SU S1 MA 259 BP 34 EP 35 UT WOS:000393453600094 ER PT J AU Sheriff, N De Sousa, SMC Menzies, AM Tsang, VHM Long, GV Tonks, KT AF Sheriff, Nisa De Sousa, Sunita M. C. Menzies, Alexander M. Tsang, Venessa H. M. Long, Georgina V. Tonks, Katherine T. TI Fall in TSH by >= 80% is associated with development of ipilimumab-induced hypophysitis SO CLINICAL ENDOCRINOLOGY TC 0 Z9 0 SN 0300-0664 EI 1365-2265 PD JAN PY 2017 VL 86 SU S1 MA 262 BP 36 EP 36 UT WOS:000393453600097 ER PT J AU Rodrigues, DN Boysen, G Sumanasuriya, S Seed, G De Marzo, AM de Bono, J AF Rodrigues, Daniel Nava Boysen, Gunther Sumanasuriya, Semini Seed, George De Marzo, Angelo M. de Bono, Johann TI The molecular underpinnings of prostate cancer: impacts on management and pathology practice SO JOURNAL OF PATHOLOGY TC 3 Z9 3 SN 0022-3417 EI 1096-9896 PD JAN PY 2017 VL 241 IS 2 BP 173 EP 182 DI 10.1002/path.4826 UT WOS:000392845200006 PM 27753448 ER PT J AU Yu, LY Tang, J Zhang, CM Zeng, WJ Yan, H Li, MP Chen, XP AF Yu, Lin-Yu Tang, Jie Zhang, Cong-Min Zeng, Wen-Jing Yan, Han Li, Mu-Peng Chen, Xiao-Ping TI New Immunotherapy Strategies in Breast Cancer SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH TC 0 Z9 0 SN 1660-4601 PD JAN PY 2017 VL 14 IS 1 AR 68 DI 10.3390/ijerph14010068 UT WOS:000392578200067 ER PT J AU Ishikawa, M Oashi, K AF Ishikawa, Masashi Oashi, Kohei TI Case of hypophysitis caused by nivolumab SO JOURNAL OF DERMATOLOGY TC 1 Z9 1 SN 0385-2407 EI 1346-8138 PD JAN PY 2017 VL 44 IS 1 BP 109 EP 110 DI 10.1111/1346-8138.13437 UT WOS:000392419500030 PM 27178147 ER PT J AU Nagase, K Shirai-Mizuno, R Koba, S Misago, N Narisawa, Y AF Nagase, Kotaro Shirai-Mizuno, Reiko Koba, Shinichi Misago, Noriyuki Narisawa, Yutaka TI Angiolymphoid hyperplasia with eosinophilia associated with underlying arteriovenous hemangioma SO JOURNAL OF DERMATOLOGY TC 0 Z9 0 SN 0385-2407 EI 1346-8138 PD JAN PY 2017 VL 44 IS 1 BP 110 EP 111 DI 10.1111/1346-8138.13443 UT WOS:000392419500031 PM 27178451 ER PT J AU Cappelli, LC Gutierrez, AK Baer, AN Albayda, J Manno, RL Haque, U Lipson, EJ Bleich, KB Shah, AA Naidoo, J Brahmer, JR Le, D Bingham, C AF Cappelli, Laura C. Gutierrez, Anna Kristina Baer, Alan N. Albayda, Jemima Manno, Rebecca L. Haque, Uzma Lipson, Evan J. Bleich, Karen B. Shah, Ami A. Naidoo, Jarushka Brahmer, Julie R. Le, Dung Bingham, Clifton, III TI Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab SO ANNALS OF THE RHEUMATIC DISEASES TC 10 Z9 10 SN 0003-4967 EI 1468-2060 PD JAN PY 2017 VL 76 IS 1 BP 43 EP 50 DI 10.1136/annrheumdis-2016-209595 UT WOS:000392425200007 PM 27307501 ER PT J AU Scharping, NE Menk, AV Whetstone, RD Zeng, X Delgoffe, GM AF Scharping, Nicole E. Menk, Ashley V. Whetstone, Ryan D. Zeng, Xue Delgoffe, Greg M. TI Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia SO CANCER IMMUNOLOGY RESEARCH TC 1 Z9 1 SN 2326-6066 EI 2326-6074 PD JAN PY 2017 VL 5 IS 1 BP 9 EP 16 DI 10.1158/2326-6066.CIR-16-0103 UT WOS:000392240600002 PM 27941003 ER PT J AU Kushnir, I Wolf, I AF Kushnir, Igal Wolf, Ido TI Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion SO CARDIOLOGY TC 3 Z9 3 SN 0008-6312 EI 1421-9751 PY 2017 VL 136 IS 1 BP 49 EP 51 DI 10.1159/000447053 UT WOS:000390540200008 PM 27554835 ER PT J AU Wachsmann, JW Ganti, R Peng, FY AF Wachsmann, Jason W. Ganti, Ramapriya Peng, Fangyu TI Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT SO ACADEMIC RADIOLOGY TC 0 Z9 0 SN 1076-6332 EI 1878-4046 PD JAN PY 2017 VL 24 IS 1 BP 111 EP 115 DI 10.1016/j.acra.2016.08.005 UT WOS:000389867500017 PM 27818005 ER PT J AU Zhou, J Jin, JO Kawai, T Yu, Q AF Zhou, Jing Jin, Jun-O. Kawai, Toshihisa Yu, Qing TI Endogenous programmed death ligand-1 restrains the development and onset of Sjogren's syndrome in non-obese diabetic mice SO SCIENTIFIC REPORTS TC 0 Z9 0 SN 2045-2322 PD DEC 14 PY 2016 VL 6 AR 39105 DI 10.1038/srep39105 UT WOS:000390242000001 PM 27966604 ER PT J AU Spellman, A Tang, SC AF Spellman, Alison Tang, Shou-Ching TI Immunotherapy for breast cancer: past, present, and future SO CANCER AND METASTASIS REVIEWS TC 0 Z9 0 SN 0167-7659 EI 1573-7233 PD DEC PY 2016 VL 35 IS 4 BP 525 EP 546 DI 10.1007/s10555-016-9654-9 UT WOS:000391928200004 PM 27913998 ER PT J AU Abdel-Rahman, O AF Abdel-Rahman, Omar TI Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic review SO IMMUNOTHERAPY TC 2 Z9 2 SN 1750-743X EI 1750-7448 PD DEC PY 2016 VL 8 IS 12 BP 1383 EP 1391 DI 10.2217/imt-2016-0075 UT WOS:000391864000005 PM 27892744 ER PT J AU Caturegli, P Di Dalmazi, G Lombardi, M Grosso, F Larman, HB Larman, T Taverna, G Cosottini, M Lupi, I AF Caturegli, Patrizio Di Dalmazi, Giulia Lombardi, Martina Grosso, Federica Larman, H. Benjamin Larman, Tatianna Taverna, Giacomo Cosottini, Mirco Lupi, Isabella TI Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade Insights into Pathogenesis from an Autopsy Series SO AMERICAN JOURNAL OF PATHOLOGY TC 2 Z9 2 SN 0002-9440 EI 1525-2191 PD DEC PY 2016 VL 186 IS 12 BP 3225 EP 3235 DI 10.1016/j.ajpath.2016.08.020 UT WOS:000389103800014 PM 27750046 ER PT J AU Wood, L Davies, M Rubin, K Madden, K Brennan, L Dahl, N Walker, D Gagnier, P Li, XM Kottschade, L AF Wood, Laura Davies, Marianne Rubin, Krista Madden, Kathleen Brennan, Laura Dahl, Nathan Walker, Dana Gagnier, Paul Li, Xuemei Kottschade, Lisa TI Management of endocrinopathies associated with nivolumab and ipilimumab combination therapy in solid tumors SO BJU INTERNATIONAL CT 15th International Kidney Cancer Symposium CY NOV 04-05, 2016 CL Miami, FL TC 0 Z9 0 SN 1464-4096 EI 1464-410X PD DEC PY 2016 VL 118 SU S5 BP 29 EP 29 UT WOS:000388478200048 ER PT J AU Hottinger, AF AF Hottinger, Andreas F. TI Neurologic complications of immune checkpoint inhibitors SO CURRENT OPINION IN NEUROLOGY TC 7 Z9 7 SN 1350-7540 EI 1473-6551 PD DEC PY 2016 VL 29 IS 6 BP 806 EP 812 DI 10.1097/WCO.0000000000000391 UT WOS:000387353900020 PM 27653290 ER PT J AU Dawood, S Rugo, HS AF Dawood, Shaheenah Rugo, Hope S. TI Targeting the host immune system: PD-1 and PD-L1 antibodies and breast cancer SO CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE TC 0 Z9 0 SN 1751-4258 EI 1751-4266 PD DEC PY 2016 VL 10 IS 4 BP 336 EP 342 DI 10.1097/SPC.0000000000000243 UT WOS:000387278000010 PM 27755140 ER PT J AU Jung, K Zeng, X Bilusic, M AF Jung, Kyungsuk Zeng, Xu Bilusic, Marijo TI Nivolumab-associated acute glomerulonephritis: a case report and literature review SO BMC Nephrology OI Jung, Kyungsuk/0000-0003-1306-5180 TC 3 Z9 3 SN 1471-2369 PD NOV 22 PY 2016 VL 17 AR 188 DI 10.1186/s12882-016-0408-2 UT WOS:000389279200004 PM 27876011 ER PT J AU Higham, CE Johannsson, G Shalet, SM AF Higham, Claire E. Johannsson, Gudmundur Shalet, Stephen M. TI Hypopituitarism SO LANCET TC 4 Z9 4 SN 0140-6736 EI 1474-547X PD NOV 12 PY 2016 VL 388 IS 10058 BP 2403 EP 2415 DI 10.1016/S0140-6736(16)30053-8 UT WOS:000387436900028 PM 27041067 ER PT J AU Jiang, TT Martinov, T Xin, LJ Kinder, JM Spanier, JA Fife, BT Way, SS AF Jiang, Tony T. Martinov, Tijana Xin, Lijun Kinder, Jeremy M. Spanier, Justin A. Fife, Brian T. Way, Sing Sing TI Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity SO CELL REPORTS TC 1 Z9 1 SN 2211-1247 PD NOV 8 PY 2016 VL 17 IS 7 BP 1783 EP 1794 DI 10.1016/j.celrep.2016.10.042 UT WOS:000390545900009 PM 27829150 ER PT J AU Bourke, JM O'Sullivan, M Khattak, MA AF Bourke, Jack M. O'Sullivan, Michael Khattak, Muhammad A. TI Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors) SO MEDICAL JOURNAL OF AUSTRALIA TC 1 Z9 1 SN 0025-729X EI 1326-5377 PD NOV 7 PY 2016 VL 205 IS 9 BP 418 EP 424 DI 10.5694/mja16.00586 UT WOS:000390847700014 PM 27809739 ER PT J AU de Filette, J Jansen, Y Schreuer, M Everaert, H Velkeniers, B Neyns, B Bravenboer, B AF de Filette, Jeroen Jansen, Yanina Schreuer, Max Everaert, Hendrik Velkeniers, Brigitte Neyns, Bart Bravenboer, Bert TI Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 4 Z9 4 SN 0021-972X EI 1945-7197 PD NOV PY 2016 VL 101 IS 11 BP 4431 EP 4439 DI 10.1210/jc.2016-2300 UT WOS:000390948600065 PM 27571185 ER PT J AU Hodi, FS Chesney, J Pavlick, AC Robert, C Grossmann, KF McDermott, DF Linette, GP Meyer, N Giguere, JRK Agarwala, SS Shaheen, M Ernstoff, MS Minor, DR Salama, AK Taylor, MH Ott, PA Horak, C Gagnier, P Jiang, J Wolchok, JD Postow, MA AF Hodi, F. Stephen Chesney, Jason Pavlick, Anna C. Robert, Caroline Grossmann, Kenneth F. McDermott, David F. Linette, Gerald P. Meyer, Nicolas Giguere, Jeff Rey K. Agarwala, Sanjiv S. Shaheen, Montaser Ernstoff, Marc S. Minor, David R. Salama, April K. Taylor, Matthew H. Ott, Patrick A. Horak, Christine Gagnier, Paul Jiang, Joel Wolchok, Jedd D. Postow, Michael A. TI Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial SO LANCET ONCOLOGY TC 31 Z9 31 SN 1470-2045 EI 1474-5488 PD NOV PY 2016 VL 17 IS 11 BP 1558 EP 1568 DI 10.1016/S1470-2045(16)30366-7 UT WOS:000389537600048 PM 27622997 ER PT J AU Sato, Y Hayakawa, J Ohyama, M AF Sato, Y. Hayakawa, J. Ohyama, M. TI Time course observation of thyroid-associated autoantibody and hormone and profiles in patients receiving nivolumab for metastatic melanoma SO AUSTRALASIAN JOURNAL OF DERMATOLOGY TC 0 Z9 0 SN 0004-8380 EI 1440-0960 PD NOV PY 2016 VL 57 SU 2 SI SI BP 38 EP 38 UT WOS:000387333500107 ER PT J AU Okamoto, M Okamoto, M Gotoh, K Masaki, T Ozeki, Y Ando, H Anai, M Sato, A Yoshida, Y Ueda, S Kakuma, T Shibata, H AF Okamoto, Masahide Okamoto, Mitsuhiro Gotoh, Koro Masaki, Takayuki Ozeki, Yoshinori Ando, Hisae Anai, Manabu Sato, Asami Yoshida, Yuichi Ueda, So Kakuma, Tetsuya Shibata, Hirotaka TI Fulminant type1 diabetes mellitus with anti-programmed cell death-1 therapy SO JOURNAL OF DIABETES INVESTIGATION TC 7 Z9 7 SN 2040-1116 EI 2040-1124 PD NOV PY 2016 VL 7 IS 6 BP 915 EP 918 DI 10.1111/jdi.12531 UT WOS:000387115200017 PM 27181090 ER PT J AU Diem, S Keller, F Ruesch, R Maillard, SA Speiser, DE Dummer, R Siano, M Urner-Bloch, U Goldinger, SM Flatz, L AF Diem, Stefan Keller, Fabienne Ruesch, Reinhard Maillard, Samia A. Speiser, Daniel E. Dummer, Reinhard Siano, Marco Urner-Bloch, Ursula Goldinger, Simone M. Flatz, Lukas TI Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy? SO JOURNAL OF IMMUNOTHERAPY TC 3 Z9 3 SN 1524-9557 EI 1537-4513 PD NOV-DEC PY 2016 VL 39 IS 9 BP 379 EP 382 UT WOS:000385990600006 PM 27662340 ER PT J AU Tripathi, A Kaymakcalan, MD LeBoeuf, NR Harshman, LC AF Tripathi, Abhishek Kaymakcalan, Marina D. LeBoeuf, Nicole R. Harshman, Lauren C. TI Programmed cell death-1 pathway inhibitors in genitourinary malignancies: specific side-effects and their management SO CURRENT OPINION IN UROLOGY TC 0 Z9 0 SN 0963-0643 EI 1473-6586 PD NOV PY 2016 VL 26 IS 6 BP 548 EP 555 DI 10.1097/MOU.0000000000000332 UT WOS:000384839600009 PM 27517638 ER PT J AU Okano, Y Satoh, T Horiguchi, K Toyoda, M Osaki, A Matsumoto, S Tomaru, T Nakajima, Y Ishii, S Ozawa, A Shibusawa, N Shimada, T Higuchi, T Chikamatsu, K Yamada, M AF Okano, Yudai Satoh, Tetsurou Horiguchi, Kazuhiko Toyoda, Minoru Osaki, Aya Matsumoto, Shunichi Tomaru, Takuya Nakajima, Yasuyo Ishii, Sumiyasu Ozawa, Atsushi Shibusawa, Nobuyuki Shimada, Takehiro Higuchi, Tetsuya Chikamatsu, Kazuaki Yamada, Masanobu TI Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma SO ENDOCRINE JOURNAL TC 7 Z9 7 SN 0918-8959 EI 1348-4540 PD OCT 20 PY 2016 VL 63 IS 10 BP 905 EP 912 UT WOS:000386540100005 PM 27440480 ER PT J AU Zaied, A Lee, A AF Zaied, Ali Lee, Augustine TI Nivolumab-Induced Autoimmune Diabetic Ketoacidosis SO CHEST CT CHEST Annual Meeting CY OCT 22-26, 2016 CL Los Angeles, CA TC 0 Z9 0 SN 0012-3692 PD OCT PY 2016 VL 150 IS 4 SU S BP 255A EP 255A DI 10.1016/j.chest.2016.08.268 UT WOS:000400118600243 ER PT J AU Ferdousy, F Williams, CC Sherman, B Fouty, B Vu, M AF Ferdousy, Faiza Williams, Christopher Caesar Sherman, Benjamin Fouty, Brian Vu, Mary TI Where Is the Storm Coming From: A Case of Thyroid Storm Secondary to Ipilimumab SO CHEST CT CHEST Annual Meeting CY OCT 22-26, 2016 CL Los Angeles, CA TC 0 Z9 0 SN 0012-3692 PD OCT PY 2016 VL 150 IS 4 SU S BP 379A EP 379A DI 10.1016/j.chest.2016.08.392 UT WOS:000400118601098 ER PT J AU Hong, S Fang, W Zhang, L AF Hong, S. Fang, W. Zhang, L. TI Pooled analysis of treatment-related hypothyroidism with anti-PD-1/PD-L1 therapies in cancer patients SO ANNALS OF ONCOLOGY TC 0 Z9 0 SN 0923-7534 EI 1569-8041 PD OCT 1 PY 2016 VL 27 SU 6 MA 1437PD DI 10.1093/annonc/mdw390.5 UT WOS:000393913000524 ER PT J AU Latteyer, S Tiedje, V Schilling, B Fuhrer, D AF Latteyer, S. Tiedje, V. Schilling, B. Fuehrer, D. TI Perspectives for immunotherapy in endocrine cancer SO ENDOCRINE-RELATED CANCER TC 2 Z9 2 SN 1351-0088 EI 1479-6821 PD OCT PY 2016 VL 23 IS 10 BP R469 EP R484 DI 10.1530/ERC-16-0169 UT WOS:000387602700006 PM 27485460 ER PT J AU Koessler, T Olivier, T Fertani, S Marinari, E Dutoit, V Dietrich, P-Y AF Koessler, T. Olivier, T. Fertani, S. Marinari, E. Dutoit, V. Dietrich, P. -Y. TI Ipilimumab-related hypophysitis may precede severe CNS immune attack SO ANNALS OF ONCOLOGY TC 0 Z9 0 SN 0923-7534 EI 1569-8041 PD OCT PY 2016 VL 27 IS 10 BP 1975 EP 1976 DI 10.1093/annonc/mdw255 UT WOS:000386018200029 PM 27358386 ER PT J AU Friedman, CF Proverbs-Singh, TA Postow, MA AF Friedman, Claire F. Proverbs-Singh, Tracy A. Postow, Michael A. TI Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors A Review SO JAMA ONCOLOGY OI Friedman, Claire/0000-0003-2621-8553 TC 23 Z9 23 SN 2374-2437 EI 2374-2445 PD OCT 1 PY 2016 VL 2 IS 10 BP 1346 EP 1353 DI 10.1001/jamaoncol.2016.1051 UT WOS:000386488600019 PM 27367787 ER PT J AU Weber, JS Postow, M Lao, CD Schadendorf, D AF Weber, Jeffrey S. Postow, Michael Lao, Christopher D. Schadendorf, Dirk TI Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents SO ONCOLOGIST TC 7 Z9 7 SN 1083-7159 EI 1549-490X PD OCT PY 2016 VL 21 IS 10 BP 1230 EP 1240 DI 10.1634/theoncologist.2016-0055 UT WOS:000386483400011 PM 27401894 ER PT J AU Lin, HY Chin, YT Nana, AW Shih, YJ Lai, HY Tang, HY Leinung, M Mousa, SA Davis, PJ AF Lin, Hung-Yun Chin, Yu-Tang Nana, Andre Wendindonde Shih, Ya-Jung Lai, Hsuan-Yu Tang, Heng-Yuan Leinung, Matthew Mousa, Shaker A. Davis, Paul J. TI Actions of L-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells SO STEROIDS TC 2 Z9 2 SN 0039-128X EI 1878-5867 PD OCT PY 2016 VL 114 SI SI BP 59 EP 67 DI 10.1016/j.steroids.2016.05.006 UT WOS:000386319000009 PM 27221508 ER PT J AU Sbardella, E Joseph, RN Jafar-Mohammadi, B Isidori, AM Cudlip, S Grossman, AB AF Sbardella, Emilia Joseph, Robin N. Jafar-Mohammadi, Bahram Isidori, Andrea M. Cudlip, Simon Grossman, Ashley B. TI Pituitary stalk thickening: the role of an innovative MRI imaging analysis which may assist in determining clinical management SO EUROPEAN JOURNAL OF ENDOCRINOLOGY TC 0 Z9 1 SN 0804-4643 EI 1479-683X PD OCT PY 2016 VL 175 IS 4 BP 255 EP 263 DI 10.1530/EJE-16-0455 UT WOS:000384194000008 PM 27418059 ER PT J AU Kottschade, L Brys, A Peikert, T Ryder, M Raffals, L Brewer, J Mosca, P Markovic, S AF Kottschade, Lisa Brys, Adam Peikert, Tobias Ryder, Mabel Raffals, Laura Brewer, Jerry Mosca, Paul Markovic, Svetomir CA Midwest Melanoma Partnership TI A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy SO MELANOMA RESEARCH TC 1 Z9 1 SN 0960-8931 EI 1473-5636 PD OCT PY 2016 VL 26 IS 5 BP 469 EP 480 DI 10.1097/CMR.0000000000000273 UT WOS:000384452900006 PM 27306502 ER PT J AU Todd, A Wallace, I Thiraviaraj, A Oladipo, B Nugent, A AF Todd, A. Wallace, I Thiraviaraj, A. Oladipo, B. Nugent, A. TI Adrenal insufficiency secondary to ipilimumab induced hypophysitis: the Northern Irish experience SO IRISH JOURNAL OF MEDICAL SCIENCE TC 0 Z9 0 SN 0021-1265 EI 1863-4362 PD OCT PY 2016 VL 185 SU 7 MA P113 BP 409 EP 409 UT WOS:000383130800133 ER PT J AU Lambert, T Doucet, L AF Lambert, T. Doucet, L. TI Immunotherapy and thyroid dysfunction: an update on current understanding SO ONCOLOGIE TC 1 Z9 1 SN 1292-3818 EI 1765-2839 PD SEP PY 2016 VL 18 IS 9-10 BP 509 EP 515 DI 10.1007/s10269-016-2659-8 UT WOS:000387672600003 ER PT J AU Kahnert, K Kauffmann-Guerrero, D Huber, RM AF Kahnert, Kathrin Kauffmann-Guerrero, Diego Huber, Rudolf Maria TI SCLC-State of the Art and What Does the Future Have in Store? SO CLINICAL LUNG CANCER TC 3 Z9 3 SN 1525-7304 EI 1938-0690 PD SEP PY 2016 VL 17 IS 5 BP 325 EP 333 DI 10.1016/j.cllc.2016.05.014 UT WOS:000386317200002 PM 27397481 ER PT J AU Semper, H Muehlberg, F Schulz-Menger, J Allewelt, M Grohe, C AF Semper, H. Muehlberg, F. Schulz-Menger, J. Allewelt, M. Grohe, C. TI Drug-induced myocarditis after nivolumab treatment in a patient with PDL1-negative squamous cell carcinoma of the lung SO LUNG CANCER OI Muehlberg, Fabian/0000-0002-7981-5178 TC 2 Z9 2 SN 0169-5002 EI 1872-8332 PD SEP PY 2016 VL 99 BP 117 EP 119 DI 10.1016/j.lungcan.2016.06.025 UT WOS:000384863000020 PM 27565924 ER PT J AU Joshi, MN Whitelaw, BC Palomar, MTP Wu, Y Carroll, PV AF Joshi, M. N. Whitelaw, B. C. Palomar, M. T. P. Wu, Y. Carroll, P. V. TI Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review SO CLINICAL ENDOCRINOLOGY OI Whitelaw, Benjamin/0000-0002-7870-6666 TC 8 Z9 8 SN 0300-0664 EI 1365-2265 PD SEP PY 2016 VL 85 IS 3 BP 331 EP 339 DI 10.1111/cen.13063 UT WOS:000383475800001 PM 26998595 ER PT J AU Walter, JR Xu, S Paller, AS Choi, JN Woodruff, TK AF Walter, Jessica R. Xu, Shuai Paller, Amy S. Choi, Jennifer N. Woodruff, Teresa K. TI Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration-approved systemic therapies SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY TC 3 Z9 3 SN 0190-9622 PD SEP PY 2016 VL 75 IS 3 BP 528 EP 534 DI 10.1016/j.jaad.2016.04.031 UT WOS:000383369700026 PM 27543212 ER PT J AU Perazella, MA AF Perazella, Mark A. TI Checkmate: kidney injury associated with targeted cancer immunotherapy SO KIDNEY INTERNATIONAL TC 1 Z9 1 SN 0085-2538 EI 1523-1755 PD SEP PY 2016 VL 90 IS 3 BP 474 EP 476 DI 10.1016/j.kint.2016.05.024 UT WOS:000382415300005 PM 27521108 ER PT J AU Cives, M Simone, V Rizzo, FM Silvestris, F AF Cives, Mauro Simone, Valeria Rizzo, Francesca Maria Silvestris, Franco TI NETs: organ-related epigenetic derangements and potential clinical applications SO ONCOTARGET OI Silvestris, Francesco/0000-0002-5555-2617 TC 2 Z9 2 SN 1949-2553 PD AUG 30 PY 2016 VL 7 IS 35 BP 57414 EP 57429 DI 10.18632/oncotarget.10598 UT WOS:000386911600115 PM 27418145 ER PT J AU Iyevleva, AG Imyanitov, EN AF Iyevleva, Aglaya G. Imyanitov, Evgeny N. TI Cytotoxic and targeted therapy for hereditary cancers SO HEREDITARY CANCER IN CLINICAL PRACTICE RI Iyevleva, Aglaya/P-8305-2016 OI Iyevleva, Aglaya/0000-0001-5454-5186 TC 3 Z9 4 SN 1731-2302 EI 1897-4287 PD AUG 23 PY 2016 VL 14 AR 17 DI 10.1186/s13053-016-0057-2 UT WOS:000382524600001 PM 27555886 ER PT J AU Bickel, A Koneth, I Enzler-Tschudy, A Neuweiler, J Flatz, L Fruh, M AF Bickel, Angelika Koneth, Irene Enzler-Tschudy, Annette Neuweiler, Jorg Flatz, Lukas Fruh, Martin TI Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma SO BMC CANCER TC 3 Z9 3 SN 1471-2407 PD AUG 19 PY 2016 VL 16 AR 656 DI 10.1186/s12885-016-2718-y UT WOS:000384189500001 PM 27543082 ER PT J AU Graff, JN Alumkal, JJ Drake, CG Thomas, GV Redmond, WL Farhad, M Cetnar, JP Ey, FS Bergan, RC Slottke, R Beer, TM AF Graff, Julie N. Alumkal, Joshi J. Drake, Charles G. Thomas, George V. Redmond, William L. Farhad, Mohammad Cetnar, Jeremy P. Ey, Frederick S. Bergan, Raymond C. Slottke, Rachel Beer, Tomasz M. TI Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer SO ONCOTARGET TC 8 Z9 8 SN 1949-2553 PD AUG 16 PY 2016 VL 7 IS 33 BP 52810 EP 52817 DI 10.18632/oncotarget.10547 UT WOS:000385433000016 PM 27429197 ER PT J AU Zhou, GW Xiong, Y Chen, S Xia, F Li, Q Hu, J AF Zhou, Guo-Wu Xiong, Ye Chen, Si Xia, Fan Li, Qiang Hu, Jia TI Anti-PD-1/PD-L1 antibody therapy for pretreated advanced nonsmall-cell lung cancer: A meta-analysis of randomized clinical trials SO MEDICINE TC 1 Z9 1 SN 0025-7974 EI 1536-5964 PD AUG PY 2016 VL 95 IS 35 AR e4611 DI 10.1097/MD.0000000000004611 UT WOS:000384041400036 PM 27583876 ER PT J AU Specenier, P AF Specenier, Pol TI Ipilimumab in melanoma SO EXPERT REVIEW OF ANTICANCER THERAPY RI Specenier, Pol/E-1679-2014 OI Specenier, Pol/0000-0002-2465-5197 TC 3 Z9 3 SN 1473-7140 EI 1744-8328 PD AUG PY 2016 VL 16 IS 8 BP 811 EP 826 DI 10.1080/14737140.2016.1211936 UT WOS:000382321200004 PM 27403706 ER PT J AU Miller, AH Brock, P Yeung, SCJ AF Miller, Adam H. Brock, Patricia Yeung, Sai-Ching Jim TI Pituitary Dysfunction: A Case Series of Immune Checkpoint Inhibitor-Related Hypophysitis in an Emergency Department SO ANNALS OF EMERGENCY MEDICINE TC 0 Z9 0 SN 0196-0644 PD AUG PY 2016 VL 68 IS 2 BP 249 EP 250 DI 10.1016/j.annemergmed.2016.03.048 UT WOS:000381166800025 PM 27451306 ER PT J AU Boutros, C Tarhini, A Routier, E Lambotte, O Ladurie, FL Carbonnel, F Izzeddine, H Marabelle, A Champiat, S Berdelou, A Lanoy, E Texier, M Libenciuc, C Eggermont, AMM Soria, JC Mateus, C Robert, C AF Boutros, Celine Tarhini, Ahmad Routier, Emilie Lambotte, Olivier Ladurie, Francois Leroy Carbonnel, Franck Izzeddine, Hassane Marabelle, Aurelien Champiat, Stephane Berdelou, Armandine Lanoy, Emilie Texier, Matthieu Libenciuc, Cristina Eggermont, Alexander M. M. Soria, Jean-Charles Mateus, Christine Robert, Caroline TI Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination SO NATURE REVIEWS CLINICAL ONCOLOGY TC 22 Z9 23 SN 1759-4774 EI 1759-4782 PD AUG PY 2016 VL 13 IS 8 BP 473 EP 486 DI 10.1038/nrclinonc.2016.58 UT WOS:000380756000005 PM 27141885 ER PT J AU Abdel-Wahab, N Shah, M Suarez-Almazor, ME AF Abdel-Wahab, Noha Shah, Mohsin Suarez-Almazor, Maria E. TI Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports SO PLOS ONE OI Shah, Mohsin /0000-0002-3450-4843 TC 13 Z9 13 SN 1932-6203 PD JUL 29 PY 2016 VL 11 IS 7 AR e0160221 DI 10.1371/journal.pone.0160221 UT WOS:000381516300037 PM 27472273 ER PT J AU Kahler, KC Hassel, JC Heinzerling, L Loquai, C Moessner, R Ugurel, S Zimmer, L Gutzmer, R AF Kaehler, Katharina C. Hassel, Jessica C. Heinzerling, Lucie Loquai, Carmen Moessner, Rotraut Ugurel, Selma Zimmer, Lisa Gutzmer, Ralf CA Cutaneous Side Effects TI Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT TC 13 Z9 13 SN 1610-0379 EI 1610-0387 PD JUL PY 2016 VL 14 IS 7 BP 662 EP 681 DI 10.1111/ddg.13047 UT WOS:000384997000002 PM 27373241 ER PT J AU Katoh, M AF Katoh, Masaru TI FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review) SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE TC 7 Z9 8 SN 1107-3756 EI 1791-244X PD JUL PY 2016 VL 38 IS 1 BP 3 EP 15 DI 10.3892/ijmm.2016.2620 UT WOS:000381289700001 PM 27245147 ER PT J AU Gonzalez-Rodriguez, E Rodriguez-Abreu, D AF Gonzalez-Rodriguez, Elisa Rodriguez-Abreu, Delvys CA Spanish Grp Canc Immuno-Biotherapy TI Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events SO ONCOLOGIST TC 8 Z9 8 SN 1083-7159 EI 1549-490X PD JUL PY 2016 VL 21 IS 7 BP 804 EP 816 DI 10.1634/theoncologist.2015-0509 UT WOS:000380957400007 PM 27306911 ER PT J AU Cassler, NM Merrill, D Bichakjian, CK Brownell, I AF Cassler, Nicole M. Merrill, Dean Bichakjian, Christopher K. Brownell, Isaac TI Merkel Cell Carcinoma Therapeutic Update SO CURRENT TREATMENT OPTIONS IN ONCOLOGY OI Merrill, Eric/0000-0001-7175-5046 TC 7 Z9 7 SN 1527-2729 EI 1534-6277 PD JUL PY 2016 VL 17 IS 7 AR 36 DI 10.1007/s11864-016-0409-1 UT WOS:000380164600002 PM 27262710 ER PT J AU Bastman, JJ Serracino, HS Zhu, YW Koenig, MR Mateescu, V Sams, SB Davies, KD Raeburn, CD McIntyre, RC Haugen, BR French, JD AF Bastman, Jill J. Serracino, Hilary S. Zhu, Yuwen Koenig, Michelle R. Mateescu, Valerica Sams, Sharon B. Davies, Kurtis D. Raeburn, Christopher D. McIntyre, Robert C., Jr. Haugen, Bryan R. French, Jena D. TI Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 5 Z9 6 SN 0021-972X EI 1945-7197 PD JUL PY 2016 VL 101 IS 7 BP 2863 EP 2873 DI 10.1210/jc.2015-4227 UT WOS:000380224800031 PM 27045886 ER PT J AU Tabchi, S Messier, C Blais, N AF Tabchi, Samer Messier, Christine Blais, Normand TI Immune-mediated respiratory adverse events of checkpoint inhibitors SO CURRENT OPINION IN ONCOLOGY TC 5 Z9 5 SN 1040-8746 EI 1531-703X PD JUL PY 2016 VL 28 IS 4 BP 269 EP 277 DI 10.1097/CCO.0000000000000291 UT WOS:000377925900004 PM 27138570 ER PT J AU Torino, F Corsello, SM Salvatori, R AF Torino, Francesco Corsello, Salvatore M. Salvatori, Roberto TI Endocrinological side-effects of immune checkpoint inhibitors SO CURRENT OPINION IN ONCOLOGY TC 5 Z9 5 SN 1040-8746 EI 1531-703X PD JUL PY 2016 VL 28 IS 4 BP 278 EP 287 DI 10.1097/CCO.0000000000000293 UT WOS:000377925900005 PM 27136136 ER PT J AU Antoun, J Titah, C Cochereau, I AF Antoun, Joelle Titah, Cherif Cochereau, Isabelle TI Ocular and orbital side-effects of checkpoint inhibitors: a review article SO CURRENT OPINION IN ONCOLOGY TC 3 Z9 3 SN 1040-8746 EI 1531-703X PD JUL PY 2016 VL 28 IS 4 BP 288 EP 294 DI 10.1097/CCO.0000000000000296 UT WOS:000377925900006 PM 27136135 ER PT J AU Akturk, HK Meek, S Joseph, R AF Akturk, Halis K. Meek, Shon Joseph, Richard TI Nivolumab Related Insulin-dependent Diabetes SO DIABETES CT 76th Scientific Sessions of the American-Diabetes-Association CY JUN 10-14, 2016 CL New Orleans, LA TC 0 Z9 0 SN 0012-1797 EI 1939-327X PD JUN PY 2016 VL 65 SU 1 MA 1586-P BP A414 EP A414 UT WOS:000398372802207 ER PT J AU Tanaka, R Fujisawa, Y Maruyama, H Nakamura, Y Yoshino, K Ohtsuka, M Fujimoto, M AF Tanaka, Ryota Fujisawa, Yasuhiro Maruyama, Hiroshi Nakamura, Yasuhiro Yoshino, Koji Ohtsuka, Mikio Fujimoto, Manabu TI Nivolumab-induced thyroid dysfunction SO JAPANESE JOURNAL OF CLINICAL ONCOLOGY TC 5 Z9 5 SN 0368-2811 EI 1465-3621 PD JUN PY 2016 VL 46 IS 6 BP 575 EP 579 DI 10.1093/jjco/hyw036 UT WOS:000381162500012 PM 27012985 ER PT J AU Kourie, HR Klastersky, J AF Kourie, Hampig Raphael Klastersky, Jean TI Immune checkpoint inhibitors side effects and management SO IMMUNOTHERAPY TC 9 Z9 9 SN 1750-743X EI 1750-7448 PD JUN PY 2016 VL 8 IS 7 BP 799 EP 807 DI 10.2217/imt-2016-0029 UT WOS:000378931200006 PM 27349979 ER PT J AU Hansen, E Sahasrabudhe, D Sievert, L AF Hansen, Elizabeth Sahasrabudhe, Deepak Sievert, Lynn TI A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome SO CANCER IMMUNOLOGY IMMUNOTHERAPY TC 4 Z9 4 SN 0340-7004 EI 1432-0851 PD JUN PY 2016 VL 65 IS 6 BP 765 EP 767 DI 10.1007/s00262-016-1835-4 UT WOS:000378872600011 PM 27067877 ER PT J AU Spain, L Larkin, J Martin-Liberal, J AF Spain, Lavinia Larkin, James Martin-Liberal, Juan TI Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome" SO CANCER IMMUNOLOGY IMMUNOTHERAPY TC 1 Z9 1 SN 0340-7004 EI 1432-0851 PD JUN PY 2016 VL 65 IS 6 BP 769 EP 770 DI 10.1007/s00262-016-1845-2 UT WOS:000378872600012 PM 27194054 ER PT J AU Bonnet, C Beinse, G Cabel, L Cochereau, D Lavaud, P Rochefort, P Tabouret, E Turpin, A Verlingue, L Vicier, C Massard, C AF Bonnet, Clement Beinse, Guillaume Cabel, Luc Cochereau, Delphine Lavaud, Pernelle Rochefort, Pauline Tabouret, Emeline Turpin, Anthony Verlingue, Loic Vicier, Cecile Massard, Christophe TI ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies SO BULLETIN DU CANCER TC 1 Z9 1 SN 0007-4551 EI 1769-6917 PD JUN PY 2016 VL 103 IS 6 BP 594 EP 603 DI 10.1016/j.bulcan.2016.04.001 UT WOS:000378244300010 PM 27229364 ER PT J AU Miyoshi, Y Ogawa, O Oyama, Y AF Miyoshi, Yuka Ogawa, Osamu Oyama, Yu TI Nivolumab, an Anti-Programmed Cell Death-1 Antibody, Induces Fulminant Type 1 Diabetes SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TC 10 Z9 10 SN 0040-8727 EI 1349-3329 PD JUN PY 2016 VL 239 IS 2 BP 155 EP 158 DI 10.1620/tjem.239.155 UT WOS:000378100900010 PM 27297738 ER PT J AU Lewis, C AF Lewis, Colleen TI Programmed Death-1 Inhibition in Cancer With a Focus on Non-Small Cell Lung Cancer: Rationale, Nursing Implications, and Patient Management Strategies SO CLINICAL JOURNAL OF ONCOLOGY NURSING TC 1 Z9 1 SN 1092-1095 EI 1538-067X PD JUN PY 2016 VL 20 IS 3 BP 319 EP 326 DI 10.1188/16.CJON.319-326 UT WOS:000377115800017 ER PT J AU Muro, K Chung, HC Shankaran, V Geva, R Catenacci, D Gupta, S Eder, JP Golan, T Le, DT Burtness, B McRee, AJ Lin, CC Pathiraja, K Lunceford, J Emancipator, K Juco, J Koshiji, M Bang, YJ AF Muro, Kei Chung, Hyun Cheol Shankaran, Veena Geva, Ravit Catenacci, Daniel Gupta, Shilpa Eder, Joseph Paul Golan, Talia Le, Dung T. Burtness, Barbara McRee, Autumn J. Lin, Chia-Chi Pathiraja, Kumudu Lunceford, Jared Emancipator, Kenneth Juco, Jonathan Koshiji, Minori Bang, Yung-Jue TI Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial SO LANCET ONCOLOGY TC 62 Z9 66 SN 1470-2045 EI 1474-5488 PD JUN PY 2016 VL 17 IS 6 BP 717 EP 726 DI 10.1016/S1470-2045(16)00175-3 UT WOS:000377066400056 PM 27157491 ER PT J AU Hofmann, L Forschner, A Loquai, C Goldinger, SM Zimmer, L Ugurel, S Schmidgen, MI Gutzmer, R Utikal, JS Goeppner, D Hassel, JC Meier, F Tietze, JK Thomas, I Weishaupt, C Leverkus, M Wahl, R Dietrich, U Garbe, C Kirchberger, MC Eigentler, T Berking, C Gesierich, A Krackhardt, AM Schadendorf, D Schuler, G Dummer, R Heinzerling, LM AF Hofmann, Lars Forschner, Andrea Loquai, Carmen Goldinger, Simone M. Zimmer, Lisa Ugurel, Selma Schmidgen, Maria I. Gutzmer, Ralf Utikal, Jochen S. Goeppner, Daniela Hassel, Jessica C. Meier, Friedegund Tietze, Julia K. Thomas, Ioannis Weishaupt, Carsten Leverkus, Martin Wahl, Renate Dietrich, Ursula Garbe, Claus Kirchberger, Michael C. Eigentler, Thomas Berking, Carola Gesierich, Anja Krackhardt, Angela M. Schadendorf, Dirk Schuler, Gerold Dummer, Reinhard Heinzerling, Lucie M. TI Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy SO EUROPEAN JOURNAL OF CANCER OI Hofmann, Lars/0000-0002-9727-9823; Utikal, Jochen/0000-0001-5316-0241; Eigentler, Thomas/0000-0003-0019-2770 TC 36 Z9 38 SN 0959-8049 EI 1879-0852 PD JUN PY 2016 VL 60 BP 190 EP 209 DI 10.1016/j.ejca.2016.02.025 UT WOS:000376449700019 PM 27085692 ER PT J AU Zimmer, L Goldinger, SM Hofmann, L Loquai, C Ugurel, S Thomas, I Schmidgen, MI Gutzmer, R Utikal, JS Goeppner, D Hassel, JC Meier, F Tietze, JK Forschner, A Weishaupt, C Leverkus, M Wahl, R Dietrich, U Garbe, C Kirchberger, MC Eigentler, T Berking, C Gesierich, A Krackhardt, AM Schadendorf, D Schuler, G Dummer, R Heinzerling, LM AF Zimmer, Lisa Goldinger, Simone M. Hofmann, Lars Loquai, Carmen Ugurel, Selma Thomas, Ioannis Schmidgen, Maria I. Gutzmer, Ralf Utikal, Jochen S. Goeppner, Daniela Hassel, Jessica C. Meier, Friedegund Tietze, Julia K. Forschner, Andrea Weishaupt, Carsten Leverkus, Martin Wahl, Renate Dietrich, Ursula Garbe, Claus Kirchberger, Michael C. Eigentler, Thomas Berking, Carola Gesierich, Anja Krackhardt, Angela M. Schadendorf, Dirk Schuler, Gerold Dummer, Reinhard Heinzerling, Lucie M. TI Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy SO EUROPEAN JOURNAL OF CANCER OI Utikal, Jochen/0000-0001-5316-0241; Eigentler, Thomas/0000-0003-0019-2770 TC 35 Z9 36 SN 0959-8049 EI 1879-0852 PD JUN PY 2016 VL 60 BP 210 EP 225 DI 10.1016/j.ejca.2016.02.024 UT WOS:000376449700020 PM 27084345 ER PT J AU Shimizu, T Seto, T Hirai, F Takenoyama, M Nosaki, K Tsurutani, J Kaneda, H Iwasa, T Kawakami, H Noguchi, K Shimamoto, T Nakagawa, K AF Shimizu, Toshio Seto, Takashi Hirai, Fumihiko Takenoyama, Mitsuhiro Nosaki, Kaname Tsurutani, Junji Kaneda, Hiroyasu Iwasa, Tsutomu Kawakami, Hisato Noguchi, Kazuo Shimamoto, Takashi Nakagawa, Kazuhiko TI Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors SO INVESTIGATIONAL NEW DRUGS TC 2 Z9 2 SN 0167-6997 EI 1573-0646 PD JUN PY 2016 VL 34 IS 3 BP 347 EP 354 DI 10.1007/s10637-016-0347-6 UT WOS:000376129000009 PM 27000274 ER PT J AU Wen, XZ Wang, Y Ding, Y Li, DD Li, JJ Guo, YQ Peng, RQ Zhao, JJ Zhang, X Zhang, XS AF Wen, Xizhi Wang, Yao Ding, Ya Li, Dandan Li, Jingjing Guo, Yiqun Peng, Ruiqing Zhao, Jingjing Zhang, Xing Zhang, Xiao-Shi TI Safety of immune checkpoint inhibitors in Chinese patients with melanoma SO MELANOMA RESEARCH TC 0 Z9 0 SN 0960-8931 EI 1473-5636 PD JUN PY 2016 VL 26 IS 3 BP 284 EP 289 DI 10.1097/CMR.0000000000000256 UT WOS:000375687400010 PM 27116334 ER PT J AU Eryilmaz, MK Mutlu, H Salim, DK Musri, FY Tural, D Bassorgun, I Coskun, HS AF Eryilmaz, Melek Karakurt Mutlu, Hasan Salim, Derya Kivrak Musri, Fatma Yalcin Tural, Deniz Bassorgun, Ibrahim Coskun, Hasan Senol TI Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy SO JOURNAL OF ONCOLOGY PHARMACY PRACTICE RI Bassorgun, Cumhur Ibrahim/I-6615-2017 OI Bassorgun, Cumhur Ibrahim/0000-0003-2440-511X TC 0 Z9 0 SN 1078-1552 EI 1477-092X PD JUN PY 2016 VL 22 IS 3 BP 533 EP 536 DI 10.1177/1078155215572930 UT WOS:000374794300018 PM 25694346 ER PT J AU Abdallah, AO Herlopian, A Ravilla, R Bansal, M Chandra-Reddy, S Mahmoud, F Ong, S Gokden, M Hutchins, L AF Abdallah, Al-Ola Herlopian, Aline Ravilla, Rahul Bansal, Meghana Chandra-Reddy, Sowmya Mahmoud, Fade Ong, Shirley Gokden, Murat Hutchins, Laura TI Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature SO JOURNAL OF ONCOLOGY PHARMACY PRACTICE TC 5 Z9 5 SN 1078-1552 EI 1477-092X PD JUN PY 2016 VL 22 IS 3 BP 537 EP 542 DI 10.1177/1078155215572932 UT WOS:000374794300019 PM 25712627 ER PT J AU Callahan, MK Postow, MA Wolchok, JD AF Callahan, Margaret K. Postow, Michael A. Wolchok, Jedd D. TI Targeting T Cell Co-receptors for Cancer Therapy SO IMMUNITY TC 46 Z9 47 SN 1074-7613 EI 1097-4180 PD MAY 17 PY 2016 VL 44 IS 5 BP 1069 EP 1078 DI 10.1016/j.immuni.2016.04.023 UT WOS:000376478500008 PM 27192570 ER PT J AU Sul, J Blumenthal, GM Jiang, XP He, K Keegan, P Pazdur, R AF Sul, Joohee Blumenthal, Gideon M. Jiang, Xiaoping He, Kun Keegan, Patricia Pazdur, Richard TI FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1 SO ONCOLOGIST TC 23 Z9 25 SN 1083-7159 EI 1549-490X PD MAY PY 2016 VL 21 IS 5 BP 643 EP 650 DI 10.1634/theoncologist.2015-0498 UT WOS:000385664400021 PM 27026676 ER PT J AU Dieci, MV Griguolo, G Miglietta, F Guarneri, V AF Dieci, Maria Vittoria Griguolo, Gaia Miglietta, Federica Guarneri, Valentina TI The immune system and hormone-receptor positive breast cancer: Is it really a dead end? SO CANCER TREATMENT REVIEWS RI dieci, maria vittoria/K-6645-2016 OI Griguolo, Gaia/0000-0002-8782-4509; DIECI, MARIA VITTORIA/0000-0002-3967-9861 TC 10 Z9 10 SN 0305-7372 EI 1532-1967 PD MAY PY 2016 VL 46 BP 9 EP 19 DI 10.1016/j.ctrv.2016.03.011 UT WOS:000377739400002 PM 27055087 ER PT J AU Oppel-Heuchel, H Grimm, MO AF Oppel-Heuchel, H. Grimm, M. -O. TI Therapy monitoring and management of adverse events in PD-1/PD-L1 immune checkpoint inhibition SO UROLOGE TC 2 Z9 2 SN 0340-2592 EI 1433-0563 PD MAY PY 2016 VL 55 IS 5 BP 677 EP 688 DI 10.1007/s00120-016-0109-2 UT WOS:000376257600024 PM 27146870 ER PT J AU Duchnowska, R Peksa, R Radecka, B Mandat, T Trojanowski, T Jarosz, B Czartoryska-Arlukowicz, B Olszewski, WP Och, W Kalinka-Warzocha, E Kozlowski, W Kowalczyk, A Loi, S Biernat, W Jassem, J AF Duchnowska, Renata Peksa, Rafal Radecka, Barbara Mandat, Tomasz Trojanowski, Tomasz Jarosz, Bozena Czartoryska-Arlukowicz, Bogumila Olszewski, Wojciech P. Och, Waldemar Kalinka-Warzocha, Ewa Kozlowski, Wojciech Kowalczyk, Anna Loi, Sherene Biernat, Wojciech Jassem, Jacek CA Polish Brain Metastasis Consortium TI Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis SO BREAST CANCER RESEARCH TC 8 Z9 8 SN 1465-542X EI 1465-5411 PD APR 27 PY 2016 VL 18 AR 43 DI 10.1186/s13058-016-0702-8 UT WOS:000375100800001 PM 27117582 ER PT J AU Cohen, PR Tomson, BN Elkin, SK Marchlik, E Carter, JL Kurzrock, R AF Cohen, Philip R. Tomson, Brett N. Elkin, Sheryl K. Marchlik, Erica Carter, Jennifer L. Kurzrock, Razelle TI Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics SO ONCOTARGET TC 4 Z9 4 SN 1949-2553 PD APR 26 PY 2016 VL 7 IS 17 BP 23454 EP 23467 DI 10.18632/oncotarget.8032 UT WOS:000377706200037 PM 26981779 ER PT J AU Wilgenhof, S Corthals, J Heirman, C van Baren, N Lucas, S Kvistborg, P Thielemans, K Neyns, B AF Wilgenhof, Sofie Corthals, Jurgen Heirman, Carlo van Baren, Nicolas Lucas, Sophie Kvistborg, Pia Thielemans, Kris Neyns, Bart TI Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma SO JOURNAL OF CLINICAL ONCOLOGY TC 22 Z9 22 SN 0732-183X EI 1527-7755 PD APR 20 PY 2016 VL 34 IS 12 BP 1330 EP + DI 10.1200/JCO.2015.63.4121 UT WOS:000374335100012 PM 26926680 ER PT J AU Soliman, HH Minton, SE Han, HS Ismail-Khan, R Neuger, A Khambati, F Noyes, D Lush, R Chiappori, AA Roberts, JD Link, C Vahanian, NN Mautino, M Streicher, H Sullivan, DM Antonia, SJ AF Soliman, Hatem H. Minton, Susan E. Han, Hyo Sook Ismail-Khan, Roohi Neuger, Anthony Khambati, Fatema Noyes, David Lush, Richard Chiappori, Alberto A. Roberts, John D. Link, Charles Vahanian, Nicholas N. Mautino, Mario Streicher, Howard Sullivan, Daniel M. Antonia, Scott J. TI A Phase I study of indoximod in patients with advanced malignancies SO ONCOTARGET TC 6 Z9 6 SN 1949-2553 PD APR 19 PY 2016 VL 7 IS 16 BP 22928 EP 22938 DI 10.18632/oncotarget.8216 UT WOS:000377705900145 PM 27008709 ER PT J AU Papavasileiou, E Prasad, S Freitag, SK Sobrin, L Lobo, AM AF Papavasileiou, Evangelia Prasad, Sashank Freitag, Suzanne K. Sobrin, Lucia Lobo, Ann-Marie TI Ipilimumab-induced Ocular and Orbital Inflammation-A Case Series and Review of the Literature SO OCULAR IMMUNOLOGY AND INFLAMMATION TC 10 Z9 10 SN 0927-3948 EI 1744-5078 PD APR PY 2016 VL 24 IS 2 BP 140 EP 146 DI 10.3109/09273948.2014.1001858 UT WOS:000375335600004 PM 25760920 ER PT J AU Eigentler, TK Hassel, JC Berking, C Aberle, J Bachmann, O Grunwald, V Kahler, KC Loquai, C Reinmuth, N Steins, M Zimmer, L Sendl, A Gutzmer, R AF Eigentler, Thomas K. Hassel, Jessica C. Berking, Carola Aberle, Jens Bachmann, Oliver Gruenwald, Viktor Kaehler, Katharina C. Loquai, Carmen Reinmuth, Niels Steins, Martin Zimmer, Lisa Sendl, Anna Gutzmer, Ralf TI Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy SO CANCER TREATMENT REVIEWS RI Eigentler, Thomas/K-8570-2015 OI Eigentler, Thomas/0000-0003-0019-2770; Bachmann, Oliver/0000-0002-6830-2975 TC 28 Z9 31 SN 0305-7372 EI 1532-1967 PD APR PY 2016 VL 45 BP 7 EP 18 DI 10.1016/j.ctrv.2016.02.003 UT WOS:000374611500002 PM 26922661 ER PT J AU Champiat, S Lambotte, O Barreau, E Belkhir, R Berdelou, A Carbonnel, F Cauquil, C Chanson, P Collins, M Durrbach, A Ederhy, S Feuillet, S Francois, H Lazarovici, J Le Pavec, J De Martin, E Mateus, C Michot, JM Samuel, D Soria, JC Robert, C Eggermont, A Marabelle, A AF Champiat, S. Lambotte, O. Barreau, E. Belkhir, R. Berdelou, A. Carbonnel, F. Cauquil, C. Chanson, P. Collins, M. Durrbach, A. Ederhy, S. Feuillet, S. Francois, H. Lazarovici, J. Le Pavec, J. De Martin, E. Mateus, C. Michot, J. -M. Samuel, D. Soria, J. -C. Robert, C. Eggermont, A. Marabelle, A. TI Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper SO ANNALS OF ONCOLOGY TC 43 Z9 44 SN 0923-7534 EI 1569-8041 PD APR PY 2016 VL 27 IS 4 BP 559 EP 574 DI 10.1093/annonc/mdv623 UT WOS:000374237700004 PM 26715621 ER PT J AU Azpilikueta, A Agorreta, J Labiano, S Perez-Gracia, JL Sanchez-Paulete, AR Aznar, MA Ajona, D Gil-Bazo, I Larrayoz, M Teijeira, A Rodriguez-Ruiz, ME Pio, R Montuenga, LM Melero, I AF Azpilikueta, Arantza Agorreta, Jackeline Labiano, Sara Luis Perez-Gracia, Jose Sanchez-Paulete, Alfonso R. Angela Aznar, M. Ajona, Daniel Gil-Bazo, Ignacio Larrayoz, Marta Teijeira, Alvaro Rodriguez-Ruiz, Maria E. Pio, Ruben Montuenga, Luis M. Melero, Ignacio TI Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies SO JOURNAL OF THORACIC ONCOLOGY RI Pio, Ruben/F-5353-2017; Sanchez-Paulete, Alfonso/I-2430-2017; Teijeira, Alvaro/I-6903-2017; Perez-Gracia, Jose Luis/I-8372-2017; Aznar, M Angela/K-1688-2014; Azpilicueta, Arantza/K-2701-2017 OI Pio, Ruben/0000-0002-6831-6111; Larrayoz, Marta/0000-0001-6097-8244; Sanchez-Paulete, Alfonso/0000-0001-7475-1913; Teijeira, Alvaro/0000-0002-7339-4464; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Aznar, M Angela/0000-0002-7970-1672; Azpilicueta, Arantza/0000-0001-8511-6050; MELERO BERMEJO, IGNACIO/0000-0002-1360-348X TC 1 Z9 1 SN 1556-0864 EI 1556-1380 PD APR PY 2016 VL 11 IS 4 BP 524 EP 536 DI 10.1016/j.jtho.2016.01.013 UT WOS:000373864500008 PM 26845193 ER PT J AU Brauner, E Gunda, V Vanden Borre, P Zurakowski, D Kim, YS Dennett, KV Amin, S Freeman, GJ Parangi, S AF Brauner, Eran Gunda, Viswanath Vanden Borre, Pierre Zurakowski, David Kim, Yon Seon Dennett, Kate Virginia Amin, Salma Freeman, Gordon James Parangi, Sareh TI Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer SO ONCOTARGET TC 4 Z9 5 SN 1949-2553 PD MAR 29 PY 2016 VL 7 IS 13 BP 17194 EP 17211 UT WOS:000375692900142 PM 26943572 ER PT J AU Merchant, MS Wright, M Baird, K Wexler, LH Rodriguez-Galindo, C Bernstein, D Delbrook, C Lodish, M Bishop, R Wolchok, JD Streicher, H Mackall, CL AF Merchant, Melinda S. Wright, Matthew Baird, Kristin Wexler, Leonard H. Rodriguez-Galindo, Carlos Bernstein, Donna Delbrook, Cindy Lodish, Maya Bishop, Rachel Wolchok, Jedd D. Streicher, Howard Mackall, Crystal L. TI Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors SO CLINICAL CANCER RESEARCH TC 12 Z9 13 SN 1078-0432 EI 1557-3265 PD MAR 15 PY 2016 VL 22 IS 6 BP 1364 EP 1370 DI 10.1158/1078-0432.CCR-15-0491 UT WOS:000373358900011 PM 26534966 ER PT J AU Rossi, E Sgambato, A De Chiara, G Casaluce, F Losanno, T Sacco, PC Santabarbara, G Gridelli, C AF Rossi, Emanuela Sgambato, Assunta De Chiara, Giovanni Casaluce, Francesca Losanno, Tania Sacco, Paola Claudia Santabarbara, Giuseppe Gridelli, Cesare TI Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer SO EXPERT REVIEW OF CLINICAL PHARMACOLOGY RI Gridelli, Cesare/K-7909-2016 TC 5 Z9 5 SN 1751-2433 EI 1751-2441 PD MAR 3 PY 2016 VL 9 IS 3 BP 419 EP 428 DI 10.1586/17512433.2016.1133289 UT WOS:000371319800003 PM 26681547 ER PT J AU Wei, XX Fong, L Small, EJ AF Wei, Xiao X. Fong, Lawrence Small, Eric J. TI Prospects for the use of ipilimumab in treating advanced prostate cancer SO EXPERT OPINION ON BIOLOGICAL THERAPY TC 3 Z9 3 SN 1471-2598 EI 1744-7682 PD MAR 3 PY 2016 VL 16 IS 3 BP 421 EP 432 DI 10.1517/14712598.2016.1136284 UT WOS:000370270300001 PM 26698365 ER PT J AU Spain, L Diem, S Larkin, J AF Spain, Lavinia Diem, Stefan Larkin, James TI Management of toxicities of immune checkpoint inhibitors SO CANCER TREATMENT REVIEWS TC 49 Z9 52 SN 0305-7372 EI 1532-1967 PD MAR PY 2016 VL 44 BP 51 EP 60 DI 10.1016/j.ctrv.2016.02.001 UT WOS:000372379200006 PM 26874776 ER PT J AU Aleksova, J Mahendran, D Teede, H Lau, P AF Aleksova, Jasna Mahendran, Dinesh Teede, Helena Lau, Peter TI Treating type 1 diabetes with glucocorticosteroids: a case report of PD-1 receptor inhibition induced type 1 diabetes SO CLINICAL ENDOCRINOLOGY CT Annual Scientific Meeting of the Endocrine-Society-of-Australia CY AUG 23-26, 2015 CL Adelaide, AUSTRALIA TC 0 Z9 0 SN 0300-0664 EI 1365-2265 PD MAR PY 2016 VL 84 SU 1 SI SI MA 46 BP 5 EP 5 UT WOS:000372310400013 ER PT J AU Scott, E Menzies, A Long, G Tacon, L Guminski, A Tsang, V AF Scott, Emma Menzies, Alexander Long, Georgina Tacon, Lyndal Guminski, Alex Tsang, Venessa TI Endocrinopathies associated with immune modulation therapy for the treatment of metastatic melanoma SO CLINICAL ENDOCRINOLOGY CT Annual Scientific Meeting of the Endocrine-Society-of-Australia CY AUG 23-26, 2015 CL Adelaide, AUSTRALIA TC 0 Z9 0 SN 0300-0664 EI 1365-2265 PD MAR PY 2016 VL 84 SU 1 SI SI MA 196 BP 28 EP 28 UT WOS:000372310400078 ER PT J AU Hsieh, A Hockings, G Nye, E AF Hsieh, Amy Hockings, Greg Nye, Elisabeth TI Endocrine collateral damage SO CLINICAL ENDOCRINOLOGY CT Annual Scientific Meeting of the Endocrine-Society-of-Australia CY AUG 23-26, 2015 CL Adelaide, AUSTRALIA TC 0 Z9 0 SN 0300-0664 EI 1365-2265 PD MAR PY 2016 VL 84 SU 1 SI SI MA 207 BP 30 EP 30 UT WOS:000372310400083 ER PT J AU Aschenbrenner, DS AF Aschenbrenner, Diane S. TI New Indication for Nivolumab SO AMERICAN JOURNAL OF NURSING TC 1 Z9 1 SN 0002-936X EI 1538-7488 PD MAR PY 2016 VL 116 IS 3 BP 23 EP 23 DI 10.1097/01.NAJ.0000481276.92062.cc UT WOS:000371351000001 PM 27123623 ER PT J AU Freeman-Keller, M Kim, Y Cronin, H Richards, A Gibney, G Weber, JS AF Freeman-Keller, Morganna Kim, Youngchul Cronin, Heather Richards, Allison Gibney, Geoffrey Weber, Jeffrey S. TI Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes SO CLINICAL CANCER RESEARCH TC 34 Z9 35 SN 1078-0432 EI 1557-3265 PD FEB 15 PY 2016 VL 22 IS 4 BP 886 EP 894 DI 10.1158/1078-0432.CCR-15-1136 UT WOS:000370128500014 PM 26446948 ER PT J AU Johnson, DB Sullivan, RJ Ott, PA Carlino, MS Khushalani, NI Ye, F Guminski, A Puzanov, I Lawrence, DP Buchbinder, EI Mudigonda, T Spencer, K Bender, C Lee, J Kaufman, HL Menzies, AM Hassel, JC Mehnert, JM Sosman, JA Long, GV Clark, JI AF Johnson, Douglas B. Sullivan, Ryan J. Ott, Patrick A. Carlino, Matteo S. Khushalani, Nikhil I. Ye, Fei Guminski, Alexander Puzanov, Igor Lawrence, Donald P. Buchbinder, Elizabeth I. Mudigonda, Tejaswi Spencer, Kristen Bender, Carolin Lee, Jenny Kaufman, Howard L. Menzies, Alexander M. Hassel, Jessica C. Mehnert, Janice M. Sosman, Jeffrey A. Long, Georgina V. Clark, Joseph I. TI Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders SO JAMA ONCOLOGY TC 51 Z9 51 SN 2374-2437 EI 2374-2445 PD FEB PY 2016 VL 2 IS 2 BP 234 EP 240 DI 10.1001/jamaoncol.2015.4368 UT WOS:000383680200018 PM 26633184 ER PT J AU Faje, A AF Faje, Alexander TI Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights SO PITUITARY TC 16 Z9 17 SN 1386-341X EI 1573-7403 PD FEB PY 2016 VL 19 IS 1 BP 82 EP 92 DI 10.1007/s11102-015-0671-4 UT WOS:000372932200010 PM 26186958 ER PT J AU Khoja, L Atenafu, EG Ye, Q Gedye, C Chappell, M Hogg, D Butler, MO Joshua, AM AF Khoja, Leila Atenafu, Eshetu G. Ye, Qian Gedye, Craig Chappell, Maryanne Hogg, David Butler, Marcus O. Joshua, Anthony M. TI Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma SO ONCOLOGY LETTERS OI Atenafu, Eshetu/0000-0002-4613-3680 TC 6 Z9 6 SN 1792-1074 EI 1792-1082 PD FEB PY 2016 VL 11 IS 2 BP 1581 EP 1585 DI 10.3892/ol.2015.4069 UT WOS:000369554200116 ER PT J AU Narita, T Oiso, N Taketomo, Y Okahashi, K Yamauchi, K Sato, M Uchida, S Matsuda, H Kawada, A AF Narita, Tomohiko Oiso, Naoki Taketomo, Yasunori Okahashi, Kazunori Yamauchi, Kohei Sato, Masako Uchida, Shusuke Matsuda, Hiromasa Kawada, Akira TI Serological aggravation of autoimmune thyroid disease in two cases receiving nivolumab SO JOURNAL OF DERMATOLOGY TC 8 Z9 8 SN 0385-2407 EI 1346-8138 PD FEB PY 2016 VL 43 IS 2 BP 210 EP 214 DI 10.1111/1346-8138.13028 UT WOS:000369159100018 PM 26198822 ER PT J AU Brummer, GC Bowen, AR Bowen, GM AF Brummer, Grace C. Bowen, Anneli R. Bowen, Glen M. TI Merkel Cell Carcinoma: Current Issues Regarding Diagnosis, Management, and Emerging Treatment Strategies SO AMERICAN JOURNAL OF CLINICAL DERMATOLOGY TC 1 Z9 1 SN 1175-0561 EI 1179-1888 PD FEB PY 2016 VL 17 IS 1 BP 49 EP 62 DI 10.1007/s40257-015-0163-3 UT WOS:000368988100005 PM 26596990 ER PT J AU Michot, JM Bigenwald, C Champiat, S Collins, M Carbonnel, F Postel-Vinay, S Berdelou, A Varga, A Bahleda, R Hollebecque, A Massard, C Fuerea, A Ribrag, V Gazzah, A Armand, JP Amellal, N Angevin, E Noel, N Boutros, C Mateus, C Robert, C Soria, JC Marabelle, A Lambotte, O AF Michot, J. M. Bigenwald, C. Champiat, S. Collins, M. Carbonnel, F. Postel-Vinay, S. Berdelou, A. Varga, A. Bahleda, R. Hollebecque, A. Massard, C. Fuerea, A. Ribrag, V. Gazzah, A. Armand, J. P. Amellal, N. Angevin, E. Noel, N. Boutros, C. Mateus, C. Robert, C. Soria, J. C. Marabelle, A. Lambotte, O. TI Immune-related adverse events with immune checkpoint blockade: a comprehensive review SO EUROPEAN JOURNAL OF CANCER OI , Jean-Marie/0000-0003-3482-3331; ANGEVIN, Eric/0000-0001-6249-7209 TC 72 Z9 74 SN 0959-8049 EI 1879-0852 PD FEB PY 2016 VL 54 BP 139 EP 148 DI 10.1016/j.ejca.2015.11.016 UT WOS:000369150000018 PM 26765102 ER PT J AU Katsuta, E Tanaka, S Mogushi, K Shimada, S Akiyama, Y Aihara, A Matsumura, S Mitsunori, Y Ban, D Ochiai, T Kudo, A Fukamachi, H Tanaka, H Nakayama, K Arii, S Tanabe, M AF Katsuta, Eriko Tanaka, Shinji Mogushi, Kaoru Shimada, Shu Akiyama, Yoshimitsu Aihara, Arihiro Matsumura, Satoshi Mitsunori, Yusuke Ban, Daisuke Ochiai, Takanori Kudo, Atsushi Fukamachi, Hiroshi Tanaka, Hiroshi Nakayama, Koh Arii, Shigeki Tanabe, Minoru TI CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells SO INTERNATIONAL JOURNAL OF ONCOLOGY TC 2 Z9 2 SN 1019-6439 EI 1791-2423 PD FEB PY 2016 VL 48 IS 2 BP 657 EP 669 DI 10.3892/ijo.2015.3299 UT WOS:000366897500023 PM 26691441 ER PT J AU Goh, G Walradt, T Markarov, V Blom, A Riaz, N Doumani, R Stafstrom, K Moshiri, A Yelistratova, L Levinsohn, J Chan, TA Nghiem, P Lifton, RP Choi, J AF Goh, Gerald Walradt, Trent Markarov, Vladimir Blom, Astrid Riaz, Nadeem Doumani, Ryan Stafstrom, Krista Moshiri, Ata Yelistratova, Lola Levinsohn, Jonathan Chan, Timothy A. Nghiem, Paul Lifton, Richard P. Choi, Jaehyuk TI Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy SO ONCOTARGET RI Nghiem, Paul/A-9210-2011 OI Nghiem, Paul/0000-0003-2784-963X TC 24 Z9 24 SN 1949-2553 PD JAN 19 PY 2016 VL 7 IS 3 BP 3393 EP 3405 UT WOS:000369951800090 PM 26655088 ER PT J AU Jeroen, D Yanina, J Max, S Hendrik, E Brigitte, V Bart, N Bert, B AF Jeroen, de Filette Yanina, Jansen Max, Schreuer Hendrik, Everaert Brigitte, Velkeniers Bart, Neyns Bert, Bravenboer TI Incidence of thyroid immune-related adverse events in melanoma patients treated with pembrolizumab in an expanded access program SO ACTA CLINICA BELGICA TC 0 Z9 0 SN 1784-3286 EI 2295-3337 PY 2016 VL 71 SU 3 BP 19 EP 19 UT WOS:000398388600031 ER PT J AU Hartkopf, AD Taran, FA Wallwiener, M Walter, CB Kramer, B Grischke, EM Brucker, SY AF Hartkopf, Andreas D. Taran, Florin-Andrei Wallwiener, Markus Walter, Christina B. Kraemer, Bernhard Grischke, Eva-Maria Brucker, Sara Y. TI PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer SO BREAST CARE TC 1 Z9 1 SN 1661-3791 EI 1661-3805 PY 2016 VL 11 IS 6 BP 385 EP 390 DI 10.1159/000453569 UT WOS:000390546400002 PM 28228704 ER PT J AU Kwok, G Yau, TCC Chiu, JW Tse, E Kwong, YL AF Kwok, Gerry Yau, Thomas C. C. Chiu, Joanne W. Tse, Eric Kwong, Yok-Lam TI Pembrolizumab (Keytruda) SO HUMAN VACCINES & IMMUNOTHERAPEUTICS TC 2 Z9 2 SN 2164-5515 EI 2164-554X PY 2016 VL 12 IS 11 BP 2777 EP 2789 DI 10.1080/21645515.2016.1199310 UT WOS:000388736900021 PM 27398650 ER PT J AU Escudier, B Lougheed, JC Albiges, L AF Escudier, Bernard Lougheed, Julie C. Albiges, Laurence TI Cabozantinib for the treatment of renal cell carcinoma SO EXPERT OPINION ON PHARMACOTHERAPY TC 0 Z9 0 SN 1465-6566 EI 1744-7666 PY 2016 VL 17 IS 18 BP 2499 EP 2504 DI 10.1080/14656566.2016.1258059 UT WOS:000389065000012 PM 27835047 ER PT J AU Hao, ZL Sadek, I AF Hao, Zhonglin Sadek, Ibrahim TI Sunitinib: the antiangiogenic effects and beyond SO ONCOTARGETS AND THERAPY TC 1 Z9 1 SN 1178-6930 PY 2016 VL 9 BP 5495 EP 5505 DI 10.2147/OTT.S112242 UT WOS:000383158900001 PM 27660467 ER PT J AU Karydis, I Chan, PY Wheater, M Arriola, E Szlosarek, PW Ottensmeier, CH AF Karydis, Ioannis Chan, Pui Ying Wheater, Matthew Arriola, Edurne Szlosarek, Peter W. Ottensmeier, Christian H. TI Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma SO ONCOIMMUNOLOGY OI Karydis, Ioannis/0000-0003-0284-3549 TC 3 Z9 3 SN 2162-402X PY 2016 VL 5 IS 5 AR e1143997 DI 10.1080/2162402X.2016.1143997 UT WOS:000379162200056 PM 27467964 ER PT J AU Arefanian, H Tredget, EB Mok, DCM Ramji, Q Rafati, S Rodriguez-Barbosa, J Korbutt, GS Rajotte, RV Gill, RG Rayat, GR AF Arefanian, Hossein Tredget, Eric B. Mok, Dereck C. M. Ramji, Qahir Rafati, Shahin Rodriguez-Barbosa, Jose Korbutt, Gregory S. Rajotte, Ray V. Gill, Ron G. Rayat, Gina R. TI Porcine Islet-Specific Tolerance Induced by the Combination of Anti-LFA-1 and Anti-CD154 mAbs Is Dependent on PD-1 SO CELL TRANSPLANTATION OI Rodriguez-Barbosa, Jose-Ignacio/0000-0001-7427-5654 TC 0 Z9 0 SN 0963-6897 EI 1555-3892 PY 2016 VL 25 IS 2 BP 327 EP 342 DI 10.3727/096368915X688506 UT WOS:000370833700011 PM 26109574 ER PT J AU Abdel-Rahman, O ElHalawani, H Fouad, M AF Abdel-Rahman, Omar ElHalawani, Hesham Fouad, Mona TI Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis SO FUTURE ONCOLOGY OI Elhalawani, Hesham /0000-0001-9848-2623; Abdel-Rahman, Omar/0000-0002-5117-2502 TC 16 Z9 17 SN 1479-6694 EI 1744-8301 PY 2016 VL 12 IS 3 BP 413 EP 425 DI 10.2217/fon.15.222 UT WOS:000368937200016 PM 26775673 ER PT J AU Guibert, N Mazieres, J AF Guibert, Nicolas Mazieres, Julien TI Nivolumab for treating non-small cell lung cancer SO EXPERT OPINION ON BIOLOGICAL THERAPY OI MAZIERES, JULIEN/0000-0002-5921-7613 TC 7 Z9 7 SN 1471-2598 EI 1744-7682 PD DEC 2 PY 2015 VL 15 IS 12 BP 1789 EP 1797 DI 10.1517/14712598.2015.1114097 UT WOS:000366518300001 PM 26574148 ER PT J AU Lu, J Lee-Gabel, L Nadeau, MC Ferencz, TM Soefje, SA AF Lu, Jing Lee-Gabel, Linda Nadeau, Michelle C. Ferencz, Thomas M. Soefje, Scott A. TI Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy SO JOURNAL OF ONCOLOGY PHARMACY PRACTICE TC 15 Z9 18 SN 1078-1552 EI 1477-092X PD DEC PY 2015 VL 21 IS 6 BP 451 EP 467 DI 10.1177/1078155214538087 UT WOS:000364096500007 PM 24917416 ER PT J AU Pham, A Ye, DW Pal, S AF Anh Pham Ye, Da-Wei Pal, Sumanta TI Overview and management of toxicities associated with systemic therapies for advanced renal cell carcinoma SO UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS TC 4 Z9 4 SN 1078-1439 EI 1873-2496 PD DEC PY 2015 VL 33 IS 12 BP 517 EP 527 DI 10.1016/j.urolonc.2015.07.020 UT WOS:000368293900016 PM 26351153 ER PT J AU Mills, TA Orloff, M Domingo-Vidal, M Cotzia, P Birbe, RC Draganova-Tacheva, R Cantarin, MPM Tuluc, M Martinez-Outschoorn, U AF Mills, Teresa Anne Orloff, Mariana Domingo-Vidal, Marina Cotzia, Paolo Birbe, Ruth C. Draganova-Tacheva, Rossitza Cantarin, Maria P. Martinez Tuluc, Madalina Martinez-Outschoorn, Ubaldo TI Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates SO SEMINARS IN ONCOLOGY TC 1 Z9 1 SN 0093-7754 EI 1532-8708 PD DEC PY 2015 VL 42 IS 6 BP 909 EP 914 DI 10.1053/j.seminoncol.2015.09.006 UT WOS:000366870000012 PM 26615135 ER PT J AU Naidoo, J Page, DB Li, BT Connell, LC Schindler, K Lacouture, ME Postow, MA Wolchok, JD AF Naidoo, J. Page, D. B. Li, B. T. Connell, L. C. Schindler, K. Lacouture, M. E. Postow, M. A. Wolchok, J. D. TI Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies SO ANNALS OF ONCOLOGY OI Li, Bob/0000-0001-6661-8733 TC 117 Z9 123 SN 0923-7534 EI 1569-8041 PD DEC PY 2015 VL 26 IS 12 BP 2375 EP 2391 DI 10.1093/annonc/mdv383 UT WOS:000366374700004 PM 26371282 ER PT J AU Lam, T Chan, MMK Sweeting, AN De Sousa, SMC Clements, A Carlino, MS Long, GV Tonks, K Chua, E Kefford, RF Chipps, DR AF Lam, T. Chan, M. M. K. Sweeting, A. N. De Sousa, S. M. C. Clements, A. Carlino, M. S. Long, G. V. Tonks, K. Chua, E. Kefford, R. F. Chipps, D. R. TI Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series (vol 45, pg 1066, 2015) SO INTERNAL MEDICINE JOURNAL TC 0 Z9 0 SN 1444-0903 EI 1445-5994 PD DEC PY 2015 VL 45 IS 12 BP 1318 EP 1318 DI 10.1111/imj.12943 UT WOS:000366362900022 ER PT J AU Daud, A AF Daud, Adil TI Current and Emerging Perspectives on Immunotherapy for Melanoma SO SEMINARS IN ONCOLOGY TC 11 Z9 11 SN 0093-7754 EI 1532-8708 PD DEC PY 2015 VL 42 IS 6 SU 3 BP S3 EP S11 DI 10.1053/j.seminoncol.2015.10.003 UT WOS:000366870100002 PM 26598057 ER PT J AU Marques, P Grossman, A AF Marques, Pedro Grossman, Ashley TI Ipilimumab-Induced Autoimmune Hypophysitis: Diagnostic and Management Challenges Illustrated by a Clinical Case SO ACTA MEDICA PORTUGUESA TC 1 Z9 1 SN 1646-0758 PD NOV-DEC PY 2015 VL 28 IS 6 BP 775 EP 779 UT WOS:000368526700018 PM 27265913 ER PT J AU Heaney, AP Sumerel, B Rajalingam, R Bergsneider, M Yong, WH Liau, LM AF Heaney, Anthony P. Sumerel, Brittany Rajalingam, Raja Bergsneider, Marvin Yong, William H. Liau, Linda M. TI HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 3 Z9 4 SN 0021-972X EI 1945-7197 PD NOV PY 2015 VL 100 IS 11 BP 4092 EP 4097 DI 10.1210/jc.2015-2702 UT WOS:000364925700037 PM 26317559 ER PT J AU Elhalawani, H Fouad, M Abdel-Rahman, OM AF Elhalawani, H. Fouad, M. Abdel-Rahman, O. M. TI Risk of endocrine complications and elevated liver transaminases in patients with solid tumors treated with immune checkpoint inhibitors; A meta-analysis SO ANNALS OF ONCOLOGY CT Meeting of the European-Society-for-Medical-Oncology (ESMO) CY NOV 20-21, 2015 CL Lausanne, SWITZERLAND TC 0 Z9 0 SN 0923-7534 EI 1569-8041 PD NOV PY 2015 VL 26 SU 8 MA 21P BP 8 EP 8 UT WOS:000365160300022 ER PT J AU Gaudy, C Clevy, C Monestier, S Dubois, N Preau, Y Mallet, S Richard, MA Grob, JJ Valero, R Beliard, S AF Gaudy, Caroline Clevy, Celine Monestier, Sandrine Dubois, Noemie Preau, Yanis Mallet, Stephanie Richard, Marie-Aleth Grob, Jean-Jacques Valero, Rene Beliard, Sophie TI Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes SO DIABETES CARE TC 22 Z9 25 SN 0149-5992 EI 1935-5548 PD NOV PY 2015 VL 38 IS 11 BP E182 EP E183 DI 10.2337/dc15-1331 UT WOS:000364342500004 PM 26310693 ER PT J AU Quirk, SK Shure, AK Agrawal, DK AF Quirk, Shannon K. Shure, Anna K. Agrawal, Devendra K. TI Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma SO TRANSLATIONAL RESEARCH TC 11 Z9 12 SN 1931-5244 EI 1878-1810 PD NOV PY 2015 VL 166 IS 5 BP 412 EP 424 DI 10.1016/j.trsl.2015.06.005 UT WOS:000363711600002 PM 26118951 ER PT J AU Yamazaki, N Kiyohara, Y Uhara, H Fukushima, S Uchi, H Shibagaki, N Tsutsumida, A Yoshikawa, S Okuyama, R Ito, Y Tokudome, T AF Yamazaki, N. Kiyohara, Y. Uhara, H. Fukushima, S. Uchi, H. Shibagaki, N. Tsutsumida, A. Yoshikawa, S. Okuyama, R. Ito, Y. Tokudome, T. TI Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma SO CANCER CHEMOTHERAPY AND PHARMACOLOGY TC 9 Z9 9 SN 0344-5704 EI 1432-0843 PD NOV PY 2015 VL 76 IS 5 BP 997 EP 1004 DI 10.1007/s00280-015-2873-x UT WOS:000363245800013 PM 26410424 ER PT J AU Bacanovic, S Burger, IA Stolzmann, P Hafner, J Huellner, MW AF Bacanovic, Sara Burger, Irene A. Stolzmann, Paul Hafner, Juerg Huellner, Martin W. TI Ipilimumab-Induced Adrenalitis A Possible Pitfall in F-18-FDG-PET/CT SO CLINICAL NUCLEAR MEDICINE TC 7 Z9 7 SN 0363-9762 EI 1536-0229 PD NOV PY 2015 VL 40 IS 11 BP e518 EP e519 DI 10.1097/RLU.0000000000000887 UT WOS:000363043000009 PM 26164177 ER PT J AU Johnson, DB Mudigonda, TV Sosman, JA AF Johnson, Douglas B. Mudigonda, Tejaswi V. Sosman, Jeffrey A. TI Melanoma and a Headache SO JAMA ONCOLOGY TC 1 Z9 1 SN 2374-2437 EI 2374-2445 PD NOV PY 2015 VL 1 IS 8 BP 1167 EP 1168 DI 10.1001/jamaoncol.2015.2537 UT WOS:000383677700026 PM 26225893 ER PT J AU Araujo, PB Coelho, MCA Arruda, M Gadelha, MR Neto, LV AF Araujo, P. B. Coelho, M. C. A. Arruda, M. Gadelha, M. R. Neto, L. V. TI Ipilimumab-induced hypophysitis: review of the literature SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION OI Vieira Neto, Leonardo/0000-0002-1595-3985 TC 11 Z9 12 SN 1720-8386 PD NOV PY 2015 VL 38 IS 11 BP 1159 EP 1166 DI 10.1007/s40618-015-0301-z UT WOS:000362681800002 PM 25957829 ER PT J AU Tirumani, SH Ramaiya, NH Keraliya, A Bailey, ND Ott, PA Hodi, FS Nishino, M AF Tirumani, Sree Harsha Ramaiya, Nikhil H. Keraliya, Abhishek Bailey, Nancy D. Ott, Patrick A. Hodi, F. Stephen Nishino, Mizuki TI Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab SO CANCER IMMUNOLOGY RESEARCH TC 14 Z9 14 SN 2326-6066 EI 2326-6074 PD OCT PY 2015 VL 3 IS 10 BP 1185 EP 1192 DI 10.1158/2326-6066.CIR-15-0102 UT WOS:000363408400010 PM 26100356 ER PT J AU Kurose, K Ohue, Y Wada, H Iida, S Ishida, T Kojima, T Doi, T Suzuki, S Isobe, M Funakoshi, T Kakimi, K Nishikawa, H Udono, H Oka, M Ueda, R Nakayama, E AF Kurose, Koji Ohue, Yoshihiro Wada, Hisashi Iida, Shinsuke Ishida, Takashi Kojima, Takashi Doi, Toshihiko Suzuki, Susumu Isobe, Midori Funakoshi, Takeru Kakimi, Kazuhiro Nishikawa, Hiroyoshi Udono, Heiichiro Oka, Mikio Ueda, Ryuzo Nakayama, Eiichi TI Phase Ia Study of FoxP3(+) CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients SO CLINICAL CANCER RESEARCH RI Funakoshi, Takeru/A-7994-2015 OI Funakoshi, Takeru/0000-0002-8893-4590 TC 16 Z9 16 SN 1078-0432 EI 1557-3265 PD OCT 1 PY 2015 VL 21 IS 19 BP 4327 EP 4336 DI 10.1158/1078-0432.CCR-15-0357 UT WOS:000363330500014 PM 26429981 ER PT J AU Gao, J He, Q Subudhi, S Aparicio, A Zurita-Saavedra, A Lee, DH Jimenez, C Suarez-Almazor, M Sharma, P AF Gao, J. He, Q. Subudhi, S. Aparicio, A. Zurita-Saavedra, A. Lee, D. H. Jimenez, C. Suarez-Almazor, M. Sharma, P. TI Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience SO ONCOGENE TC 14 Z9 14 SN 0950-9232 EI 1476-5594 PD OCT PY 2015 VL 34 IS 43 BP 5411 EP 5417 DI 10.1038/onc.2015.5 UT WOS:000363479700001 PM 25659583 ER PT J AU Lam, T Chan, MMK Sweeting, AN De Sousa, SMC Clements, A Carlino, MS Long, GV Tonks, K Chua, E Kefford, RF Chipps, DR AF Lam, T. Chan, M. M. K. Sweeting, A. N. De Sousa, S. M. C. Clements, A. Carlino, M. S. Long, G. V. Tonks, K. Chua, E. Kefford, R. F. Chipps, D. R. TI Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series SO INTERNAL MEDICINE JOURNAL OI De Sousa, Sunita/0000-0003-0127-6482 TC 2 Z9 2 SN 1444-0903 EI 1445-5994 PD OCT PY 2015 VL 45 IS 10 BP 1066 EP 1073 DI 10.1111/imj.12819 UT WOS:000362402700013 PM 26010858 ER PT J AU Bertrand, A Kostine, M Barnetche, T Truchetet, ME Schaeverbeke, T AF Bertrand, Anne Kostine, Marie Barnetche, Thomas Truchetet, Marie-Elise Schaeverbeke, Thierry TI Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis SO BMC MEDICINE TC 55 Z9 56 SN 1741-7015 PD SEP 4 PY 2015 VL 13 AR 211 DI 10.1186/s12916-015-0455-8 UT WOS:000360675100001 PM 26337719 ER PT J AU Mellati, M Eaton, KD Brooks-Worrell, BM Hagopian, WA Martins, R Palmer, JP Hirsch, IB AF Mellati, Mahnaz Eaton, Keith D. Brooks-Worrell, Barbara M. Hagopian, William A. Martins, Renato Palmer, Jerry P. Hirsch, Irl B. TI Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes SO DIABETES CARE TC 12 Z9 12 SN 0149-5992 EI 1935-5548 PD SEP PY 2015 VL 38 IS 9 BP E137 EP E138 DI 10.2337/dc15-0889 UT WOS:000363416500004 PM 26116720 ER PT J AU Kong, YM Brown, NK Morris, GP Flynn, JC AF Kong, Y. M. Brown, N. K. Morris, G. P. Flynn, J. C. TI The Essential Role of Circulating Thyroglobulin in Maintaining Dominance of Natural Regulatory T Cell Function to Prevent Autoimmune Thyroiditis SO HORMONE AND METABOLIC RESEARCH RI Morris, Gerald/I-3680-2016 OI Morris, Gerald/0000-0002-1097-4453; Brown, Nicholas/0000-0002-0046-2315 TC 3 Z9 3 SN 0018-5043 EI 1439-4286 PD SEP PY 2015 VL 47 IS 10 BP 711 EP 720 DI 10.1055/s-0035-1548872 UT WOS:000361145500004 PM 26158397 ER PT J AU Iglesias, P Soria, A Diez, JJ AF Iglesias, Pedro Soria, Ainara Jose Diez, Juan TI Autoimmune endocrinopathies induced by immunomodulating antibodies in the treatment of cancer SO MEDICINA CLINICA TC 0 Z9 0 SN 0025-7753 EI 1578-8989 PD SEP PY 2015 VL 145 IS 6 BP 264 EP 268 DI 10.1016/j.medcli.2015.02.010 UT WOS:000361165600007 PM 25851909 ER PT J AU Baltzer, A Forkel, S Brehmer, F Schon, MP Kretschmer, L Kai, T AF Baltzer, A. Forkel, S. Brehmer, F. Schoen, M. P. Kretschmer, L. Kai, T. TI Hypophysitis under Ipilimumab? Indeed Neuroborreliosis SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT TC 0 Z9 0 SN 1610-0379 EI 1610-0387 PD AUG PY 2015 VL 13 SU 2 MA P50 BP 43 EP 43 UT WOS:000360219800096 ER PT J AU Waidmann, O Trojan, J AF Waidmann, Oliver Trojan, Joerg TI Novel drugs in clinical development for hepatocellular carcinoma SO EXPERT OPINION ON INVESTIGATIONAL DRUGS TC 8 Z9 8 SN 1354-3784 EI 1744-7658 PD AUG PY 2015 VL 24 IS 8 BP 1075 EP 1082 DI 10.1517/13543784.2015.1058776 UT WOS:000358751200007 PM 26108356 ER PT J AU McKinney, EF Lee, JC Jayne, DRW Lyons, PA Smith, KGC AF McKinney, Eoin F. Lee, James C. Jayne, David R. W. Lyons, Paul A. Smith, Kenneth G. C. TI T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection SO NATURE OI Lee, James/0000-0001-5711-9385 TC 53 Z9 54 SN 0028-0836 EI 1476-4687 PD JUL 30 PY 2015 VL 523 IS 7562 BP 612 EP + DI 10.1038/nature14468 UT WOS:000358655200049 PM 26123020 ER PT J AU Eatrides, JM Weber, J Egan, K Acierno, M Schell, M Lillienfeld, H Creelan, B AF Eatrides, Jennifer M. Weber, Jeffrey Egan, Kathleen Acierno, Marjorie Schell, Michael Lillienfeld, Howard Creelan, Ben TI Autoimmune hypophysitis is a marker of favorable outcome during treatment of melanoma with ipilimumab SO CANCER RESEARCH CT AACR Special Conference on Advances in Melanoma - From Biology to Therapy CY SEP 20-23, 2014 CL Philadelphia, PA TC 0 Z9 0 SN 0008-5472 EI 1538-7445 PD JUL 15 PY 2015 VL 75 SU 14 MA B23 DI 10.1158/1538-7445.MEL2014-B23 UT WOS:000370972700041 ER PT J AU Gedye, C van der Westhuizen, A John, T AF Gedye, C. van der Westhuizen, A. John, T. TI Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities SO INTERNAL MEDICINE JOURNAL TC 3 Z9 3 SN 1444-0903 EI 1445-5994 PD JUL PY 2015 VL 45 IS 7 BP 696 EP 701 DI 10.1111/imj.12653 UT WOS:000357432200003 PM 25444021 ER PT J AU Wu, H Sun, Y Ye, HH Yang, S Lee, SL de las Morenas, A AF Wu, Hao Sun, Yue Ye, Huihui Yang, Shi Lee, Stephanie L. de las Morenas, Antonio TI Anaplastic Thyroid Cancer: Outcome and the Mutation/Expression Profiles of Potential Targets SO PATHOLOGY & ONCOLOGY RESEARCH TC 9 Z9 9 SN 1219-4956 EI 1532-2807 PD JUL PY 2015 VL 21 IS 3 BP 695 EP 701 DI 10.1007/s12253-014-9876-5 UT WOS:000355624700023 PM 25588542 ER PT J AU Weber, JS Yang, JC Atkins, MB Disis, ML AF Weber, Jeffrey S. Yang, James C. Atkins, Michael B. Disis, Mary L. TI Toxicities of Immunotherapy for the Practitioner SO JOURNAL OF CLINICAL ONCOLOGY TC 83 Z9 86 SN 0732-183X EI 1527-7755 PD JUN 20 PY 2015 VL 33 IS 18 BP 2092 EP U154 DI 10.1200/JCO.2014.60.0379 UT WOS:000361652800016 PM 25918278 ER PT J AU Gibney, GT Atkins, MB AF Gibney, Geoffrey T. Atkins, Michael B. TI Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma SO JOURNAL OF CLINICAL ONCOLOGY TC 3 Z9 3 SN 0732-183X EI 1527-7755 PD JUN 10 PY 2015 VL 33 IS 17 BP 1873 EP U27 DI 10.1200/JCO.2014.60.1807 UT WOS:000355999800005 PM 25964248 ER PT J AU Martin-Liberal, J Furness, AJS Joshi, K Peggs, KS Quezada, SA Larkin, J AF Martin-Liberal, Juan Furness, Andrew J. S. Joshi, Kroopa Peggs, Karl S. Quezada, Sergio A. Larkin, James TI Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report SO CANCER IMMUNOLOGY IMMUNOTHERAPY TC 32 Z9 33 SN 0340-7004 EI 1432-0851 PD JUN PY 2015 VL 64 IS 6 BP 765 EP 767 DI 10.1007/s00262-015-1689-1 UT WOS:000355775500012 PM 25828465 ER PT J AU Tiu, C Pezaro, C Davis, ID Grossmann, M Parente, P AF Tiu, Crescens Pezaro, Carmel Davis, Ian D. Grossmann, Mathis Parente, Phillip TI Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management SO ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY TC 2 Z9 2 SN 1743-7555 EI 1743-7563 PD JUN PY 2015 VL 11 IS 2 BP 190 EP 194 DI 10.1111/ajco.12348 UT WOS:000354212500013 PM 25855890 ER PT J AU Schroder, PM Khattar, M Baum, CE Miyahara, Y Chen, WH Vyas, R Muralidharan, S Mierzejewska, B Stepkowski, SM AF Schroder, Paul M. Khattar, Mithun Baum, Caitlin E. Miyahara, Yoshihiro Chen, Wenhao Vyas, Rohit Muralidharan, Shravan Mierzejewska, Beata Stepkowski, Stanislaw M. TI PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCR beta mAb therapy SO DIABETOLOGIA TC 1 Z9 1 SN 0012-186X EI 1432-0428 PD JUN PY 2015 VL 58 IS 6 BP 1309 EP 1318 DI 10.1007/s00125-015-3564-1 UT WOS:000353893000021 PM 25794782 ER PT J AU Robert, C Joshua, AM Kefford, R Joseph, RW Wolchok, JD Hodi, FS Hamid, O Weber, JS Gangadhar, TC Dronca, RS Patnaik, A Zarour, HM Hwu, WJ Hersey, P Daud, A Giannotti, M Li, XN Ebbinghaus, S Kang, SP Ribas, A AF Robert, Caroline Joshua, Anthony M. Kefford, Richard Joseph, Richard Wayne Wolchok, Jedd D. Hodi, F. Stephen Hamid, Omid Weber, Jeffrey S. Gangadhar, Tara C. Dronca, Roxana Stefania Patnaik, Amita Zarour, Hassane M. Hwu, Wen-Jen Hersey, Peter Daud, Adil Giannotti, Maxine Li, Xiaoyun Nicole Ebbinghaus, Scot Kang, Soonmo Peter Ribas, Antoni TI Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001. SO JOURNAL OF CLINICAL ONCOLOGY CT Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) CY MAY 29-JUN 02, 2015 CL Chicago, IL TC 4 Z9 4 SN 0732-183X EI 1527-7755 PD MAY 20 PY 2015 VL 33 IS 15 SU S MA 9050 UT WOS:000358036901960 ER PT J AU Orlov, S Salari, F Kashat, L Walfish, PG AF Orlov, Steven Salari, Farnaz Kashat, Lawrence Walfish, Paul G. TI Induction of Painless Thyroiditis in Patients Receiving Programmed Death 1 Receptor Immunotherapy for Metastatic Malignancies SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 13 Z9 13 SN 0021-972X EI 1945-7197 PD MAY PY 2015 VL 100 IS 5 BP 1738 EP 1741 DI 10.1210/jc.2014-4560 UT WOS:000357669000022 PM 25751110 ER PT J AU Wyluda, EJ Cheng, JH Schell, TD Haley, JS Mallon, C Neves, RI Robertson, G Sivik, J Mackley, H Talamo, G Drabick, JJ AF Wyluda, Edward J. Cheng, Jihua Schell, Todd D. Haley, Jeremy S. Mallon, Carol Neves, Rogerio I. Robertson, Gavin Sivik, Jeffrey Mackley, Heath Talamo, Giampaolo Drabick, Joseph J. TI Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy SO CANCER BIOLOGY & THERAPY OI Robertson, Gavin P./0000-0003-0152-2997 TC 9 Z9 9 SN 1538-4047 EI 1555-8576 PD MAY PY 2015 VL 16 IS 5 BP 662 EP 670 DI 10.1080/15384047.2015.1026507 UT WOS:000354981300004 PM 25806780 ER PT J AU El Khatib, MM Sakuma, T Tonne, JM Mohamed, MS Holditch, SJ Lu, B Kudva, YC Ikeda, Y AF El Khatib, M. M. Sakuma, T. Tonne, J. M. Mohamed, M. S. Holditch, S. J. Lu, B. Kudva, Y. C. Ikeda, Y. TI beta-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection SO GENE THERAPY TC 2 Z9 2 SN 0969-7128 EI 1476-5462 PD MAY PY 2015 VL 22 IS 5 BP 430 EP 438 DI 10.1038/gt.2015.18 UT WOS:000354106200009 PM 25786871 ER PT J AU Buddhisa, S Rinchai, D Ato, M Bancroft, GJ Lertmemongkolchai, G AF Buddhisa, Surachat Rinchai, Darawan Ato, Manabu Bancroft, Gregory J. Lertmemongkolchai, Ganjana TI Programmed Death Ligand 1 on Burkholderia pseudomallei-Infected Human Polymorphonuclear Neutrophils Impairs T Cell Functions SO JOURNAL OF IMMUNOLOGY OI Rinchai, Darawan/0000-0001-8851-7730; Lertmemongkolchai, Ganjana/0000-0001-6972-585X TC 7 Z9 7 SN 0022-1767 EI 1550-6606 PD MAY 1 PY 2015 VL 194 IS 9 BP 4413 EP 4421 DI 10.4049/jimmunol.1402417 UT WOS:000353727400039 PM 25801435 ER PT J AU Eggermont, AMM Chiarion-Sileni, V Grob, JJ Dummer, R Wolchok, JD Schmidt, H Hamid, O Robert, C Ascierto, PA Richards, JM Lebbe, C Ferraresi, V Smylie, M Weber, JS Maio, M Konto, C Hoos, A de Pril, V Gurunath, RK de Schaetzen, G Suciu, S Testori, A AF Eggermont, Alexander M. M. Chiarion-Sileni, Vanna Grob, Jean-Jacques Dummer, Reinhard Wolchok, Jedd D. Schmidt, Henrik Hamid, Omid Robert, Caroline Ascierto, Paolo A. Richards, Jon M. Lebbe, Celeste Ferraresi, Virginia Smylie, Michael Weber, Jeffrey S. Maio, Michele Konto, Cyril Hoos, Axel de Pril, Veerle Gurunath, Ravichandra Karra de Schaetzen, Gaetan Suciu, Stefan Testori, Alessandro TI Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial SO LANCET ONCOLOGY OI coral, sandra/0000-0002-1308-3082 TC 196 Z9 203 SN 1470-2045 EI 1474-5488 PD MAY PY 2015 VL 16 IS 5 BP 522 EP 530 DI 10.1016/S1470-2045(15)70122-1 UT WOS:000353908200046 PM 25840693 ER PT J AU Henderson, AD Thomas, DA AF Henderson, Amanda D. Thomas, Dilip A. TI A Case Report of Orbital Inflammatory Syndrome Secondary to Ipilimumab SO OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY TC 3 Z9 3 SN 0740-9303 EI 1537-2677 PD MAY-JUN PY 2015 VL 31 IS 3 BP E68 EP E70 DI 10.1097/IOP.0000000000000081 UT WOS:000354222200010 PM 24814274 ER PT J AU Johnson, DB Friedman, DL Berry, E Decker, I Ye, F Zhao, SL Morgans, AK Puzanov, I Sosman, JA Lovly, CM AF Johnson, Douglas B. Friedman, Debra L. Berry, Elizabeth Decker, Ilka Ye, Fei Zhao, Shilin Morgans, Alicia K. Puzanov, Igor Sosman, Jeffrey A. Lovly, Christine M. TI Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center SO CANCER IMMUNOLOGY RESEARCH TC 15 Z9 15 SN 2326-6066 EI 2326-6074 PD MAY PY 2015 VL 3 IS 5 BP 464 EP 469 DI 10.1158/2326-6066.CIR-14-0217 UT WOS:000353701500006 PM 25649350 ER PT J AU Su, D Singer, EA Srinivasan, R AF Su, Daniel Singer, Eric A. Srinivasan, Ramaprasad TI Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology SO CURRENT OPINION IN ONCOLOGY TC 6 Z9 8 SN 1040-8746 EI 1531-703X PD MAY PY 2015 VL 27 IS 3 BP 217 EP 223 DI 10.1097/CCO.0000000000000186 UT WOS:000352650300010 PM 25811348 ER PT J AU Zhou, J Jin, JO Du, J Yu, Q AF Zhou, Jing Jin, Jun-O Du, Juan Yu, Qing TI Blockade of PD-L1 accelerates the development of Sjogren's syndrome in non-obese diabetic mice SO JOURNAL OF IMMUNOLOGY CT Annual Meeting of the American-Association-of-Immunologists (IMMUNOLOGY) CY MAY 08-12, 2015 CL New Orleans, LA TC 0 Z9 0 SN 0022-1767 EI 1550-6606 PD MAY 1 PY 2015 VL 194 SU 1 MA HUM3P.256 UT WOS:000379404500158 ER PT J AU Pauken, KE Nelson, CE Martinov, T Spanier, JA Heffernan, JR Sahli, NL Quarnstrom, CF Osum, KC Schenkel, JM Jenkins, MK Blazar, BR Vezys, V Fife, BT AF Pauken, Kristen E. Nelson, Christine E. Martinov, Tijana Spanier, Justin A. Heffernan, James R. Sahli, Nathanael L. Quarnstrom, Clare F. Osum, Kevin C. Schenkel, Jason M. Jenkins, Marc K. Blazar, Bruce R. Vezys, Vaiva Fife, Brian T. TI Cutting Edge: Identification of Autoreactive CD4(+) and CD8(+) T Cell Subsets Resistant to PD-1 Pathway Blockade SO JOURNAL OF IMMUNOLOGY OI Jenkins, Marc/0000-0001-8009-7655 TC 4 Z9 4 SN 0022-1767 EI 1550-6606 PD APR 15 PY 2015 VL 194 IS 8 BP 3551 EP + DI 10.4049/jimmunol.1402262 UT WOS:000353247000005 PM 25769925 ER PT J AU Schmutz, JL AF Schmutz, J. -L. TI A new form of hypophisitis following ipilimumab therapy SO ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE TC 0 Z9 0 SN 0151-9638 EI 2214-5451 PD APR PY 2015 VL 142 IS 4 BP 307 EP 308 DI 10.1016/j.annder.2015.02.001 UT WOS:000354008400018 PM 25770731 ER PT J AU Hughes, J Vudattu, N Sznol, M Gettinger, S Kluger, H Lupsa, B Herold, KC AF Hughes, Jing Vudattu, Nalini Sznol, Mario Gettinger, Scott Kluger, Harriet Lupsa, Beatrice Herold, Kevan C. TI Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy SO DIABETES CARE TC 42 Z9 43 SN 0149-5992 EI 1935-5548 PD APR PY 2015 VL 38 IS 4 BP e55 EP e57 DI 10.2337/dc14-2349 UT WOS:000351630900003 PM 25805871 ER PT J AU Cheng, R Cooper, A Kench, J Watson, G Bye, W McNeil, C Shackel, N AF Cheng, Robert Cooper, Adam Kench, James Watson, Geoff Bye, William McNeil, Catriona Shackel, Nicholas TI Ipilimumab-induced toxicities and the gastroenterologist SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY TC 13 Z9 13 SN 0815-9319 EI 1440-1746 PD APR PY 2015 VL 30 IS 4 BP 657 EP 666 DI 10.1111/jgh.12888 UT WOS:000351403200012 PM 25641691 ER PT J AU Lesokhin, AM Callahan, MK Postow, MA Wolchok, JD AF Lesokhin, Alexander M. Callahan, Margaret K. Postow, Michael A. Wolchok, Jedd D. TI On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation SO SCIENCE TRANSLATIONAL MEDICINE TC 32 Z9 33 SN 1946-6234 EI 1946-6242 PD MAR 25 PY 2015 VL 7 IS 280 AR 280sr1 DI 10.1126/scitranslmed.3010274 UT WOS:000351772700006 PM 25810313 ER PT J AU Tanaka, R Fujisawa, Y Maruyama, H Nakamura, Y Yoshino, K Ohtsuka, M Fujimoto, M AF Tanaka, R. Fujisawa, Y. Maruyama, H. Nakamura, Y. Yoshino, K. Ohtsuka, M. Fujimoto, M. TI CASE SERIES OF THYROID DYSFUNCTION INDUCED BY NIVOLUMAB (ANTI-PD-1; ONO-4538) SO ANNALS OF ONCOLOGY CT 13th International Congress on Targeted Anticancer Therapies (TAT) CY MAR 02-04, 2015 CL Paris, FRANCE TC 0 Z9 0 SN 0923-7534 EI 1569-8041 PD MAR PY 2015 VL 26 SU 2 MA P8.09 BP 35 EP 35 DI 10.1093/annonc/mdv097.8 UT WOS:000354729300040 ER PT J AU Wozniak, S Mackiewicz-Wysocka, M Krokowicz, L Kwinta, L Mackiewicz, J AF Wozniak, Sebastian Mackiewicz-Wysocka, Malgorzata Krokowicz, Lukasz Kwinta, Lukasz Mackiewicz, Jacek TI Febrile Neutropenia in a Metastatic Melanoma Patient Treated with Ipilimumab - Case Report SO ONCOLOGY RESEARCH AND TREATMENT TC 2 Z9 2 SN 2296-5270 EI 2296-5262 PD MAR PY 2015 VL 38 IS 3 BP 105 EP 108 DI 10.1159/000377650 UT WOS:000351191600003 PM 25792081 ER PT J AU Venditti, O De Lisi, D Caricato, M Caputo, D Capolupo, GT Taffon, C Pagliara, E Battisi, S Frezza, AM Muda, AO Tonini, G Santini, D AF Venditti, Olga De Lisi, Delia Caricato, Marco Caputo, Damiano Capolupo, Gabriella Teresa Taffon, Chiara Pagliara, Elisa Battisi, Sofia Frezza, Anna Maria Muda, Andrea Onetti Tonini, Giuseppe Santini, Daniele TI Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis SO BMC CANCER RI Caricato, Marco/C-1680-2013; Caputo, Damiano/J-4332-2016; Frezza, Anna Maria/E-2798-2017 OI Caricato, Marco/0000-0002-5610-1615; Caputo, Damiano/0000-0001-7058-1945; Frezza, Anna Maria/0000-0003-2335-7224; ONETTI MUDA, ANDREA/0000-0002-0274-6178; Santini, Daniele/0000-0002-9118-3337; Tonini, Giuseppe/0000-0003-4442-8677; Coppola, Roberto/0000-0001-5798-0714 TC 2 Z9 2 SN 1471-2407 PD MAR 1 PY 2015 VL 15 AR 87 DI 10.1186/s12885-015-1074-7 UT WOS:000350327400001 PM 25885696 ER PT J AU Min, L Hodi, FS Giobbie-Hurder, A Ott, PA Luke, JJ Donahue, H Davis, M Carroll, RS Kaiser, UB AF Min, Le Hodi, Frank Stephen Giobbie-Hurder, Anita Ott, Patrick A. Luke, Jason J. Donahue, Hilary Davis, Meredith Carroll, Rona S. Kaiser, Ursula B. TI Systemic High-Dose Corticosteroid Treatment Does Not Improve the Outcome of Ipilimumab-Related Hypophysitis: A Retrospective Cohort Study SO CLINICAL CANCER RESEARCH TC 24 Z9 24 SN 1078-0432 EI 1557-3265 PD FEB 15 PY 2015 VL 21 IS 4 BP 749 EP 755 DI 10.1158/1078-0432.CCR-14-2353 UT WOS:000349851200013 PM 25538262 ER PT J AU Schultheis, AM Scheel, AH Ozretic, L George, J Thomas, RK Hagemann, T Zander, T Wolf, J Buettner, R AF Schultheis, Anne M. Scheel, Andreas H. Ozretic, Luka George, Julie Thomas, Roman K. Hagemann, Thorsten Zander, Thomas Wolf, Juergen Buettner, Reinhard TI PD-L1 expression in small cell neuroendocrine carcinomas SO EUROPEAN JOURNAL OF CANCER TC 39 Z9 39 SN 0959-8049 EI 1879-0852 PD FEB PY 2015 VL 51 IS 3 BP 421 EP 426 DI 10.1016/j.ejca.2014.12.006 UT WOS:000350834100017 PM 25582496 ER PT J AU Breckwoldt, M Bendszus, M AF Breckwoldt, M. Bendszus, M. TI Cerebral MR imaging of malignant melanoma SO RADIOLOGE TC 2 Z9 3 SN 0033-832X EI 1432-2102 PD FEB PY 2015 VL 55 IS 2 BP 113 EP 119 DI 10.1007/s00117-014-2761-0 UT WOS:000349962300006 PM 25589420 ER PT J AU Stahl, T Loquai, C AF Stahl, T. Loquai, C. TI Treatment side effects and follow-up of malignant melanoma SO RADIOLOGE TC 0 Z9 0 SN 0033-832X EI 1432-2102 PD FEB PY 2015 VL 55 IS 2 BP 136 EP 143 DI 10.1007/s00117-014-2764-x UT WOS:000349962300009 PM 25631244 ER PT J AU Albarel, F Gaudy, C Castinetti, F Carre, T Morange, I Conte-Devolx, B Grob, JJ Brue, T AF Albarel, Frederique Gaudy, Caroline Castinetti, Frederic Carre, Tiphaine Morange, Isabelle Conte-Devolx, Bernard Grob, Jean-Jacrues Brue, Thierry TI Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma SO EUROPEAN JOURNAL OF ENDOCRINOLOGY OI Brue, Thierry/0000-0001-8482-6691; Castinetti, Frederic/0000-0002-1808-8800 TC 28 Z9 28 SN 0804-4643 EI 1479-683X PD FEB PY 2015 VL 172 IS 2 DI 10.1530/EJE-14-0845 UT WOS:000349458000017 PM 25416723 ER PT J AU Li, RY Lee, J Kim, MS Liu, V Moulik, M Li, HY Yi, Q Xie, AN Chen, WH Yang, LN Li, YM Tsai, TH Oka, K Chan, L Yechoor, V AF Li, Rongying Lee, Jeongkyung Kim, Mi-sun Liu, Victoria Moulik, Mousumi Li, Haiyan Yi, Qing Xie, Aini Chen, Wenhao Yang, Lina Li, Yimin Tsai, Tsung Huang Oka, Kazuhiro Chan, Lawrence Yechoor, Vijay TI PD-L1-Driven Tolerance Protects Neurogenin3-Induced Islet Neogenesis to Reverse Established Type 1 Diabetes in NOD Mice SO DIABETES TC 4 Z9 4 SN 0012-1797 EI 1939-327X PD FEB PY 2015 VL 64 IS 2 BP 529 EP 540 DI 10.2337/db13-1737 UT WOS:000348827100023 PM 25332429 ER PT J AU Ma, Y Liu, XC Zhu, JY Li, WH Guo, LJ Han, X Song, B Cheng, SS Jie, L AF Ma, Yuan Liu, Xiuchun Zhu, Jingyan Li, Wanhu Guo, Liangjun Han, Xiao Song, Bao Cheng, Sensen Jie, Liu TI Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE TC 6 Z9 8 SN 1940-5901 PY 2015 VL 8 IS 9 BP 16585 EP 16591 UT WOS:000365273300127 PM 26629188 ER PT J AU Alonso-Gordoa, T Capdevila, J Grande, E AF Alonso-Gordoa, T. Capdevila, J. Grande, E. TI GEP-NETs UPDATE Biotherapy for neuroendocrine tumours SO EUROPEAN JOURNAL OF ENDOCRINOLOGY TC 6 Z9 6 SN 0804-4643 EI 1479-683X PD JAN PY 2015 VL 172 IS 1 DI 10.1530/EJE-14-0354 UT WOS:000349457200006 PM 25430657 ER PT J AU De Remigis, A de Gruijl, TD Uram, JN Tzou, SC Iwama, S Talor, MV Armstrong, TD Santegoets, SJAM Slovin, SF Zheng, L Laheru, DA Jaffee, EM Gerritsen, WR van den Eertwegh, AJM Le, DT Caturegli, P AF De Remigis, Alessandra de Gruijl, Tanja D. Uram, Jennifer N. Tzou, Schey-Cherng Iwama, Shintaro Talor, Monica V. Armstrong, Todd D. Santegoets, Saskia J. A. M. Slovin, Susan F. Zheng, Lei Laheru, Daniel A. Jaffee, Elizabeth M. Gerritsen, Winald R. van den Eertwegh, Alfons J. M. Le, Dung T. Caturegli, Patrizio TI Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival SO INTERNATIONAL JOURNAL OF CANCER RI Gerritsen, W.R./H-8031-2014 TC 7 Z9 7 SN 0020-7136 EI 1097-0215 PD JAN 1 PY 2015 VL 136 IS 1 BP 127 EP 137 DI 10.1002/ijc.28973 UT WOS:000344011400014 PM 24832153 ER PT J AU Louiset, E Desailloud, R AF Louiset, Estelle Desailloud, Rachel TI Hypophysitis induced by monoclonal antibody SO CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION TC 0 Z9 0 SN 2100-9619 PD DEC PY 2014 VL 18 IS 10 BP 292 EP 296 UT WOS:000350097500004 ER PT J AU Marlier, J Cocquyt, V Brochez, L Van Belle, S Kruse, V AF Marlier, Joke Cocquyt, Veronique Brochez, Lieve Van Belle, Simon Kruse, Vibeke TI Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports SO ENDOCRINE TC 11 Z9 11 SN 1355-008X EI 1559-0100 PD DEC PY 2014 VL 47 IS 3 BP 878 EP 883 DI 10.1007/s12020-014-0199-9 UT WOS:000345404900028 PM 24554495 ER PT J AU Faje, AT Sullivan, R Lawrence, D Tritos, NA Fadden, R Klibanski, A Nachtigall, L AF Faje, Alexander T. Sullivan, Ryan Lawrence, Donald Tritos, Nicholas A. Fadden, Riley Klibanski, Anne Nachtigall, Lisa TI Ipilimumab-Induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients With Metastatic Melanoma SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 49 Z9 49 SN 0021-972X EI 1945-7197 PD NOV PY 2014 VL 99 IS 11 BP 4078 EP 4085 DI 10.1210/jc.2014-2306 UT WOS:000346743100022 PM 25078147 ER PT J AU Chodakiewitz, Y Brown, S Boxerman, JL Brody, JM Rogg, JM AF Chodakiewitz, Yosef Brown, Sanford Boxerman, Jerrold L. Brody, Jeffrey M. Rogg, Jeffrey M. TI Ipilimumab treatment associated pituitary hypophysitis: Clinical presentation and imaging diagnosis SO CLINICAL NEUROLOGY AND NEUROSURGERY TC 14 Z9 14 SN 0303-8467 EI 1872-6968 PD OCT PY 2014 VL 125 BP 125 EP 130 DI 10.1016/j.clineuro.2014.06.011 UT WOS:000343346900024 PM 25127260 ER PT J AU Eytan, E Wang, KX Miniowitz-Shemtov, S Sitry-Shevah, D Kaisari, S Yen, TJ Liu, ST Hershko, A AF Eytan, Esther Wang, Kexi Miniowitz-Shemtov, Shirly Sitry-Shevah, Danielle Kaisari, Sharon Yen, Tim J. Liu, Song-Tao Hershko, Avram TI Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31(comet) SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA OI Yen, Tim/0000-0003-2159-0997 TC 31 Z9 34 SN 0027-8424 PD AUG 19 PY 2014 VL 111 IS 33 BP 12019 EP 12024 DI 10.1073/pnas.1412901111 UT WOS:000340438800040 PM 25092294 ER PT J AU De Sousa, SMC Long, GV Tonks, KT AF De Sousa, Sunita M. C. Long, Georgina V. Tonks, Katherine T. TI Ipilimumab-induced hypophysitis: early Australian experience SO MEDICAL JOURNAL OF AUSTRALIA TC 2 Z9 2 SN 0025-729X PD AUG 18 PY 2014 VL 201 IS 4 BP 198 EP 199 DI 10.5694/mja14.00803 UT WOS:000341076300009 PM 25164840 ER PT J AU Bjasch, D Maggio, EM Fitsche, A Moch, H Goldinger, SM Dummer, R Mihic-Probst, D AF Bjasch, D. Maggio, E. Marquez Fitsche, A. Moch, H. Goldinger, S. M. Dummer, R. Mihic-Probst, D. TI Immunreactivity for CTLA-4 in anterior pituitary gland cells and neutrophils suggest antibody dependent cytotoxicity to trigger Ipilimumab induced hypophysitis SO VIRCHOWS ARCHIV TC 0 Z9 0 SN 0945-6317 EI 1432-2307 PD AUG PY 2014 VL 465 SU 1 MA PS-07-024 BP S187 EP S188 UT WOS:000344386801253 ER PT J AU Nallapaneni, NN Mourya, R Bhatt, VR Malhotra, S Ganti, AK Tendulkar, KK AF Nallapaneni, Neelima N. Mourya, Rajesh Bhatt, Vijaya Raj Malhotra, Sakshi Ganti, Apar Kishor Tendulkar, Ketki K. TI Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash SO JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK TC 13 Z9 13 SN 1540-1405 EI 1540-1413 PD AUG PY 2014 VL 12 IS 8 BP 1077 EP 1081 UT WOS:000340218200002 PM 25099440 ER PT J AU Izzedine, H Gueutin, V Gharbi, C Mateus, C Robert, C Routier, E Thomas, M Baumelou, A Rouvier, P AF Izzedine, Hassane Gueutin, Victor Gharbi, Chems Mateus, Christine Robert, Caroline Routier, Emilie Thomas, Marina Baumelou, Alain Rouvier, Philippe TI Kidney injuries related to ipilimumab SO INVESTIGATIONAL NEW DRUGS TC 40 Z9 40 SN 0167-6997 EI 1573-0646 PD AUG PY 2014 VL 32 IS 4 BP 769 EP 773 DI 10.1007/s10637-014-0092-7 UT WOS:000339817800023 PM 24687600 ER PT J AU Li, T Ma, R Zhu, JY Wang, FS Huang, L Leng, XS AF Li Tao Ma Rui Zhu Jiye Wang Fushun Huang Lei Leng Xisheng TI Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection SO CHINESE MEDICAL JOURNAL TC 1 Z9 2 SN 0366-6999 PD JUL 20 PY 2014 VL 127 IS 14 BP 2686 EP 2692 DI 10.3760/cma.j.issn.0366-6999.20140740 UT WOS:000339860900026 PM 25043090 ER PT J AU du Rusquec, P Saint-Jean, M Brocard, A Peuvrel, L Khammari, A Quereux, G Dreno, B AF du Rusquec, Pauline Saint-Jean, Melanie Brocard, Anabelle Peuvrel, Lucie Khammari, Amir Quereux, Gaelle Dreno, Brigitte TI Ipilimumab-induced Autoimmune Pancytopenia in a Case of Metastatic Melanoma SO JOURNAL OF IMMUNOTHERAPY TC 10 Z9 10 SN 1524-9557 EI 1537-4513 PD JUL-AUG PY 2014 VL 37 IS 6 BP 348 EP 350 UT WOS:000338135400004 PM 24911795 ER PT J AU Rijavec, E Genova, C Barletta, G Burrafato, G Biello, F Dal Bello, MG Coco, S Truini, A Alama, A Boccardo, F Grossi, F AF Rijavec, Erika Genova, Carlo Barletta, Giulia Burrafato, Giovanni Biello, Federica Dal Bello, Maria Giovanna Coco, Simona Truini, Anna Alama, Angela Boccardo, Francesco Grossi, Francesco TI Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy SO EXPERT OPINION ON BIOLOGICAL THERAPY RI Genova, Carlo/K-1884-2014; Coco, Simona/J-6051-2016 OI Coco, Simona/0000-0002-5296-4325; Grossi, Francesco/0000-0003-2694-968X; Genova, Carlo/0000-0003-3690-8582 TC 4 Z9 4 SN 1471-2598 EI 1744-7682 PD JUL PY 2014 VL 14 IS 7 BP 1007 EP 1017 DI 10.1517/14712598.2014.907786 UT WOS:000337023000012 PM 24702205 ER PT J AU Alkhaddo, JB Khowaja, A Saeed, A Burmeister, L AF Alkhaddo, Jamil Bawerjan Khowaja, Ameer Saeed, Asad Burmeister, Lynn TI Serial TSH Levels during Treatment and Onset of Ipilimumab-Induced Hypophysitis. Failure of TSH Alone to Make the Diagnosis SO ENDOCRINE REVIEWS TC 0 Z9 0 SN 0163-769X EI 1945-7189 PD JUN PY 2014 VL 35 IS 3 SU S MA MON-0676 UT WOS:000209805102011 ER PT J AU Buddhdev, K Buddhdev, BM AF Buddhdev, Kajalben Buddhdev, Bhuvin Mukesh TI A Rare Case of Ipilimumab Induced Pituitary Hypophysitis: An Evolving Clinical Entity SO ENDOCRINE REVIEWS TC 0 Z9 0 SN 0163-769X EI 1945-7189 PD JUN PY 2014 VL 35 IS 3 SU S MA MON-0677 UT WOS:000209805102012 ER PT J AU Faje, AT Sullivan, R Lawrence, D Tritos, NA Klibanski, A Nachtigall, LB AF Faje, Alexander Terence Sullivan, Ryan Lawrence, Donald Tritos, Nicholas A. Klibanski, Anne Nachtigall, Lisa B. TI Ipilimumab-Induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients with Metastatic Melanoma SO ENDOCRINE REVIEWS TC 0 Z9 0 SN 0163-769X EI 1945-7189 PD JUN PY 2014 VL 35 IS 3 SU S MA MON-0674 UT WOS:000209805102009 ER PT J AU Krull, I Rogowski-Lehmann, N Sigrist, S Siano, M Brandle, M Bilz, S AF Krull, Ina Rogowski-Lehmann, Natalie Sigrist, Sarah Siano, Marco Brandle, Michael Bilz, Stefan TI Thyroid Dysfunction in a Patient Treated with Ipilimumab: Autoimmune Thyroid Disease Associated with Anti-CTLA-4 Therapy SO ENDOCRINE REVIEWS TC 0 Z9 0 SN 0163-769X EI 1945-7189 PD JUN PY 2014 VL 35 IS 3 SU S MA SAT-0494 UT WOS:000209805108234 ER PT J AU Min, L Hodi, FS Carroll, RS Kaiser, UB AF Min, Le Hodi, F. Stephen Carroll, Rona S. Kaiser, Ursula B. TI Hypophysitis Associated with Ipilimumab, a Novel Immunotherapy for Metastatic Melanoma: Analysis of 26 Cases SO ENDOCRINE REVIEWS TC 0 Z9 0 SN 0163-769X EI 1945-7189 PD JUN PY 2014 VL 35 IS 3 SU S MA MON-0675 UT WOS:000209805102010 ER PT J AU Kong, YCM Flynn, JC AF Kong, Yi-chi M. Flynn, Jeffrey C. TI Opportunistic autoimmune disorcers potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1 SO FRONTIERS IN IMMUNOLOGY TC 29 Z9 30 SN 1664-3224 PD MAY 16 PY 2014 VL 5 AR 206 DI 10.3389/fimmu.2014.00206 UT WOS:000354220400001 PM 24904570 ER PT J AU Fischli, S Allelein, S Zander, T Henzen, C AF Fischli, S. Allelein, S. Zander, T. Henzen, C. TI Endocrinologic side effects of oncologic treatment with anti-CTLA-4-antibodies SO DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT TC 2 Z9 2 SN 0012-0472 EI 1439-4413 PD MAY PY 2014 VL 139 IS 19 BP 996 EP 1000 DI 10.1055/s-0034-1369961 UT WOS:000335452200005 PM 24782152 ER PT J AU Iwama, S De Remigis, A Callahan, MK Slovin, SF Wolchok, JD Caturegli, P AF Iwama, Shintaro De Remigis, Alessandra Callahan, Margaret K. Slovin, Susan F. Wolchok, Jedd D. Caturegli, Patrizio TI Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody SO SCIENCE TRANSLATIONAL MEDICINE TC 48 Z9 48 SN 1946-6234 EI 1946-6242 PD APR 2 PY 2014 VL 6 IS 230 AR 230ra45 DI 10.1126/scitranslmed.3008002 UT WOS:000333905000003 PM 24695685 ER PT J AU Ryder, M Callahan, M Postow, MA Wolchok, J Fagin, JA AF Ryder, Mabel Callahan, Margaret Postow, Michael A. Wolchok, Jedd Fagin, James A. TI Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution SO ENDOCRINE-RELATED CANCER TC 68 Z9 68 SN 1351-0088 EI 1479-6821 PD APR PY 2014 VL 21 IS 2 BP 371 EP 381 DI 10.1530/ERC-13-0499 UT WOS:000344787300024 PM 24610577 ER PT J AU Mittal, K Ebos, J Rini, B AF Mittal, Kriti Ebos, John Rini, Brian TI Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond SO SEMINARS IN ONCOLOGY TC 43 Z9 51 SN 0093-7754 EI 1532-8708 PD APR PY 2014 VL 41 IS 2 BP 235 EP 251 DI 10.1053/j.seminoncol.2014.02.007 UT WOS:000335538600009 PM 24787295 ER PT J AU Vanden Borre, P McFadden, DG Gunda, V Sadow, PM Varmeh, S Bernasconi, M Jacks, T Parangi, S AF Vanden Borre, Pierre McFadden, David G. Gunda, Viswanath Sadow, Peter M. Varmeh, Shohreh Bernasconi, Maria Jacks, Tyler Parangi, Sareh TI The Next Generation of Orthotopic Thyroid Cancer Models: Immunocompetent Orthotopic Mouse Models of BRAF(V600E)-Positive Papillary and Anaplastic Thyroid Carcinoma SO THYROID TC 2 Z9 2 SN 1050-7256 EI 1557-9077 PD APR 1 PY 2014 VL 24 IS 4 BP 705 EP 714 DI 10.1089/thy.2013.0483 UT WOS:000334110700012 PM 24295207 ER PT J AU Gelao, L Criscitiello, C Esposito, A Goldhirsch, A Curigliano, G AF Gelao, Lucia Criscitiello, Carmen Esposito, Angela Goldhirsch, Aron Curigliano, Giuseppe TI Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an "Innocent Bystander" SO TOXINS TC 21 Z9 21 SN 2072-6651 PD MAR PY 2014 VL 6 IS 3 BP 914 EP 933 DI 10.3390/toxins6030914 UT WOS:000335755700008 PM 24594636 ER PT J AU Kochupurakkal, NM Kruger, AJ Tripathi, S Zhu, B Adams, L Rainbow, DB Rossini, A Greiner, DL Sayegh, MH Wicker, LS Guleria, I AF Kochupurakkal, Nora M. Kruger, Annie J. Tripathi, Sudipta Zhu, Bing Adams, La Tonya Rainbow, Daniel B. Rossini, Aldo Greiner, Dale L. Sayegh, Mohamed H. Wicker, Linda S. Guleria, Indira TI Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes SO PLOS ONE TC 14 Z9 14 SN 1932-6203 PD FEB 28 PY 2014 VL 9 IS 2 AR e89561 DI 10.1371/journal.pone.0089561 UT WOS:000332396200059 PM 24586872 ER PT J AU Min, L Hodi, FS AF Min, Le Hodi, F. Stephen TI Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and Rhabdomyolysis SO CANCER IMMUNOLOGY RESEARCH TC 40 Z9 42 SN 2326-6066 EI 2326-6074 PD JAN PY 2014 VL 2 IS 1 BP 15 EP 18 DI 10.1158/2326-6066.CIR-13-0146 UT WOS:000340030900003 PM 24778161 ER PT J AU Borodic, GE Hinkle, D AF Borodic, Gary E. Hinkle, David TI Ipilimumab-Induced Orbital Inflammation Resembling Graves Disease With Subsequent Development of Systemic Hyperthyroidism From CTLA-4 Receptor Suppression SO OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY TC 5 Z9 5 SN 0740-9303 EI 1537-2677 PD JAN-FEB PY 2014 VL 30 IS 1 BP 83 EP 83 DI 10.1097/IOP.0000000000000033 UT WOS:000335559600041 PM 24398505 ER PT J AU Scarpati, GD Fusciello, C Perri, F Sabbatino, F Ferrone, S Carlomagno, C Pepe, S AF Scarpati, Giuseppina Della Vittoria Fusciello, Celeste Perri, Francesco Sabbatino, Francesco Ferrone, Soldano Carlomagno, Chiara Pepe, Stefano TI Ipilimumab in the treatment of metastatic melanoma: management of adverse events SO ONCOTARGETS AND THERAPY OI Sabbatino, Francesco/0000-0001-6431-8278 TC 24 Z9 24 SN 1178-6930 PY 2014 VL 7 BP 203 EP 209 DI 10.2147/OTT.S57335 UT WOS:000331840100001 ER PT J AU Torino, F Barnabei, A Paragliola, RM Marchetti, P Salvatori, R Corsello, SM AF Torino, Francesco Barnabei, Agnese Paragliola, Rosa Maria Marchetti, Paolo Salvatori, Roberto Corsello, Salvatore Maria TI mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses SO EUROPEAN JOURNAL OF ENDOCRINOLOGY RI Marchetti, Paolo/K-1469-2016 TC 32 Z9 32 SN 0804-4643 EI 1479-683X PD DEC PY 2013 VL 169 IS 6 BP R153 EP R164 DI 10.1530/EJE-13-0434 UT WOS:000327539100002 PM 24001893 ER PT J AU de Hollanda, A Aranda, GB Mora, M Gaba, L Halperin, I AF de Hollanda, Ana Aranda, Gloria B. Mora, Mireia Gaba, Lydia Halperin, Irene TI Ipilimumab, a cause of autoimmune hypophysitis SO ENDOCRINOLOGIA Y NUTRICION TC 1 Z9 1 SN 1575-0922 EI 1579-2021 PD DEC PY 2013 VL 60 IS 10 BP 604 EP 606 UT WOS:000209715100010 PM 23607982 ER PT J AU Lammert, A Schneider, HJ Bergmann, T Benck, U Kramer, BK Gartner, R Metzner, C Schofl, C Berking, C AF Lammert, A. Schneider, H. J. Bergmann, T. Benck, U. Kraemer, B. K. Gaertner, R. Metzner, C. Schoefl, C. Berking, C. TI Hypophysitis Caused by Ipilimumab in Cancer Patients: Hormone Replacement or Immunosuppressive Therapy SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES TC 17 Z9 17 SN 0947-7349 EI 1439-3646 PD NOV PY 2013 VL 121 IS 10 BP 581 EP 587 DI 10.1055/s-0033-1355337 UT WOS:000328122000002 PM 24122241 ER PT J AU Torino, F Barnabei, A Paragliola, R Baldelli, R Appetecchia, M Corsello, SM AF Torino, Francesco Barnabei, Agnese Paragliola, Rosamaria Baldelli, Roberto Appetecchia, Marialuisa Corsello, Salvatore Maria TI Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs SO THYROID OI Appetecchia, Marialuisa/0000-0002-2124-1335 TC 26 Z9 26 SN 1050-7256 EI 1557-9077 PD NOV 1 PY 2013 VL 23 IS 11 BP 1345 EP 1366 DI 10.1089/thy.2013.0241 UT WOS:000326578800002 PM 23750887 ER PT J AU Gupta, S Jaworska-Bieniek, K Lubinski, J Jakubowska, A AF Gupta, Satish Jaworska-Bieniek, Katarzyna Lubinski, Jan Jakubowska, Anna TI Can selenium be a modifier of cancer risk in CHEK2 mutation carriers? SO MUTAGENESIS RI Jakubowska, Anna/O-8050-2014 TC 4 Z9 5 SN 0267-8357 EI 1464-3804 PD NOV PY 2013 VL 28 IS 6 BP 625 EP 629 DI 10.1093/mutage/get050 UT WOS:000326380000002 PM 24106007 ER PT J AU Zovato, S Sartorato, P Camozzi, V Chiarion, V Pigozzo, J Faoro, S Opocher, G AF Zovato, S. Sartorato, P. Camozzi, V. Chiarion, V. Pigozzo, J. Faoro, S. Opocher, G. TI Endocrine toxicities after treatment with ipilimumab SO EUROPEAN JOURNAL OF CANCER CT European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO CY SEP 27-OCT 01, 2013 CL Amsterdam, NETHERLANDS RI Opocher, Giuseppe/F-3950-2014; Pigozzo, Jacopo/K-2503-2016 OI Opocher, Giuseppe/0000-0002-9845-9623; Pigozzo, Jacopo/0000-0003-2427-8915 TC 0 Z9 0 SN 0959-8049 EI 1879-0852 PD SEP PY 2013 VL 49 SU 2 MA 3750 BP S872 EP S872 UT WOS:000326843605358 ER PT J AU Thum, D Kigitsidou, E Belloni, B Andres, C Krackhardt, A Ring, J Hein, R AF Thum, D. Kigitsidou, E. Belloni, B. Andres, C. Krackhardt, A. Ring, J. Hein, R. TI Development of nodal Erythema in Combination with autoimmune Hepatitis and Hypophysitis during Treatment with Ipilimumab in a Patient with metastatic malignant Melanoma (Stage IV) SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT TC 0 Z9 0 SN 1610-0379 PD SEP PY 2013 VL 11 IS 9 BP 931 EP 931 UT WOS:000323202300092 ER PT J AU Hermes, I Tsiogka, M Rompoti, N Suttorp, W Zimmer, L Schadendorf, D AF Hermes, I Tsiogka, M. Rompoti, N. Suttorp, W. Zimmer, L. Schadendorf, D. TI Autoimmuno-hypophysitis, Autoimmuno-colitis and Autoimmuno-hepatitis in a Patient with metastatic Melanoma during Therapy with CTLA-4 Antibody Ipilimumab SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT TC 0 Z9 0 SN 1610-0379 PD SEP PY 2013 VL 11 IS 9 BP 932 EP 932 UT WOS:000323202300094 ER PT J AU Corsello, SM Salvatori, R Barnabei, A De Vecchis, L Marchetti, P Torino, F AF Corsello, Salvatore Maria Salvatori, Roberto Barnabei, Agnese De Vecchis, Liana Marchetti, Paolo Torino, Francesco TI Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not) SO CANCER CHEMOTHERAPY AND PHARMACOLOGY RI Marchetti, Paolo/K-1469-2016 TC 6 Z9 6 SN 0344-5704 PD AUG PY 2013 VL 72 IS 2 BP 489 EP 490 DI 10.1007/s00280-013-2213-y UT WOS:000322132600022 PM 23779068 ER PT J AU Burgess, D Loh, KP Lee, SY Ali, S AF Burgess, David Loh, Kah Poh Lee, Shin Yin Ali, Syed TI SIXTH CRANIAL NERVE PALSY AS AN UNUSUAL PRESENTING SYMPTOM OF IPILIMUMAB-INDUCED HYPOPHYSITIS SO JOURNAL OF GENERAL INTERNAL MEDICINE CT 36th Annual Meeting of the Society-of-General-Internal-Medicine CY APR 24-27, 2013 CL Denver, CO RI Loh, Kian Ping/M-3122-2016 OI Loh, Kian Ping/0000-0002-1491-743X TC 0 Z9 0 SN 0884-8734 EI 1525-1497 PD JUN PY 2013 VL 28 SU 1 BP S390 EP S391 UT WOS:000331939302242 ER PT J AU Lecouflet, M Verschoore, M Giard, C Gohier, P Le Corre, Y Milea, D Martin, L AF Lecouflet, M. Verschoore, M. Giard, C. Gohier, P. Le Corre, Y. Milea, D. Martin, L. TI Orbital myositis associated with ipilimumab SO ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE TC 14 Z9 14 SN 0151-9638 PD JUN-JUL PY 2013 VL 140 IS 6-7 BP 448 EP 451 DI 10.1016/j.annder.2013.02.029 UT WOS:000321686000008 PM 23773743 ER PT J AU Postow, MA Luke, JJ Bluth, DJ Ramaiya, N Panageas, KS Lawrence, DP Ibrahim, N Flaherty, KT Sullivan, RJ Ott, PA Callahan, DK Harding, JJ D'Angelo, SP Dickson, AA Schwartz, GK Chapman, PB Gnjatic, S Wolchok, JD Hodi, FS Carvajal, RD AF Postow, Michael A. Luke, Jason J. Bluth, Mark J. Ramaiya, Nikhil Panageas, Katherine S. Lawrence, Donald P. Ibrahim, Nageatte Flaherty, Keith T. Sullivan, Ryan J. Ott, Patrick A. Callahan, Margaret K. Harding, James J. D'Angelo, Sandra P. Dickson, Mark A. Schwartz, Gary K. Chapman, Paul B. Gnjatic, Sacha Wolchok, Jedd D. Hodi, F. Stephen Carvajal, Richard D. TI Ipilimumab for Patients With Advanced Mucosal Melanoma SO ONCOLOGIST TC 37 Z9 37 SN 1083-7159 PD JUN PY 2013 VL 18 IS 6 BP 726 EP 732 DI 10.1634/theoncologist.2012-0464 UT WOS:000321043200019 PM 23716015 ER PT J AU Fecher, LA Agarwala, SS Hodi, FS Weber, JS AF Fecher, Leslie A. Agarwala, Sanjiv S. Hodi, F. Stephen Weber, Jeffrey S. TI Ipilimumab and Its Toxicities: A Multidisciplinary Approach SO ONCOLOGIST TC 83 Z9 85 SN 1083-7159 EI 1549-490X PD JUN PY 2013 VL 18 IS 6 BP 733 EP 743 DI 10.1634/theoncologist.2012-0483 UT WOS:000321043200020 PM 23774827 ER PT J AU Gardiner, D Lalezari, J Lawitz, E DiMicco, M Ghalib, R Reddy, KR Chang, KM Sulkowski, M O' Marro, S Anderson, J He, B Kansra, V McPhee, F Wind-Rotolo, M Grasela, D Selby, M Korman, AJ Lowy, I AF Gardiner, David Lalezari, Jay Lawitz, Eric DiMicco, Michael Ghalib, Rheem Reddy, K. Rajender Chang, Kyong-Mi Sulkowski, Mark O' Marro, Steven Anderson, Jeffrey He, Bing Kansra, Vikram McPhee, Fiona Wind-Rotolo, Megan Grasela, Dennis Selby, Mark Korman, Alan J. Lowy, Israel TI A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection SO PLOS ONE TC 60 Z9 64 SN 1932-6203 PD MAY 22 PY 2013 VL 8 IS 5 AR e63818 DI 10.1371/journal.pone.0063818 UT WOS:000320362700065 PM 23717490 ER PT J AU Caturegli, P Iwama, S AF Caturegli, Patrizio Iwama, Shintaro TI From Japan With Love: Another Tessera in the Hypophysitis Mosaic SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM TC 14 Z9 14 SN 0021-972X PD MAY PY 2013 VL 98 IS 5 BP 1865 EP 1868 DI 10.1210/jc.2013-1912 UT WOS:000318688200045 PM 23650339 ER PT J AU Schulte, BM Kers-Rebel, ED Prosser, AC Galama, JMD van Kuppeveld, FJM Adema, GJ AF Schulte, Barbara M. Kers-Rebel, Esther D. Prosser, Amy C. Galama, Jochem M. D. van Kuppeveld, Frank J. M. Adema, Gosse J. TI Differential Susceptibility and Response of Primary Human Myeloid BDCA1(+) Dendritic Cells to Infection with Different Enteroviruses SO PLOS ONE RI Adema, G.J./H-8007-2014; Kers-Rebel, Esther/F-2312-2016 TC 3 Z9 3 SN 1932-6203 PD APR 24 PY 2013 VL 8 IS 4 AR e62502 DI 10.1371/journal.pone.0062502 UT WOS:000318340400112 PM 23638101 ER PT J AU Sibaud, V Robert, C AF Sibaud, V. Robert, C. TI Pigmentary disorders induced by anticancer agents. Part II: Targeted therapies SO ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE RI Sibaud, Vincent/P-6270-2014 OI Sibaud, Vincent/0000-0003-2585-6633 TC 5 Z9 6 SN 0151-9638 PD APR PY 2013 VL 140 IS 4 BP 266 EP 273 DI 10.1016/j.annder.2013.01.442 UT WOS:000319714000006 PM 23567227 ER PT J AU Assi, H Wilson, KS AF Assi, H. Wilson, K. S. TI Immune toxicities and long remission duration after ipilimumab therapy for metastatic melanoma: two illustrative cases SO CURRENT ONCOLOGY TC 8 Z9 10 SN 1198-0052 PD APR PY 2013 VL 20 IS 2 BP E165 EP E169 DI 10.3747/co.20.1265 UT WOS:000317474700014 PM 23559884 ER PT J AU Corsello, SM Barnabei, A Marchetti, P De Vecchis, L Salvatori, R Torino, F AF Corsello, Salvatore Maria Barnabei, Agnese Marchetti, Paolo De Vecchis, Liana Salvatori, Roberto Torino, Francesco TI Endocrine Side Effects Induced by Immune Checkpoint Inhibitors SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM RI Marchetti, Paolo/K-1469-2016 TC 85 Z9 85 SN 0021-972X EI 1945-7197 PD APR PY 2013 VL 98 IS 4 BP 1361 EP 1375 DI 10.1210/jc.2012-4075 UT WOS:000317195600037 PM 23471977 ER PT J AU van der Hiel, B Blank, CU Haanen, JBAG Stokkel, MPM AF van der Hiel, Bernies Blank, Christian U. Haanen, John B. A. G. Stokkel, Marcel P. M. TI Detection of Early Onset of Hypophysitis by F-18-FDG PET-CT in a Patient With Advanced Stage Melanoma Treated With Ipilimumab SO CLINICAL NUCLEAR MEDICINE TC 14 Z9 14 SN 0363-9762 PD APR PY 2013 VL 38 IS 4 BP E182 EP E184 DI 10.1097/RLU.0b013e3182639765 UT WOS:000316004900005 PM 23455528 ER PT J AU Tsioga, M Voigtlaender, R Suttorp, W Zimmer, L Schlamann, M Sure, U Lahner, H Moeller, LC Fuehrer, D AF Tsioga, M. Voigtlaender, R. Suttorp, W. Zimmer, L. Schlamann, M. Sure, U. Lahner, H. Moeller, L. C. Fuehrer, D. TI Immune-related hypophysitis in three patients with metastatic melanoma undergoing Ipilimumab treatment SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES TC 0 Z9 0 SN 0947-7349 PD MAR PY 2013 VL 121 IS 3 MA P10 DI 10.1055/s-0033-1336692 UT WOS:000316659000075 ER PT J AU Bernardo, SG Moskalenko, M Pan, M Shah, S Sidhu, HK Sicular, S Harcharik, S Chang, R Friedlander, P Saenger, YM AF Bernardo, Sebastian G. Moskalenko, Marina Pan, Michael Shah, Shaily Sidhu, Harleen K. Sicular, Serge Harcharik, Sara Chang, Rui Friedlander, Philip Saenger, Yvonne M. TI Elevated rates of transaminitis during ipilimumab therapy for metastatic melanoma SO MELANOMA RESEARCH TC 18 Z9 19 SN 0960-8931 PD FEB PY 2013 VL 23 IS 1 BP 47 EP 54 DI 10.1097/CMR.0b013e32835c7e68 UT WOS:000313067700008 PM 23262440 ER PT J AU Basso, D Fogar, P Falconi, M Fadi, E Sperti, C Frasson, C Greco, E Tamburrino, D Teolato, S Moz, S Bozzato, D Pelloso, M Padoan, A De Franchis, G Gnatta, E Facco, M Zambon, CF Navaglia, F Pasquali, C Basso, G Semenzato, G Pedrazzoli, S Pederzoli, P Plebani, M AF Basso, Daniela Fogar, Paola Falconi, Massimo Fadi, Elisa Sperti, Cosimo Frasson, Chiara Greco, Eliana Tamburrino, Domenico Teolato, Sara Moz, Stefania Bozzato, Dania Pelloso, Michela Padoan, Andrea De Franchis, Giuseppe Gnatta, Elisa Facco, Monica Zambon, Carlo-Federico Navaglia, Filippo Pasquali, Claudio Basso, Giuseppe Semenzato, Gianpietro Pedrazzoli, Sergio Pederzoli, Paolo Plebani, Mario TI Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study SO PLOS ONE RI ; SEMENZATO, GIANPIETRO/J-7727-2016; Basso, Daniela/J-7855-2016; Padoan, Andrea/J-7869-2016; Zambon, Carlo Federico/J-8187-2016; Teolato, Sara/J-8642-2016; Facco, Monica/F-7732-2017 OI BASSO, GIUSEPPE/0000-0002-2634-9302; SEMENZATO, GIANPIETRO/0000-0002-6061-4595; Basso, Daniela/0000-0001-8745-6171; Falconi, Massimo/0000-0001-9654-7243; Padoan, Andrea/0000-0003-1284-7885; Zambon, Carlo Federico/0000-0002-4244-879X; Teolato, Sara/0000-0002-0327-9858; Facco, Monica/0000-0003-0100-5789 TC 15 Z9 16 SN 1932-6203 PD JAN 24 PY 2013 VL 8 IS 1 AR e54824 DI 10.1371/journal.pone.0054824 UT WOS:000314023600116 PM 23359812 ER PT J AU Pennock, GK Waterfield, W Wolchok, JD AF Pennock, Gregory K. Waterfield, William Wolchok, Jedd D. TI Patient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma How Different are these From Conventional Treatment Responses? SO AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS TC 27 Z9 27 SN 0277-3732 PD DEC PY 2012 VL 35 IS 6 BP 606 EP 611 DI 10.1097/COC.0b013e318209cda9 UT WOS:000311384000017 PM 21336089 ER PT J AU Menzel, PL Geng, A Marquez, C Scala, M Minor, D Abendroth, R AF Menzel, P. L. Geng, A. Marquez, C. Scala, M. Minor, D. Abendroth, R. TI Low-dose Conformal Radiation Therapy for Ipilimumab-induced Hypophysitis SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS CT 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) CY OCT 28-31, 2012 CL Boston, MA TC 0 Z9 0 SN 0360-3016 PD NOV 1 PY 2012 VL 84 IS 3 SU S BP S279 EP S279 UT WOS:000310542900703 ER PT J AU Forde, PM Rock, K Wilson, G O'Byrne, KJ AF Forde, Patrick M. Rock, Kathy Wilson, Graham O'Byrne, Kenneth J. TI Ipilimumab-induced Immune-related Renal Failure - A Case Report SO ANTICANCER RESEARCH TC 29 Z9 29 SN 0250-7005 PD OCT PY 2012 VL 32 IS 10 BP 4607 EP 4608 UT WOS:000310111800057 PM 23060594 ER PT J AU Fizazi, K Albiges, L Massard, C Escudier, B Loriot, Y AF Fizazi, K. Albiges, L. Massard, C. Escudier, B. Loriot, Y. TI Novel and bone-targeted agents for CRPC SO ANNALS OF ONCOLOGY TC 4 Z9 5 SN 0923-7534 PD SEP PY 2012 VL 23 SU 10 BP 264 EP 267 DI 10.1093/annonc/mds353 UT WOS:000309410600037 ER PT J AU Nikolajczyk, BS Jagannathan-Bogdan, M Denis, GV AF Nikolajczyk, Barbara S. Jagannathan-Bogdan, Madhumita Denis, Gerald V. TI The outliers become a stampede as immunometabolism reaches a tipping point SO IMMUNOLOGICAL REVIEWS OI Denis, Gerald/0000-0001-9886-0401 TC 28 Z9 29 SN 0105-2896 PD SEP PY 2012 VL 249 SI SI BP 253 EP 275 DI 10.1111/j.1600-065X.2012.01142.x UT WOS:000307567300017 PM 22889227 ER PT J AU Henry, RA Kendall, PL Thomas, JW AF Henry, Rachel A. Kendall, Peggy L. Thomas, James W. TI Autoantigen-Specific B-Cell Depletion Overcomes Failed Immune Tolerance in Type 1 Diabetes SO DIABETES RI Bonami, Rachel/L-8453-2013 OI Bonami, Rachel/0000-0001-7575-6943 TC 13 Z9 14 SN 0012-1797 PD AUG PY 2012 VL 61 IS 8 BP 2037 EP 2044 DI 10.2337/db11-1746 UT WOS:000306891100019 PM 22698916 ER PT J AU Weber, JS Kahler, KC Hauschild, A AF Weber, Jeffrey S. Kaehler, Katharina C. Hauschild, Axel TI Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab SO JOURNAL OF CLINICAL ONCOLOGY TC 395 Z9 398 SN 0732-183X PD JUL 20 PY 2012 VL 30 IS 21 BP 2691 EP 2697 DI 10.1200/JCO.2012.41.6750 UT WOS:000306556900023 PM 22614989 ER PT J AU Juszczak, A Gupta, A Karavitaki, N Middleton, MR Grossman, AB AF Juszczak, Agata Gupta, Avinash Karavitaki, Niki Middleton, Mark R. Grossman, Ashley B. TI Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review SO EUROPEAN JOURNAL OF ENDOCRINOLOGY OI KARAVITAKI, NIKI/0000-0002-4696-0643 TC 52 Z9 54 SN 0804-4643 PD JUL PY 2012 VL 167 IS 1 BP 1 EP 5 DI 10.1530/EJE-12-0167 UT WOS:000305811400001 PM 22495490 ER PT J AU Hirahara, K Ghoreschi, K Yang, XP Takahashi, H Laurence, A Vahedi, G Sciume, G Hall, AO Dupont, CD Francisco, LM Chen, Q Tanaka, M Kanno, Y Sun, HW Sharpe, AH Hunter, CA O'Shea, JJ AF Hirahara, Kiyoshi Ghoreschi, Kamran Yang, Xiang-Ping Takahashi, Hayato Laurence, Arian Vahedi, Golnaz Sciume, Giuseppe Hall, Aisling O'Hara Dupont, Christopher D. Francisco, Loise M. Chen, Qian Tanaka, Masao Kanno, Yuka Sun, Hong-Wei Sharpe, Arlene H. Hunter, Christopher A. O'Shea, John J. TI Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1 SO IMMUNITY RI Kanno, Yuka/B-5802-2013; Laurence, Arian/A-8770-2009; Sciume, Giuseppe/K-8985-2016; Hirahara, Kiyoshi/E-2460-2017 OI Laurence, Arian/0000-0003-0942-8292; Sciume, Giuseppe/0000-0003-0131-512X; Hirahara, Kiyoshi/0000-0002-9128-9449; Kanno, Yuka/0000-0001-5668-9319 TC 93 Z9 101 SN 1074-7613 PD JUN 29 PY 2012 VL 36 IS 6 BP 1017 EP 1030 DI 10.1016/j.immuni.2012.03.024 UT WOS:000306097100018 PM 22726954 ER PT J AU Carra, T Gaudy-Marqueste, C Albarel, F Monestier, S Mallet, S Brue, T Richard, MA Grob, JJ AF Carra, Typhanie Gaudy-Marqueste, Caroline Albarel, Frederique Monestier, Sandrine Mallet, Stephanie Brue, Thierry Richard, Marie-Aleth Grob, Jean Jacques TI Ipilimumab-induced hypophysitis in melanoma patients SO JOURNAL OF CLINICAL ONCOLOGY CT 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) CY JUN 01-06, 2012 CL Chicago, IL TC 0 Z9 0 SN 0732-183X PD MAY 20 PY 2012 VL 30 IS 15 SU S MA 8568 UT WOS:000318009800645 ER PT J AU Min, L Vaidya, A Becker, C AF Min, Le Vaidya, Anand Becker, Carolyn TI ASSOCIATION OF IPILIMUMAB THERAPY FOR ADVANCED MELANOMA WITH SECONDARY ADRENAL INSUFFICIENCY: A CASE SERIES SO ENDOCRINE PRACTICE TC 31 Z9 31 SN 1530-891X PD MAY-JUN PY 2012 VL 18 IS 3 BP 351 EP 355 DI 10.4158/EP11273.OR UT WOS:000304234100006 PM 22138079 ER PT J AU Madan, RA Mohebtash, M Arlen, PM Vergati, M Rauckhorst, M Steinberg, SM Tsang, KY Poole, DJ Parnes, HL Wright, JJ Dahut, WL Schlom, J Gulley, JL AF Madan, Ravi A. Mohebtash, Mahsa Arlen, Philip M. Vergati, Matteo Rauckhorst, Myrna Steinberg, Seth M. Tsang, Kwong Y. Poole, Diane J. Parnes, Howard L. Wright, John J. Dahut, William L. Schlom, Jeffrey Gulley, James L. TI Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial SO LANCET ONCOLOGY RI Gulley, James/K-4139-2016 OI Gulley, James/0000-0002-6569-2912 TC 155 Z9 156 SN 1470-2045 EI 1474-5488 PD MAY PY 2012 VL 13 IS 5 BP 501 EP 508 DI 10.1016/S1470-2045(12)70006-2 UT WOS:000303508700041 PM 22326924 ER PT J AU van den Eertwegh, AJM Versluis, J van den Berg, HP Santegoets, SJAM van Moorselaar, RJA van der Sluis, TM Gall, HE Harding, TC Jooss, K Lowy, I Pinedo, HM Scheper, RJ Stam, AGM von Blomberg, BME de Gruijl, TD Hege, K Sacks, N Gerritsen, WR AF van den Eertwegh, Alfons J. M. Versluis, Jurjen van den Berg, H. Pieter Santegoets, Saskia J. A. M. van Moorselaar, R. Jeroen A. van der Sluis, Tim M. Gall, Helen E. Harding, Thomas C. Jooss, Karin Lowy, Israel Pinedo, Herbert M. Scheper, Rik J. Stam, Anita G. M. von Blomberg, B. Mary E. de Gruijl, Tanja D. Hege, Kristen Sacks, Natalie Gerritsen, Winald R. TI Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial SO LANCET ONCOLOGY RI Gerritsen, W.R./H-8031-2014 TC 163 Z9 164 SN 1470-2045 PD MAY PY 2012 VL 13 IS 5 BP 509 EP 517 DI 10.1016/S1470-2045(12)70007-4 UT WOS:000303508700042 PM 22326922 ER PT J AU Torino, F Barnabei, A De Vecchis, L Salvatori, R Corsello, SM AF Torino, Francesco Barnabei, Agnese De Vecchis, Liana Salvatori, Roberto Corsello, Salvatore M. TI Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare Disease SO ONCOLOGIST RI Inov Farmaceutica, Inct/K-2313-2013 TC 29 Z9 32 SN 1083-7159 EI 1549-490X PD APR PY 2012 VL 17 IS 4 BP 525 EP 535 DI 10.1634/theoncologist.2011-0404 UT WOS:000303874200011 PM 22477725 ER PT J AU Barnard, ZR Walcott, BP Kahle, KT Nahed, BV Coumans, JV AF Barnard, Zachary R. Walcott, Brian P. Kahle, Kristopher T. Nahed, Brian V. Coumans, Jean Valery TI Hyponatremia associated with Ipilimumab-induced hypophysitis SO MEDICAL ONCOLOGY TC 17 Z9 18 SN 1357-0560 PD MAR PY 2012 VL 29 IS 1 BP 374 EP 377 DI 10.1007/s12032-010-9794-7 UT WOS:000300317200056 PM 21264545 ER PT J AU Tomasini, P Khobta, N Greillier, L Barlesi, F AF Tomasini, Pascale Khobta, Nataliya Greillier, Laurent Barlesi, Fabrice TI Ipilimumab: its potential in non-small cell lung cancer SO THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY TC 24 Z9 25 SN 1758-8340 EI 1758-8359 PD MAR PY 2012 VL 4 IS 2 BP 43 EP 50 DI 10.1177/1758834011431718 UT WOS:000209001900001 PM 22423263 ER PT J AU Sharma, A Shah, SR Illum, H Dowell, J AF Sharma, Anant Shah, Sachin R. Illum, Henrik Dowell, Jonathan TI Vemurafenib Targeted Inhibition of Mutated BRAF for Treatment of Advanced Melanoma and Its Potential in Other Malignancies SO DRUGS TC 30 Z9 32 SN 0012-6667 EI 1179-1950 PY 2012 VL 72 IS 17 BP 2207 EP 2222 UT WOS:000312361200004 PM 23116250 ER PT J AU Bronstein, Y Ng, CS Hwu, P Hwu, WJ AF Bronstein, Yulia Ng, Chaan S. Hwu, Patrick Hwu, Wen-Jen TI Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti-CTLA-4 Antibody Therapy SO AMERICAN JOURNAL OF ROENTGENOLOGY TC 48 Z9 48 SN 0361-803X PD DEC PY 2011 VL 197 IS 6 BP W992 EP W1000 DI 10.2214/AJR.10.6198 UT WOS:000297369900005 PM 22109345 ER PT J AU Tu, ZD Li, Y Smith, DS Sheibani, N Huang, S Kern, T Lin, F AF Tu, Zhidan Li, Yan Smith, Dawn S. Sheibani, Nader Huang, Suber Kern, Timothy Lin, Feng TI Retinal Pericytes Inhibit Activated T Cell Proliferation SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE RI li, yan/B-8629-2015 TC 21 Z9 22 SN 0146-0404 PD NOV PY 2011 VL 52 IS 12 BP 9005 EP 9010 DI 10.1167/iovs.11-8008 UT WOS:000297631400032 PM 22003106 ER PT J AU Hamnvik, OPR Larsen, PR Marqusee, E AF Hamnvik, Ole-Petter Riksfjord Larsen, P. Reed Marqusee, Ellen TI Thyroid Dysfunction from Antineoplastic Agents SO JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE RI Hamnvik, Ole-Petter/D-1719-2011 TC 47 Z9 49 SN 0027-8874 EI 1460-2105 PD NOV PY 2011 VL 103 IS 21 BP 1572 EP 1587 DI 10.1093/jnci/djr373 UT WOS:000296662700006 PM 22010182 ER PT J AU Klagge, A Weidinger, C Krause, K Jessnitzer, B Gutknecht, M Fuhrer, D AF Klagge, Antje Weidinger, Carl Krause, Kerstin Jessnitzer, Beate Gutknecht, Monika Fuhrer, Dagmar TI The role of FOXO3 in DNA damage response in thyrocytes SO ENDOCRINE-RELATED CANCER TC 6 Z9 6 SN 1351-0088 PD OCT PY 2011 VL 18 IS 5 BP 555 EP 564 DI 10.1530/ERC-11-0138 UT WOS:000302239000007 PM 21712344 ER PT J AU Newland, SA Phillips, JM Mastroeni, P Azuma, M Zaccone, P Cooke, A AF Newland, Stephen A. Phillips, Jenny M. Mastroeni, Pietro Azuma, Miyuki Zaccone, Paola Cooke, Anne TI PD-L1 blockade overrides Salmonella typhimurium-mediated diabetes prevention in NOD mice: No role for Tregs SO EUROPEAN JOURNAL OF IMMUNOLOGY RI Cooke, Anne/E-8709-2012 TC 4 Z9 4 SN 0014-2980 PD OCT PY 2011 VL 41 IS 10 BP 2966 EP 2976 DI 10.1002/eji.201141544 UT WOS:000296199000019 PM 21792877 ER PT J AU Man, JH Zhang, XM AF Man, Jianghong Zhang, Xuemin TI CUEDC2: an emerging key player in inflammation and tumorigenesis SO PROTEIN & CELL TC 9 Z9 13 SN 1674-800X PD SEP PY 2011 VL 2 IS 9 BP 699 EP 703 DI 10.1007/s13238-011-1089-z UT WOS:000310522000004 PM 21976060 ER PT J AU Thangavelu, G Murphy, KM Yagita, H Boon, L Anderson, CC AF Thangavelu, Govindarajan Murphy, Kenneth M. Yagita, Hideo Boon, Louis Anderson, Colin C. TI The role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplants SO IMMUNOBIOLOGY TC 2 Z9 3 SN 0171-2985 PD AUG PY 2011 VL 216 IS 8 BP 918 EP 924 DI 10.1016/j.imbio.2011.01.007 UT WOS:000294080400007 PM 21281982 ER PT J AU O'Regan, KN Jagannathan, JP Ramaiya, N Hodi, FS AF O'Regan, Kevin N. Jagannathan, Jyothipriya P. Ramaiya, Nikhil Hodi, F. Stephen TI Radiologic Aspects of Immune-Related Tumor Response Criteria and Patterns of Immune-Related Adverse Events in Patients Undergoing Ipilimumab Therapy SO AMERICAN JOURNAL OF ROENTGENOLOGY TC 23 Z9 24 SN 0361-803X PD AUG PY 2011 VL 197 IS 2 BP W241 EP W246 DI 10.2214/AJR.10.6032 UT WOS:000293062600005 PM 21785048 ER PT J AU Wei, J Loke, P Zang, XX Allison, JP AF Wei, Joyce Loke, P'ng Zang, Xingxing Allison, James P. TI Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity SO JOURNAL OF EXPERIMENTAL MEDICINE TC 27 Z9 27 SN 0022-1007 PD AUG 1 PY 2011 VL 208 IS 8 BP 1683 EP 1694 DI 10.1084/jem.20100639 UT WOS:000293441500012 PM 21727190 ER PT J AU Paterson, AM Brown, KE Keir, ME Vanguri, VK Riella, LV Chandraker, A Sayegh, MH Blazar, BR Freeman, GJ Sharpe, AH AF Paterson, Alison M. Brown, Keturah E. Keir, Mary E. Vanguri, Vijay K. Riella, Leonardo V. Chandraker, Anil Sayegh, Mohamed H. Blazar, Bruce R. Freeman, Gordon J. Sharpe, Arlene H. TI The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo SO JOURNAL OF IMMUNOLOGY TC 48 Z9 49 SN 0022-1767 PD AUG 1 PY 2011 VL 187 IS 3 BP 1097 EP U75 DI 10.4049/jimmunol.1003496 UT WOS:000292874200007 PM 21697456 ER PT J AU Hegde, S Lockridge, JL Becker, YA Ma, SD Kenney, SC Gumperz, JE AF Hegde, Subramanya Lockridge, Jennifer L. Becker, Yusof A. Ma, Shidong Kenney, Shannon C. Gumperz, Jenny E. TI Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands SO JOURNAL OF AUTOIMMUNITY TC 10 Z9 10 SN 0896-8411 PD AUG PY 2011 VL 37 IS 1 BP 28 EP 38 DI 10.1016/j.jaut.2011.03.001 UT WOS:000292717100005 PM 21486688 ER PT J AU Ascierto, PA Marincola, FM AF Ascierto, Paolo A. Marincola, Francesco M. TI Combination therapy: the next opportunity and challenge of medicine SO JOURNAL OF TRANSLATIONAL MEDICINE TC 16 Z9 17 SN 1479-5876 PD JUL 21 PY 2011 VL 9 AR 115 DI 10.1186/1479-5876-9-115 UT WOS:000293999200001 PM 21777474 ER PT J AU Borodic, G Hinkle, DM Cia, YH AF Borodic, Gary Hinkle, David M. Cia, Yihong TI Drug-Induced Graves Disease From CTLA-4 Receptor Suppression SO OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY TC 31 Z9 32 SN 0740-9303 PD JUL-AUG PY 2011 VL 27 IS 4 BP E87 EP E88 DI 10.1097/IOP.0b013e3181ef72a1 UT WOS:000292633700003 PM 21242854 ER PT J AU Erdelyi, P Borsos, E Takacs-Vellai, K Kovacs, T Kovacs, AL Sigmond, T Hargitai, B Pasztor, L SenGupta, T Dengg, M Pecsi, I Toth, J Nilsen, H Vertessy, BG Vellai, T AF Erdelyi, Peter Borsos, Eva Takacs-Vellai, Krisztina Kovacs, Tibor Kovacs, Attila L. Sigmond, Timea Hargitai, Balazs Pasztor, Liz SenGupta, Tanima Dengg, Marlene Pecsi, Ildiko Toth, Judit Nilsen, Hilde Vertessy, Beata G. Vellai, Tibor TI Shared developmental roles and transcriptional control of autophagy and apoptosis in Caenorhabditis elegans SO JOURNAL OF CELL SCIENCE RI Vertessy, Beata/H-6202-2012; Pasztor, Liz/C-9753-2010 OI Pasztor, Liz/0000-0003-2630-5673; Nilsen, Hilde/0000-0003-2115-2663 TC 19 Z9 43 SN 0021-9533 PD MAY 1 PY 2011 VL 124 IS 9 BP 1510 EP 1518 DI 10.1242/jcs.080192 UT WOS:000289621300016 PM 21502138 ER PT J AU Culver, ME Gatesman, ML Mancl, EE Lowe, DK AF Culver, Morgan E. Gatesman, Mandy L. Mancl, Erin E. Lowe, Denise K. TI Ipilimumab: A Novel Treatment for Metastatic Melanoma SO ANNALS OF PHARMACOTHERAPY TC 23 Z9 24 SN 1060-0280 PD APR PY 2011 VL 45 IS 4 BP 510 EP 519 DI 10.1345/aph.1P651 UT WOS:000290137400009 PM 21505108 ER PT J AU Kahler, KC Hauschild, A AF Kaehler, Katharina C. Hauschild, Axel TI Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT TC 54 Z9 58 SN 1610-0379 PD APR PY 2011 VL 9 IS 4 BP 277 EP 285 DI 10.1111/j.1610-0387.2010.07568.x UT WOS:000288808500003 PM 21083648 ER PT J AU Bouwhuis, MG ten Hagen, TLM Suciu, S Eggermont, AMM AF Bouwhuis, Marna G. ten Hagen, Timo L. M. Suciu, Stefan Eggermont, Alexander M. M. TI Autoimmunity and treatment outcome in melanoma SO CURRENT OPINION IN ONCOLOGY TC 31 Z9 31 SN 1040-8746 PD MAR PY 2011 VL 23 IS 2 BP 170 EP 176 DI 10.1097/CCO.0b013e328341edff UT WOS:000287186900007 PM 21150603 ER PT J AU Okazaki, T Okazaki, IM Wang, JA Sugiura, D Nakaki, F Yoshida, T Kato, Y Fagarasan, S Muramatsu, M Eto, T Hioki, K Honjo, T AF Okazaki, Taku Okazaki, Il-Mi Wang, Jian Sugiura, Daisuke Nakaki, Fumio Yoshida, Taku Kato, Yu Fagarasan, Sidonia Muramatsu, Masamichi Eto, Tomoo Hioki, Kyoji Honjo, Tasuku TI PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice SO JOURNAL OF EXPERIMENTAL MEDICINE RI Nakaki, Fumio/B-8284-2015; Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016; Honjo, Tasuku/N-4470-2016 OI Nakaki, Fumio/0000-0003-4332-7735; Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan, Sidonia/0000-0003-2086-6402; TC 73 Z9 76 SN 0022-1007 PD FEB 14 PY 2011 VL 208 IS 2 BP 395 EP 407 DI 10.1084/jem.20100466 UT WOS:000287366300015 PM 21300912 ER PT J AU Min, L Vaidya, A Becker, C AF Min, Le Vaidya, Anand Becker, Carolyn TI Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy SO EUROPEAN JOURNAL OF ENDOCRINOLOGY TC 48 Z9 49 SN 0804-4643 PD FEB PY 2011 VL 164 IS 2 BP 303 EP 307 DI 10.1530/EJE-10-0833 UT WOS:000286315500020 PM 21088057 ER PT J AU Lee, SJ Lee, MH Kim, DW Lee, S Huang, SM Ryu, MJ Kim, YK Kim, SJ Kim, SJ Hwang, JH Oh, S Cho, H Kim, JM Lim, DS Jo, YS Shong, M AF Lee, Seong Jin Lee, Min Hee Kim, Dong Wook Lee, SeongEun Huang, Songmei Ryu, Min Jeong Kim, Yong Kyung Kim, Sung Jin Kim, Soung Jung Hwang, Jung Hwan Oh, Sangphil Cho, Heeyeong Kim, Jin Man Lim, Dae-Sik Jo, Young Suk Shong, Minho TI Cross-Regulation between Oncogenic BRAF(V600E) Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma SO PLOS ONE RI Lim, Dae-Sik/C-1599-2011 OI Lim, Dae-Sik/0000-0003-2356-7555 TC 13 Z9 13 SN 1932-6203 PD JAN 13 PY 2011 VL 6 IS 1 AR e16180 DI 10.1371/journal.pone.0016180 UT WOS:000286515000027 PM 21249150 ER PT S AU Fife, BT Pauken, KE AF Fife, Brian T. Pauken, Kristen E. BE Rose, NR TI The role of the PD-1 pathway in autoimmunity and peripheral tolerance SO YEAR IN IMMUNOLOGY SE Annals of the New York Academy of Sciences RI Fife, Brian/D-2042-2013 OI Fife, Brian/0000-0001-9826-5637 TC 93 Z9 103 SN 0077-8923 BN 978-1-57331-811-2 PY 2011 VL 1217 BP 45 EP 59 DI 10.1111/j.1749-6632.2010.05919.x UT WOS:000288114700004 PM 21276005 ER PT J AU Won, TJ Jung, YJ Kwon, SJ Lee, YJ Lee, DI Min, H Park, ES Joo, SS Hwang, KW AF Won, Tae Joon Jung, Yu Jin Kwon, Seok Joong Lee, Yoon Jeong Lee, Do Ik Min, Hyeyoung Park, Eon Sub Joo, Seong Soo Hwang, Kwang Woo TI Forced Expression of Programmed Death-1 Gene on T Cell Decreased the Incidence of Type 1 Diabetes SO ARCHIVES OF PHARMACAL RESEARCH TC 4 Z9 4 SN 0253-6269 PD NOV PY 2010 VL 33 IS 11 BP 1825 EP 1833 DI 10.1007/s12272.010.1115.3 UT WOS:000284740000016 PM 21116786 ER PT J AU Boasberg, P Hamid, O O'Day, S AF Boasberg, Peter Hamid, Omid O'Day, Steven TI Ipilimumab: Unleashing the Power of the Immune System Through CTLA-4 Blockade SO SEMINARS IN ONCOLOGY TC 40 Z9 41 SN 0093-7754 EI 1532-8708 PD OCT PY 2010 VL 37 IS 5 BP 440 EP 449 DI 10.1053/j.seminoncol.2010.09.004 UT WOS:000284338400004 PM 21074058 ER PT J AU Di Giacomo, AM Biagioli, M Maio, M AF Di Giacomo, Anna Maria Biagioli, Maurizio Maio, Michele TI The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies Across Clinical Indications SO SEMINARS IN ONCOLOGY OI coral, sandra/0000-0002-1308-3082 TC 125 Z9 125 SN 0093-7754 PD OCT PY 2010 VL 37 IS 5 BP 499 EP 507 DI 10.1053/j.seminoncol.2010.09.007 UT WOS:000284338400011 PM 21074065 ER PT J AU Min, LE Vaidya, A Becker, C AF Min, L. E. Vaidya, Anand Becker, Carolyn TI Ipilimumab and Graves Ophthalmopathy. SO ENDOCRINE REVIEWS CT 92nd Meeting and Expo of the Endocrine Society (ENDO 2010) CY JUN 19-22, 2010 CL San Diego, CA TC 0 Z9 0 SN 0163-769X PD JUN PY 2010 VL 31 IS 3 SU 1 UT WOS:000281989402606 ER PT J AU Van Belle, TL Juntti, T Liao, J von Herrath, MG AF Van Belle, Tom L. Juntti, Therese Liao, Jeanette von Herrath, Matthias G. TI Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment SO JOURNAL OF AUTOIMMUNITY TC 17 Z9 17 SN 0896-8411 PD JUN PY 2010 VL 34 IS 4 BP 445 EP 452 DI 10.1016/j.jaut.2009.11.010 UT WOS:000277869500013 PM 20004555 ER PT J AU Ziegler, AG Nepom, GT AF Ziegler, Anette-G. Nepom, Gerald T. TI Prediction and Pathogenesis in Type 1 Diabetes SO IMMUNITY RI Ziegler, Anette-Gabriele/M-4614-2014 OI Ziegler, Anette-Gabriele/0000-0002-6290-5548; Nepom, Gerald/0000-0002-8063-1464 TC 136 Z9 137 SN 1074-7613 PD APR 23 PY 2010 VL 32 IS 4 BP 468 EP 478 DI 10.1016/j.immuni.2010.03.018 UT WOS:000277171900004 PM 20412757 ER PT J AU Diepolder, H Obst, R AF Diepolder, Helmut Obst, Reinhard TI Making antigen invisible: a coinhibitory molecule regulates the interaction between T cells and dendritic cells SO EXPERT REVIEW OF VACCINES TC 2 Z9 2 SN 1476-0584 EI 1744-8395 PD MAR PY 2010 VL 9 IS 3 BP 243 EP 247 DI 10.1586/ERV.09.164 UT WOS:000275741800008 PM 20218851 ER PT J AU Dillard, T Yedinak, CG Alumkal, J Fleseriu, M AF Dillard, Troy Yedinak, Chris G. Alumkal, Joshi Fleseriu, Maria TI Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes SO PITUITARY RI duan, hf/F-9166-2011 TC 81 Z9 82 SN 1386-341X PD MAR PY 2010 VL 13 IS 1 BP 29 EP 38 DI 10.1007/s11102-009-0193-z UT WOS:000273685600004 PM 19639414 ER PT J AU Kuranda, K Berthon, C Dupont, C Wolowiec, D Leleu, X Polakowska, R Jouy, N Quesnel, B AF Kuranda, Klaudia Berthon, Celine Dupont, Caroline Wolowiec, Dariusz Leleu, Xavier Polakowska, Renata Jouy, Nathalie Quesnel, Bruno TI A subpopulation of malignant CD34(+)CD138(+)B7-H1(+) plasma cells is present in multiple myeloma patients SO EXPERIMENTAL HEMATOLOGY TC 13 Z9 14 SN 0301-472X PD FEB PY 2010 VL 38 IS 2 BP 124 EP 131 DI 10.1016/j.exphem.2009.11.008 UT WOS:000274091900006 PM 19948206 ER PT J AU Mitchell, AL Cordell, HJ Soemedi, R Owen, K Skinningsrud, B Wolff, AB Ericksen, M Undlien, D Husebye, E Pearce, SHS AF Mitchell, Anna L. Cordell, Heather J. Soemedi, Rachel Owen, Kate Skinningsrud, Beate Wolff, Anette Boe Ericksen, Martina Undlien, Dag Husebye, Eystein Pearce, Simon H. S. TI Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison's Disease and Graves' Disease Susceptibility SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM RI Wolff, Anette/F-9136-2013 OI Pearce, Simon/0000-0001-8384-8063 TC 23 Z9 24 SN 0021-972X EI 1945-7197 PD DEC PY 2009 VL 94 IS 12 BP 5139 EP 5145 DI 10.1210/jc.2009-1404 UT WOS:000272379400071 PM 19850680 ER PT J AU Fife, BT Pauken, KE Eagar, TN Obu, T Wu, J Tang, QZ Azuma, M Krummel, MF Bluestone, JA AF Fife, Brian T. Pauken, Kristen E. Eagar, Todd N. Obu, Takashi Wu, Jenny Tang, Qizhi Azuma, Miyuki Krummel, Matthew F. Bluestone, Jeffrey A. TI Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal SO NATURE IMMUNOLOGY RI Fife, Brian/D-2042-2013 OI Fife, Brian/0000-0001-9826-5637 TC 279 Z9 295 SN 1529-2908 PD NOV PY 2009 VL 10 IS 11 BP 1185 EP U70 DI 10.1038/ni.1790 UT WOS:000270955900011 PM 19783989 ER PT J AU Carpenter, KJ Murtagh, RD Lilienfeld, H Weber, J Murtagh, FR AF Carpenter, K. J. Murtagh, R. D. Lilienfeld, H. Weber, J. Murtagh, F. R. TI Ipilimumab-Induced Hypophysitis: MR Imaging Findings SO AMERICAN JOURNAL OF NEURORADIOLOGY TC 29 Z9 29 SN 0195-6108 EI 1936-959X PD OCT PY 2009 VL 30 IS 9 BP 1751 EP 1753 DI 10.3174/ajnr.A1623 UT WOS:000271031300024 PM 19474123 ER PT J AU Kaehler, KC Egberts, F Lorigan, P Hauschild, A AF Kaehler, Katharina C. Egberts, Friederike Lorigan, Paul Hauschild, Axel TI Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient SO MELANOMA RESEARCH RI Kahler, Katharina/B-3190-2010; Hauschild, Axel/B-3185-2010; Lorigan, Paul/J-6898-2015 OI Lorigan, Paul/0000-0002-8875-2164 TC 18 Z9 18 SN 0960-8931 PD OCT PY 2009 VL 19 IS 5 BP 333 EP 334 DI 10.1097/CMR.0b013e32832e0bff UT WOS:000270257500009 PM 19512947 ER PT J AU Truong, W Hancock, WW Plester, JC Merani, S Rayner, DC Thangavelu, G Murphy, KM Anderson, CC Shapiro, AMJ AF Truong, Wayne Hancock, Wayne W. Plester, Jennifer C. Merani, Shaheed Rayner, David C. Thangavelu, Govindarajan Murphy, Kenneth M. Anderson, Colin C. Shapiro, A. M. James TI BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice SO JOURNAL OF LEUKOCYTE BIOLOGY RI e-, a/F-9947-2012 TC 14 Z9 16 SN 0741-5400 PD JUL PY 2009 VL 86 IS 1 BP 41 EP 51 DI 10.1189/JLB.1107753 UT WOS:000267488700007 PM 19383625 ER PT J AU Klein, O Ebert, LM Nicholaou, T Browning, J Russell, SE Zuber, M Jackson, HM Dimopoulos, N Tan, BS Hoos, A Luescher, IF Davis, ID Chen, WS Cebon, J AF Klein, Oliver Ebert, Lisa M. Nicholaou, Theo Browning, Judy Russell, Sarah E. Zuber, Marina Jackson, Heather M. Dimopoulos, Nektaria Tan, Bee Shin Hoos, Axel Luescher, Immanuel F. Davis, Ian D. Chen, Weisan Cebon, Jonathan TI Melan-A-specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4 SO CLINICAL CANCER RESEARCH RI Davis, Ian/A-1430-2012; Ebert, Lisa/B-9530-2013; Chen, Weisan/E-7828-2012 OI Davis, Ian/0000-0002-9066-8244; Ebert, Lisa/0000-0002-8041-9666; Chen, Weisan/0000-0002-5221-9771 TC 56 Z9 57 SN 1078-0432 PD APR 1 PY 2009 VL 15 IS 7 BP 2507 EP 2513 DI 10.1158/1078-0432.CCR-08-2424 UT WOS:000264955800036 PM 19318477 ER PT J AU Bashey, A Medina, B Corringham, S Pasek, M Carrier, E Vrooman, L Lowy, I Solomon, SR Morris, LE Holland, HK Mason, JR Alyea, EP Soiffer, RJ Ball, ED AF Bashey, Asad Medina, Bridget Corringham, Sue Pasek, Mildred Carrier, Ewa Vrooman, Linda Lowy, Israel Solomon, Scott R. Morris, Lawrence E. Holland, H. Kent Mason, James R. Alyea, Edwin P. Soiffer, Robert J. Ball, Edward D. TI CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation SO BLOOD TC 139 Z9 142 SN 0006-4971 EI 1528-0020 PD FEB 12 PY 2009 VL 113 IS 7 BP 1581 EP 1588 DI 10.1182/blood-2008-07-168468 UT WOS:000263316400026 PM 18974373 ER PT J AU Phan, GQ Weber, JS Sondak, VK AF Phan, Giao Q. Weber, Jeffrey S. Sondak, Vernon K. TI CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues SO ANNALS OF SURGICAL ONCOLOGY TC 29 Z9 30 SN 1068-9265 PD NOV PY 2008 VL 15 IS 11 BP 3014 EP 3021 DI 10.1245/s10434-008-0104-y UT WOS:000260509400007 PM 18716842 ER PT J AU Schreiner, B Bailey, SL Shin, T Chen, L Miller, SD AF Schreiner, Bettina Bailey, Samantha L. Shin, Tahiro Chen, Lieping Miller, Stephen D. TI PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE SO EUROPEAN JOURNAL OF IMMUNOLOGY TC 48 Z9 56 SN 0014-2980 PD OCT PY 2008 VL 38 IS 10 BP 2706 EP 2717 DI 10.1002/eji.200838137 UT WOS:000260693500008 PM 18825752 ER PT J AU Slot, MC Sokolowska, MG Savelkouls, KG Janssen, RGJH Damoiseaux, JGMC Tervaert, JWC AF Slot, Marjan C. Sokolowska, Milena G. Savelkouls, Kim G. Janssen, Rob G. J. H. Damoiseaux, Jan G. M. C. Tervaert, Jan Willem Cohen TI Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis SO CLINICAL IMMUNOLOGY RI Damoiseaux, Jan/B-8993-2009 TC 35 Z9 35 SN 1521-6616 EI 1521-7035 PD JUL PY 2008 VL 128 IS 1 BP 39 EP 45 DI 10.1016/j.clim.2008.03.506 UT WOS:000257177900006 PM 18448390 ER PT J AU Hayashi, M Kouki, T Takasu, N Sunagawa, S Komiya, I AF Hayashi, Mina Kouki, Tsuyoshi Takasu, Nobuyuki Sunagawa, Sumito Komiya, Ichiro TI Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients SO EUROPEAN JOURNAL OF ENDOCRINOLOGY TC 17 Z9 17 SN 0804-4643 EI 1479-683X PD JUN PY 2008 VL 158 IS 6 BP 817 EP 822 DI 10.1530/EJE-07-0649 UT WOS:000256812800006 PM 18322304 ER PT J AU He, FR Zhu, HF Huang, H Dai, YD Shen, X Wang, M Li, L Xing, W Shen, GX AF He, F. -R. Zhu, H. -F. Huang, H. Dai, Y. D. Shen, X. Wang, M. Li, L. Xing, W. Shen, G. -X. TI Programmed death-1 ligands-transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibit both the alloresponse and the GAD65-reactive lymphocyte response SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY RI shen, Guanxin/F-7441-2011 TC 5 Z9 6 SN 0009-9104 PD JAN PY 2008 VL 151 IS 1 BP 86 EP 93 DI 10.1111/j.1365-2249.2007.03546.x UT WOS:000251432200010 PM 18005363 ER PT J AU Danial, NN AF Danial, Nika N. TI BCL-2 family proteins: Critical checkpoints of apoptotic cell death SO CLINICAL CANCER RESEARCH TC 238 Z9 259 SN 1078-0432 PD DEC 15 PY 2007 VL 13 IS 24 BP 7254 EP 7263 DI 10.1158/1078-0432.CCR-07-1598 UT WOS:000251954200009 PM 18094405 ER PT J AU Tian, C Ansari, MJI Paez-Cortez, J Bagley, J Godwin, J Donnarumma, M Sayegh, MH Lacomini, J AF Tian, Chaorui Ansari, Mohammed Javeed I. Paez-Cortez, Jesus Bagley, Jessamyn Godwin, Jonathan Donnarumma, Michela Sayegh, Mohamed H. Lacomini, John TI Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy SO JOURNAL OF IMMUNOLOGY TC 17 Z9 18 SN 0022-1767 PD NOV 15 PY 2007 VL 179 IS 10 BP 6762 EP 6769 UT WOS:000250792700044 PM 17982066 ER PT J AU Yang, JC Hughes, H Kammula, U Royal, R Sherry, RM Topalian, SL Suri, KB Levy, C Allen, T Mavroukakis, S Lowy, I White, DE Rosenberg, SA AF Yang, James C. Hughes, Harybeth Kammula, Udai Royal, Riehard Sherry, Riehard M. Topalian, Suzanne L. Suri, Kimberly B. Levy, Catherine Allen, Tamika Mavroukakis, Sharon Lowy, Israel White, Donald E. Rosenberg, Steven A. TI Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis SO JOURNAL OF IMMUNOTHERAPY TC 298 Z9 307 SN 1524-9557 PD NOV-DEC PY 2007 VL 30 IS 8 BP 825 EP 830 UT WOS:000250396700005 PM 18049334 ER PT J AU Keir, ME Freeman, GJ Sharpe, AH AF Keir, Mary E. Freeman, Gordon J. Sharpe, Arlene H. TI PD-1 regulates self-reactive CD8(+) T cell responses to antigen in lymph nodes and tissues SO JOURNAL OF IMMUNOLOGY TC 101 Z9 104 SN 0022-1767 PD OCT 15 PY 2007 VL 179 IS 8 BP 5064 EP 5070 UT WOS:000250099400013 PM 17911591 ER PT J AU Guleria, I Bupp, MG Dada, S Fife, B Tang, Q Ansari, MJ Trikudanathan, S Vadivel, N Fiorina, P Yagita, H Azuma, M Atkinson, M Bluestone, JA Sayegh, MH AF Guleria, Indira Bupp, Melanie Gubbels Dada, Shirine Fife, Brian Tang, Qizhi Ansari, Mohammed Javeed Trikudanathan, Subbulaxmi Vadivel, Nidyanandh Fiorina, Paolo Yagita, Hideo Azuma, Miyuki Atkinson, Mark Bluestone, Jeffrey A. Sayegh, Mohamed H. TI Mechanisms of PDL-1 mediated regulation of autoimmune diabetes SO CLINICAL IMMUNOLOGY RI Fife, Brian/D-2042-2013 OI Fife, Brian/0000-0001-9826-5637 TC 52 Z9 52 SN 1521-6616 PD OCT PY 2007 VL 125 IS 1 BP 16 EP 25 DI 10.1016/j.clim.2007.05.013 UT WOS:000249629800003 PM 17627890 ER PT J AU Truong, W Hancock, WW Murphy, KM Anderson, CC Shapiro, AMJ AF Truong, Wayne Hancock, Wayne W. Murphy, Kenneth M. Anderson, Colin C. Shapiro, A. M. James TI Differential effects of co-inhibitory pathways BTLA & PD-1 on the development of autoimmune diabetes in pre-diabetic NOD mice. SO AMERICAN JOURNAL OF TRANSPLANTATION CT Annual American Transplant Congress CY MAY 05-09, 2007 CL San Francisco, CA TC 0 Z9 0 SN 1600-6135 PD MAY PY 2007 VL 7 SU 2 MA 722 BP 334 EP 334 UT WOS:000246370201158 ER PT J AU Gatzka, M Walsh, CM AF Gatzka, Martina Walsh, Craig M. TI Apoptotic signal transduction and T cell tolerance SO AUTOIMMUNITY TC 32 Z9 35 SN 0891-6934 PY 2007 VL 40 IS 6 BP 442 EP 452 DI 10.1080/08916930701464962 UT WOS:000249137000007 PM 17729038 ER PT J AU Martin-Orozco, N Wang, YH Yagita, H Dong, C AF Martin-Orozco, Natalia Wang, Yi-Hong Yagita, Hideo Dong, Chen TI Cutting edge: Programed death (PD) ligand-1/PD-1 interaction is required for CD8(+) T cell tolerance to tissue antigens SO JOURNAL OF IMMUNOLOGY RI dong, chen /B-3181-2009; Martin Orozco, Natalia/E-4794-2010 OI dong, chen /0000-0002-0084-9130; TC 73 Z9 77 SN 0022-1767 PD DEC 15 PY 2006 VL 177 IS 12 BP 8291 EP 8295 UT WOS:000243416800002 PM 17142723 ER PT J AU Fife, BT Guleria, I Bupp, MG Eagar, TN Tang, QZ Bour-Jordan, H Yagita, H Azuma, M Sayegh, MH Bluestone, JA AF Fife, Brian T. Guleria, Indira Bupp, Melanie Gubbels Eagar, Todd N. Tang, Qizhi Bour-Jordan, Helene Yagita, Hideo Azuma, Miyuki Sayegh, Mohamed H. Bluestone, Jeffrey A. TI Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway SO JOURNAL OF EXPERIMENTAL MEDICINE RI Fife, Brian/D-2042-2013 OI Fife, Brian/0000-0001-9826-5637 TC 177 Z9 184 SN 0022-1007 PD NOV 27 PY 2006 VL 203 IS 12 BP 2737 EP 2747 DI 10.1084/jem.20061577 UT WOS:000242339700016 PM 17116737 ER PT J AU Beck, KE Blansfield, JA Tran, KQ Feldman, AL Hughes, MS Royal, RE Kammula, US Topalian, SL Sherry, RM Kleiner, D Quezado, M Lowy, I Yellin, M Rosenberg, SA Yang, JC AF Beck, KE Blansfield, JA Tran, KQ Feldman, AL Hughes, MS Royal, RE Kammula, US Topalian, SL Sherry, RM Kleiner, D Quezado, M Lowy, I Yellin, M Rosenberg, SA Yang, JC TI Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 SO JOURNAL OF CLINICAL ONCOLOGY RI Feldman, Andrew/D-5028-2012 OI Kleiner, David/0000-0003-3442-4453; Feldman, Andrew/0000-0001-5009-4808 TC 359 Z9 366 SN 0732-183X PD MAY 20 PY 2006 VL 24 IS 15 BP 2283 EP 2289 DI 10.1200/JCO.2005.04.5716 UT WOS:000237828500012 PM 16710025 ER PT J AU Keir, ME Liang, SC Guleria, I Latchman, YE Qipo, A Albacker, LA Koulmanda, M Freeman, GJ Sayegh, MH Sharpe, AH AF Keir, ME Liang, SC Guleria, I Latchman, YE Qipo, A Albacker, LA Koulmanda, M Freeman, GJ Sayegh, MH Sharpe, AH TI Tissue expression of PD-L1 mediates peripheral T cell tolerance SO JOURNAL OF EXPERIMENTAL MEDICINE TC 473 Z9 494 SN 0022-1007 PD APR 17 PY 2006 VL 203 IS 4 BP 883 EP 895 DI 10.1084/jem.20051776 UT WOS:000237056000014 PM 16606670 ER PT J AU Zhu, B Guleria, I Khosroshahi, A Chitnis, T Imitola, J Azuma, M Yagita, H Sayegh, MH Khoury, SJ AF Zhu, Bing Guleria, Indira Khosroshahi, Arezou Chitnis, Tanuja Imitola, Jaime Azuma, Miyuki Yagita, Hideo Sayegh, Mohamed H. Khoury, Samia J. TI Differential role of programmed programmed death-2 ligand in death-1 ligand and regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis SO JOURNAL OF IMMUNOLOGY TC 79 Z9 81 SN 0022-1767 PD MAR 15 PY 2006 VL 176 IS 6 BP 3480 EP 3489 UT WOS:000238768400023 PM 16517716 ER PT J AU Fikaris, AJ Kao, GD Brown, EJ Kazanietz, MG Meinkoth, JL AF Fikaris, AJ Kao, GD Brown, EJ Kazanietz, MG Meinkoth, JL TI Protein kinase C delta stimulates apoptosis by initiating G(1) phase cell cycle progression and S phase arrest SO JOURNAL OF BIOLOGICAL CHEMISTRY TC 0 Z9 0 SN 0021-9258 PD SEP 16 PY 2005 VL 280 IS 37 BP 32107 EP 32114 DI 10.1074/jbc.M504432200 UT WOS:000231794800010 ER PT J AU Okazaki, T Wang, P AF Okazaki, T Wang, P TI PD-1/PD-L pathway and autoimmunity SO AUTOIMMUNITY OI Okazaki, Taku/0000-0003-4790-1925 TC 45 Z9 55 SN 0891-6934 PD AUG PY 2005 VL 38 IS 5 BP 353 EP 357 DI 10.1080/08916930500124072 UT WOS:000232225200005 PM 16227150 ER PT J AU Kim, D Pemberton, H Stratford, AL Buelaert, K Watkinson, JC Lopes, V Franklyn, JA McCabe, CJ AF Kim, D Pemberton, H Stratford, AL Buelaert, K Watkinson, JC Lopes, V Franklyn, JA McCabe, CJ TI Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells SO ONCOGENE TC 55 Z9 63 SN 0950-9232 PD JUL 14 PY 2005 VL 24 IS 30 BP 4861 EP 4866 DI 10.1038/sj.onc.1208659 UT WOS:000230477900013 PM 15897900 ER PT J AU Whitfield, JF AF Whitfield, JF TI Osteogenic PTHs and vascular ossification - Is there a danger for osteoporotics? SO JOURNAL OF CELLULAR BIOCHEMISTRY TC 5 Z9 5 SN 0730-2312 PD JUN 1 PY 2005 VL 95 IS 3 BP 437 EP 444 DI 10.1002/jcb.20424 UT WOS:000229348900002 PM 15786490 ER PT J AU Eckenrode, SE Ruan, QG Yang, P Zheng, WP McIndoe, RA She, JX AF Eckenrode, SE Ruan, QG Yang, P Zheng, WP McIndoe, RA She, JX TI Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice SO DIABETES TC 25 Z9 25 SN 0012-1797 PD FEB PY 2004 VL 53 IS 2 BP 366 EP 375 DI 10.2337/diabetes.53.2.366 UT WOS:000188739600013 PM 14747287 ER PT J AU Ansari, MJI Salama, AD Chitnis, T Smith, RN Yagita, H Akiba, H Yamazaki, T Azuma, M Iwai, H Khoury, SJ Auchincloss, H Sayegh, MH AF Ansari, MJI Salama, AD Chitnis, T Smith, RN Yagita, H Akiba, H Yamazaki, T Azuma, M Iwai, H Khoury, SJ Auchincloss, H Sayegh, MH TI The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice SO JOURNAL OF EXPERIMENTAL MEDICINE RI Salama, Alan/B-5183-2010 OI khoury, samia/0000-0003-3198-6063 TC 366 Z9 388 SN 0022-1007 PD JUL 7 PY 2003 VL 198 IS 1 BP 63 EP 69 DI 10.1084/jem.20022125 UT WOS:000184132100007 PM 12847137 ER PT J AU Cherbas, L Hu, X Zhimulev, I Belyaeva, E Cherbas, P AF Cherbas, L Hu, X Zhimulev, I Belyaeva, E Cherbas, P TI EcR isoforms in Drosophila: testing tissue-specific requirements by targeted blockade and rescue SO DEVELOPMENT RI Belyaeva, Elena/N-8066-2015; Zhimulev, Igor/N-7978-2015 TC 184 Z9 188 SN 0950-1991 PD JAN PY 2003 VL 130 IS 2 BP 271 EP 284 DI 10.1242/dev.00205 UT WOS:000180733900004 PM 12466195 ER PT J AU Deplanque, G Ceraline, J Mah-Becherel, MCM Cazenave, JP Bergerat, JP Klein-Soyer, C AF Deplanque, G Ceraline, J Mah-Becherel, MCM Cazenave, JP Bergerat, JP Klein-Soyer, C TI Caffeine and the G2/M block override: A concept resulting from a misleading cell kinetic delay, independent of functional p53 SO INTERNATIONAL JOURNAL OF CANCER TC 21 Z9 27 SN 0020-7136 PD NOV 1 PY 2001 VL 94 IS 3 BP 363 EP 369 DI 10.1002/ijc.1478 UT WOS:000171322200009 PM 11745415 ER PT J AU Rothe, H Ito, Y Kolb, H AF Rothe, H Ito, Y Kolb, H TI Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas SO JOURNAL OF MOLECULAR MEDICINE-JMM TC 13 Z9 13 SN 0946-2716 EI 1432-1440 PD MAY PY 2001 VL 79 IS 4 BP 190 EP 197 DI 10.1007/s001090000182 UT WOS:000169096200008 PM 11409710 ER EF